Text

Calculation CA06454 Ceaea, Radiological Consequences Design Basis Calculation Using AST Rev 000
	ML053220421
Person / Time
Site:	Calvert Cliffs
Issue date:	11/03/2005
From:	; Constellation Energy Group
To:	; Office of Nuclear Reactor Regulation
References
	CA06454, Rev 000
	Download: ML053220421 (126)
	v • d • e

Enclosure (6)

CA06454 CEAEA Radiological Consequences Design Basis Calculation Using AST Calvert Cliffs Nuclear Power, Inc.

November 3, 2005

EN-1-100 Forms Appendix Revision 3 ESP No.: I ES200100401 Supp No. I 000 Rev. No. 000 Page1 of I FORM 19, CALCULATION COVER SHEET A. INITIATION (Control Doc Type - DCALC) Page l of 125 DCALC No.: CA06454 Revision No.: 000 Vendor Calculation (Check one): El Yes 0 No Responsible Group: FOSU Responsible Engineer: Gerard E. Gryczkowski B. CALCULATION ENGINEERING El Civil El Instr & Controls 0 Nuc Engrg DISCIPLINE: El Electrical El Mechanical n Nuc Fuel Mngmt El Other: E Reliability Engrg

Title:

CEA EJECTION EVENT USING ALTERNATE SOURCE TERMS Unit El I El 2 0 COMMON Proprietary or Safeguards Calculation El YES 0 NO Comments: NA Vendor Calc No.: NA REVISION No.: NA Vendor Name: NA Safety Class (Check one): 0 SR El AQ El NSR There are assumptions that require Verification during walkdown: AIT#: NA This calculation SUPERSEDES: NA C. REVIEW AND APPROVAL:

Responsible Engineer: Gerard E. Gryczkowski 06/0612005 Printed Nale and ignat e Date Independent Reviewer: Ian Sommerville J405 _ 05_- 06 Printed Name and Signature Date Approval: " K,_ - O /

Printed Name and ignafure Date IF the results or conclusions of this calculation or revision might affect a procedure or the basis of a procedure, a Change Notification Form (Form 14) shall be forwarded to the Procedure Development Unit with a summary of the calculation's purpose and results.

CA06454 Rev. 000 Page 2 of 125

2. LIST OF EFFECTIVE PAGES Page Latest Page Latest Page Latest Page Latest Page Latest Rev Rev Rev Rev Rev 001 0 002 0 003 0 004 0 005 0 006 0 007 0 008 0 009 0 010 0 011 0 012 0 013 0 014 0 015 0 016 0 017 0 018 0 019 0 020 0 021 0 022 0 023 0 024 0 025 0 026 0 027 0 028 0 029 0 030 0 031 0 032 0 033 0 034 0 035 0 036 0 037 0 038 0 039 0 040 0 041 0 042 0 043 0 044 0 045 0 046 0 047 0 048 0 049 0 050 0 051 0 052 0 053 0 054 0 055 0 056 0 057 0 058 0 059 0 060 0 061 0 062 0 063 0 064 0 065 0 066 0 067 0 068 0 069 0 070 0 071 0 072 0 073 0 074 0 075 0 076 0 077 0 078 0 079 0 080 0 081 0 082 0 083 0 084 0 085 0 086 0 087 0 088 0 089 0 090 0 091 0 092 0 093 0 094 0 095 0 096 0 097 0 098 0 099 0 100 0 101 0 102 0 103 0 104 0 105 0 106 0 107 0 108 0 109 0 110 0 111 0 112 0 113 0 114 0 115 0 116 0 117 0 118 0 119 0 120 0 121 0 122 0 123 0 124 0 125 0

CA06454 Rev. 000 Page 3 of 125

3. REVIEWER CONINIENTS (1) p. 13 - # 29 a - The basis for the values 109.2 and 49.27 is not obvious Response: Secondary steam releases from Section 9.3.

(2) p. 13 - Where do the values 0.10, 0.01, etc in the second table come from?

Response: Flashing fractions from Section 9.5.

(3) p. 13 - #29c - The basis for the values 107.28 is not obvious Response: Secondary steam releases from Section 9.4 (4) p. 20 - tj and t2 - 1800 - 21600 ? - 21600 should be 28800 Response: Corrected.

(5) p. 21 - Wt0 should be the summation of the various W's ; not Q's Response: Corrected.

(6) p. 22 - The values for hf and hf; at 538TF seem to taken at 544TF rather than 538TF.

Response: Corrected.

CA06454 Rev.000 Page 4 of 125

4. TABLE OF CONTENTS

01. COVER SHEET 1

02. LIST OF EFFECTIVE PAGES 2

03. REVIEWER COMMENTS 3

04. TABLE OF CONTENTS 4

05. INTRODUCTION 6

06. INPUT DATA 8

07. TECHNICAL ASSUMPTIONS 15

08. REFERENCES 16

09. METHODS OF ANALYSIS 18 09.1 RADTRAD Computations 18 09.2 Gas Gap, Primary, and Secondary Release Activities 18 09.3 8-Hour Secondary Steam Release Calculations 19 09.4 2-Hour Secondary Steam Release Calculations 20 09.5 Flashing Fraction Calculations 21

10. CALCULATIONS 24

11. DOCUMENTATION OF COMPUTER CODES 25

12. RESULTS 26

13. CONCLUSIONS 28

14. ATTACHMENTS 29 ATTACHMENT A: CEA EJECTION EVENT RELEASE ACTIVITIES 29 ATTACHMENT B: RCS AND SG TEMPERATURES DURING COOLDOWN FOR U2C15 32 ATTACHMENT C: INCONEL ALLOY 690 DATA 33 ATTACHMENT D: NUCLEAR INVENTORY FILE CEA14.NIF 37 ATTACHMENT E: NUCLEAR INVENTORY FILE PRII4.NIF 40 ATTACHMENT F: NUCLEAR INVENTORY FILE SEC05.NIF 43 ATTACHMENT G: NUCLEAR INVENTORY FILE CRCB63.NIF 45 ATTACHMENT H: RELEASE FRACTION AND TIMING FILE CEAFFI.RFT 56

CA06454 Rev.000 Page 5 of 125 ATTACHMENT 1: RELEASE FRACTION AND TIMING FILE CEAFFN.RFT 57 ATTACHMENT J: RELEASE FRACTION AND TIMING FILE CEAPRI.RFT 58 ATTACHMENT K: RELEASE FRACTION AND TIMING FILE CEAPRN.RFT 59 ATTACHMENT L: RELEASE FRACTION AND TIMING FILE CEASEC.RFT 60 ATTACHMENT M: RELEASE FRACTION AND TIMING FILE CEACTMT.RFT 61 ATTACHMENT N: CONVERSION FACTORS FILE FGR63.INP 62 ATTACHMENT 0: CONVERSION FACTORS FILE FGR14.INP 76 ATTACHMENT P: CONVERSION FACTORS FILE FGR05.INP 80 ATTACHMENT Q: CEAFFI OUTPUT FILE 82 ATTACHMENT R: CEAFFN OUTPUT FILE 84 ATTACHMENT S: CEAPRI OUTPUT FILE 86 ATTACHMENT T: CEAPRN OUTPUT FILE 88 ATTACHMENT U: CEASEC OUTPUT FILE 90 ATTACHMENT V: CEAFF12 OUTPUT FILE 92 ATTACHMENT W: CEAFFN2 OUTPUT FILE 94 ATTACHMENT X: CEAPR12 OUTPUT FILE 96 ATTACHMENT Y: CEAPRN2 OUTPUT FILE 98 ATTACHMENT Z: CEASEC2 OUTPUT FILE 100 ATTACHMENT AA: CEACTMT OUTPUT FILE 102 ATTACHMENT AB: ETP 97-064R CONTROL ROOM INLEAKAGE RESULTS 104 ATTACHMENT AC: ETP 01-035R PERFLUOROCARBON TRACER GAS TESTING 120 LAST PAGE OF REPORT 125

CA06454 Rev. 00 Page 6 of 125

5. INTRODUCTION 10 CFR 50 Appendix A GDC 28 requires that postulated reactivity accidents include consideration of the control rod ejection accident.

Standard Review Plan (SRP) 15.4.8 (Ref.38) and Regulatory Guide (RG) 1.77 (Ref.37) provided additional guidance for the offsite dose consequences of a Control Element Assembly Ejection Event (CEAEE). The offsite dose consequences 'vill be well within the guidelines of 10 CFR 100, where well within is defined as 25% of 10 CFR 100 exposure guideline values or 75 rem for thyroid and 6 rem for whole body doses. Two fission product release paths to the environment are considered independently.

The failed/melted fuel activity, resulting from a postulated CEAEE and consisting of 100% of the noble gases and 25% of the iodines contained in the fuel which is estimated to reach initiation of melting and 10% of the noble gases and iodines which are contained in the gas gaps of the fuel which experience clad failure, is released into the primary system, which is released in its entirety into the containment via the ruptured control rod drive mechanism housing. The released activity is instantaneously and uniformly mixed in the free volume of the containment and is then released at the containment TS leak rate into the environment.

The failed/melted fuel activity, resulting from a postulated CEAEE and consisting of 100% of the noble gases and 50% of the iodines contained in the fuel which is estimated to reach initiation of melting and 10% of the noble gases and iodines which are contained in the gas gaps of the fuel which experience clad failure, is released into the primary system, which is then transmitted into the secondary system via the TS steam generator tube leakage. The condenser is assumed to be unavailable due to loss of offsite power. Environmnental releases occur from both steam generators via the ADVs and MSSVs.

The actual doses resulting from a postulated CEAEE would be a composite of doses resulting from portions of the release going out via the containment and portions via the secondary system. If regulatory compliance to dose limits can be demonstrated for each of the scenarios, the dose consequences of a scenario that is a combination of the two will be encompassed by the more restrictive of the tvo analyzed scenarios. The fuel melting temperature criterion used for release of large fractions of fission gases will correspond to the initiation of melting. If the temperature is insufficient to cause incipient fuel melt but is sufficient to cause clad damage, then the gas gap activity of the affected fuel pins is assumed to be released instantaneously and uniformly into the primary system. The amount of activity accumulated in the fuel gap should be assumed to be 10% of the iodines and noble gases accumulated at the end of core life, assuming maximum full power operation.

10 CFR 50 Appendix A GDC 19 requires that a control room shall be provided from which actions can be taken to operate the nuclear unit safely under normal conditions and to maintain it in a safe condition under accident conditions. Adequate radiation protection shall be provided to permit access and occupancy of the control room under accident conditions without personnel receiving radiation exposures in excess of 5 rem whole body, or its equivalent to any part of the body, for the duration of the accident.

UFSAR 14.13 presents the licensing basis evaluation of the CEA Ejection Event. A CEAEE is defined as a rapid, uncontrolled, total withdrawal of a single or dual CEA, where a dual CEA is two CEAs connected to a single CEA extension shaft. The event is postulated to occur as a result of a complete instantaneous circumferential rupture of either the Control Element Drive Mechanism (CEDM) pressure housing or the CEDM nozzle from the reactor vessel closure head. The pressure of the Reactor Coolant System (RCS) causes the ejection of the extension shaft through the rupture and the movement of the CEA to a fully-withdrawn position. The most limiting CEA Ejection Event is a rapid total withdrawal of the highest worth CEA within 0.05 seconds and the breaching of the RCS pressure boundary. The immediate reactor core response is an exponential increase in nuclear power. At 112.2% (i.e.,

maximum analysis setpoint including uncertainties) of Reactor Thermal Power (RTP), a Variable High Pressure Trip (VHPT) is initiated. The negative Doppler feedback due to the increasing fuel temperature partially offsets the ejected CEA worth and terminates the power excursion. The insertion of the CEAs will terminate the event.

Although both the HFP and HZP cases were analyzed, the HFP case is more limiting with respect to dose (more failed fuel and a higher steaming potential). The design basis CEA Ejection Event accounts for extended burnup.

Additional evaluations concluded that ZIRLO, Erbia, and replacement steam generators will not significantly impact the results, and thus the current results remain bounding. The worst-case results show that no fuel rod will

CA06454 Rev.000 Page 7 of 125 experience clad damage and only a small fraction will reach incipient centerline melt condition (8%). The results are well within the 10 CFR 100 exposure guidelines, specifically Thyroid<50 Rem and Whole Body<1.5 Rem.

Previously, power reactor licensees have typically used the U.S.A.E.C Technical Information Document TID-14844, "Calculation of Distance Factors for Power and Test Reactor Sites," (Ref.18) as the basis for Design Basis Analysis (DBA) source terms. TID-14844 is referenced in 10 CFR 100.11, the power reactor siting regulation, which contains offsite dose limits in terms of whole body and thyroid doses. In December 1999, the Nuclear Regulatory Commission (NRC) issued a new regulation, 10 CFR 50.67, "Accident Source Term," which provided a mechanism for licensed power reactors to replace the traditional accident source term used in their DBA analyses with an Altemate Source Term (AST) methodology. Regulatory guidance for the implementation of these ASTs is provided in Regulatory Guide (RG) 1.183, "Alternative Radiological Source Terms for Evaluating Design Basis Accidents at Nuclear Power Reactors" (Ref.08). Section 50.67 of 10 CFR requires a licensee seeking to use AST to apply for a license amendment and requires that the application contain an evaluation of the consequences of affected DBAs. As part of the implementation of the AST, the Total Effective Dose Equivalent (TEDE) acceptance criterion of 10 CFR 50.67 replaces the previous whole body and thyroid dose guidelines of 10 CFR 100.11 and 10 CFR 50, Appendix A, GDC-19 for the loss-of-coolant accident (LOCA), the main steam line break (MSLB), the steam generator tube rupture (SGTR), the seized rotor event (SRE), the fuel handling accident (FHA), and the control element assembly ejection accident (CEAEE). The TEDE accident dose criteria are listed in Table 6 of RG 1 183 for offsite doses and in 10 CFR 50.67 for control room doses, which limit is 5 Rem TEDE. The Nuclear Steam Supply System (NSSS) response to the CEAEE was simulated using the CESEC computer code for the eight hour accident scenario.

The current work utilizes the alternate source term methodology of 10 CFR 50.67 and Regulatory Guide 1.183 to calculate offsite and control room doses for a CEAEE. The CEAEE was evaluated for both the containment and secondary release pathways. In addition, the secondary pathway was analyzed for both a 2 hour2.314815e-5 days 5.555556e-4 hours 3.306878e-6 weeks 7.61e-7 months and an 8 hour9.259259e-5 days 0.00222 hours 1.322751e-5 weeks 3.044e-6 months time to shutdown cooling (SDC). A bounding control room inleakage value of 3500 cfm was assumed. The following modifications and TS changes are proposed to comply with regulatory requirements.

Modification of the control room emergency ventilation system to a nominal 10000 cfm flow with a 90%

filtration efficiency for elemental and organic iodine and 99% for particulate iodine was credited.

Also credited was installation of automatic isolation dampers and radiation monitors at Access Controls 11 and 13 on the Auxiliary Building Roof. This modification limits activity ingress into the control room to either the WVest Road Inlet or the Turbine Building, thus limiting the atmospheric dispersion coefficient value.

The Technical Specification (TS 3.4.15) limit for RCS activity was reduced from 1.0 pCi/gm to 0.5 pCi/gm.

The maximum allowable containment leakage rate La contained in the Containment Leakage Rate Testing Program of TS 5.5.16 was reduced from 0.20 percent per day at Pa to 0.16 percent per day at Pa.

The exclusion area boundary (EAB), low population zone (LPZ), and control room (CR) doses for the design-basis CEAEE calculated in Attachments Q - AA are detailed in the following table.

Results EAB LPZ CR Rem Rem Rem 8 Hour Secondary Pathway 0.32616 0.08735 4.59461 2 Hour Secondary Pathway 0.35658 0.08394 1.45292 30 day Containment Pathway 0.4567 0.1187 0.9679 CEAEE Worst-Case Doses 0.5000 0.2000 4.6000 Regulatory Limits 6.3000 6.3000 5.0000 Note that all values are below the regulatory limits.

CA06454 Rev.000 Page 8 of 125

6. INPUT DATA The input data to determine the exclusion area boundary (EAB), low population zone (LPZ), and control room (CR) doses from a CEAEE are the following:

(01) Initial thermal power is 2754 MWt (UFSAR 3.2.1/Ref.1).

(02) The pin power peaking factor is 1.70. Per the Core Operating Limits Reports for Units I and 2, (Refs.2-3), the total integrated radial peaking factors (FIT) are less than or equal to 1.65. For conservatism, a pin power peaking factor of 1.70 will be used in this work.

(03) The isotopic half-lives (t1 ) were extracted from Ref.06 and are listed in column A of Attachment A. The decay constants (N.) listed in column B of Attachment A, are readily calculated via the following algorithm:

A,= In(2) I ti (04) Failed fuel for the CEA Ejection Event falls into three categories: clad failure, incipient centerline fuel melt, and full centerline fuel melt. Bechtel in 1970 (Ref.9) calculated EAB doses of 12.06 Rem Thyroid and 0.028 Rem Whole Body and LPZ doses of 4.22 Rem Thyroid and 0.011 Rem Whole Body assuming a HFP incipient centerline melting fraction of 3.6%.

Based on a NRC Request for Additional Information in 1987 (Ref.10), Combustion Engineering performed the NRC requested dose calculations at the EAB for two hours following a CEA ejection accident initiated from HZP for Unit 2 Cycle 8 in which 10% of the fuel fails. This assumption was very conservative, since it implied that all the fuel which experienced clad failure also reached the incipient fuel melting threshold. The CEA ejection analysis performed for Unit 2 Cycle 8 predicts that less than 1% of all the fuel reaches this threshold. This was acknowledge by the NRC in the SER of 6/30/87 (Ref.l 1).

Refs.33-34 concluded that no fuel pins will experience fuel or cladding damage or incipient centerline melt conditions during a CEAEE for UIC12 HZP and HFP cores. For the Unit I Cycle 15 CEA Ejection Event analysis (Ref. 12), the fraction of fuel experiencing incipient centerline melting was 8.0% for HFP and 0.824% for HZP.

The CCNPP current design basis, UFSAR 14.13, shows that no fuel rod will experience clad damage and only a small fraction will reach incipient centerline melt condition (8%). The results are well within the 10 CFR 100 exposure guidelines, specifically Thyroid<50 Rem and Whole Body<1.5 Rem.

Thus, an overall fuel damage fraction of 10% will be assumed per our design and licensing bases, of which 8%

experiences incipient centerline melting and 2 % clad damage per the most conservative analysis of record. This assumption is listed in columns L and M of Attachment A.

(05) Per Regulatory Guide 1.183 (Ref.8) and Regulatory Guide 1.77 (Ref.37), the release fractions are the following:

the amount of activity accumulated in the fuel gap should be assumed to be 10% of the iodines and noble gases (Column F of Attachment A).

For activity released directly to the containment, 100% of the noble gases and 25% of the iodines contained in the fuel which is estimated to reach initiation of melting are assumed to be released to the containment (Column E of Attachment A).

For activity released to the primary system for release via the secondary system via primary-to-secondary leakage, 100% of the noble gases and 50% of the iodines contained in the fuel which is estimated to reach initiation of melting are assumed to be released to the primary coolant (Column D of Attachment A).

CA06454 Rev.000 Page 9 of 125 (06) Per Refs.8 and 37, the released activities are assumed to be released instantaneously and homogeneously throughout the containment or the primary system at the initiation of the accident. This is incorporated into the failed fuel iodine and noble gas release fraction and timing files.

(07) Based on Inputs 4, 5, and 6, the release fraction and timing input files can be generated.

Files Release Timingi Iodine Release Noble Gas Release Attachment Hours Fraction Fraction CEAFFL.RFT 0.0001 0.08*0.5+0.02-0.1 =0.042 0.0000 H CEAFFN.RFT 0.0001 0.0000 0.081.0+0.02*0.1 =0.082 I CEAPRI.RFT 0.0001 1.0000 0.0000 J CEAPRN.RFT 0.0001 0.0000 1.0000 K CEASEC.RFT 0.0001 1.0000 0.0000 L CEACTMT.RFT 0.0001 0.08-0.25+0.02'0.1=0.022 0.0811.0+0.0210.1=0.082 M (08) The dose conversion factors (DCFs) were extracted from Refs.20-21 and inserted into input files for use by RADTRAD. This data is included in the Conversion Factor Files FGR63.INP in Attachment N for use with failed fuel isotopics, FGRI4.INP in Attachment 0 for use with primary system isotopics, and FGRO5.INP in Attachment P for use with secondary system isotopics. Note that the cloudshine data in the Conversion Factor Files corresponds to the FGR-12 data, while the inhaled chronic data in the Conversion Factor Files corresponds to the worst-case effective data in FGR-I 1. The remaining data in the Conversion Factor Files is extraneous and not used by RADTRAD.

(09) Per Ref.08, iodine releases from the steam generators to the environment should be assumed to be 97%

elemental and 3% organic. Iodine released from the failed fuel is assumed to be 95% particulate, 4.85% elemental, and 0.15% organic.

(10) For the secondary system release pathway, the duration of the cooldown from HFP, defined as 574.5 0F and 2250 psia per UFSAR Table 4.1 and Figure 4.9, to SDC, defined as 300'F and 270 psia per the EOPs, is limited by the TS 3.4.3 maximum cooldovn rate of 100°F/hr. Two CEAEE accident durations are utilized. The first scenario assumes a long 8 hour9.259259e-5 days 0.00222 hours 1.322751e-5 weeks 3.044e-6 months cooldown period based on actual plant operation (See Attachment B for the Unit 2 Cycle 15 cooldown to SDC). The second scenario assumes a 2 hour2.314815e-5 days 5.555556e-4 hours 3.306878e-6 weeks 7.61e-7 months cooldown period to maximize the two-hour EAB doses.

For the containment release pathway, the accident duration is 30 days per RG 1.183 (Ref.08).

(11) Primary and Secondar i Masses and Volumes I RCS(cf) 7286.18 Total RCS and PZR volumes normalized to STP Vrcs(cl) _ 9576 RCS volume per UFSAR T4.1 vpzrtcf) 600 PZR volume per UFSAR T4.7 vrcs(cf/lbm) 0.022132 Ref.31 Specific Vol @ 574.5 F and 2250 psia - UFSAR T4.1 F4.9 vpzr(cflbm) 0.02703 Ref.31 Specific Vol 0_ 653 F and 2250 psia - UFSAR T4.7 Mrcs(lbm) 432676.67 _ RCS mass: Vrcs/vrcs Mpzr(lbm) 22197.56 PZR mass: Vpzr/vpzr Mtot(Ibm-gm) 454874.23 206327482 RCS + PZR mass: Mrcs+Mpzr vstp(cflbm) 0.016018 Ref.31 Specific Vol @ 1 gm/cc Vtot(cf) 7286.18 Mtot*vstp @ STP 2 SG(cD 4420.04 Total SG volume normalized to STP M2sg(Ibm-g) 275942.00 125165188 SG mass per Ref.32 Sheet 30 - 102% Full Power sg(co 4420.04 M2sg-vstp t STP 3 AFW(cf) 10000.00 Auxiliary Feedwater Volume 4 Environment 5 Control Room 289194 cf Control Room Volume (Ref.19)

CA06454 Rev.O00 Page 10 of 125 (12) Containment volume:

Net free volume: 1.989E+06 cf (UFSAR Tab.14.20-3, Ref.39)

Containment sprayed volume: 1.446E+06 cf Volume fraction: 0.7273 (Ref.40)

Containment unsprayed volume: 0.543E+06 cf Volume fraction: 0.2727 (Ref.40)

Note: Assumes sprayed and unsprayed volume fractions remain unchanged from Ref.40.

(13) Containment sprays were not credited in this work.

(14) Per UFSAR 6.7.2, SIAS automatically starts three recirculation filter units of 20000 +/- 10% per TS 5.5.11. Each unit has the capacity of 50% of the design air flow and consist of activated charcoal filters preceded by HEPA filters.

If offsite power is not available, the emergency diesel generators are started. Each of tvo emergency diesel generator busses carries the load of two recirculation filter units (UFSAR Table 8-7). Thus for the CEAEE, two 18000 cfm recirculation filter units are credited after a 20 minute delay, consistent with manual initiation. A filter efficiency of 90% for inorganic iodine species and 30% for organic iodine species was assumed per RG 1.52 (Ref.28).

(15) Reduction in aerosol airborne radioactivity in the containment by natural deposition within the containment wvas credited per RG 1.183 (Ref.08). The 10th percentile Powers aerosol decontamination model (Ref.41) for PWR design basis accidents as incorporated into the RADTRAD analysis code was utilized. Aerosol particles grow by coagulating with other aerosol particles or because steam condenses on them thus gravitational settling of aerosols is usually the dominant aerosol removal process. Plateout of elemental and organic iodine species was not credited in this work.

(16) Three 110000 cfm cooling units are normally in operation in containment. Upon receipt of a SIAS, the fourth cooling unit is automatically started on the 55000 cfm low speed setting and simultaneously the other three units are switched to low speed operation. If offsite power is not available, the emergency diesel generators are started. Each of two emergency diesel generator busses carries the load of two cooling units (UFSAR 6.5.3 and 6.5.4). Thus for the CEAEE, two 55000 cfm cooling units are credited.

(17) The maximum allowable containment leakage rate La contained in the Containment Leakage Rate Testing Program of TS 5.5.16 will be reduced from 0.20 percent per day at Pa to 0.16 percent per day at Pa. Per RG 1.183, the containment should be assumed to leak at the leak rate incorporated in the technical specifications for the first 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months , and at 50% of this leak rate for the remaining duration of the accident.

(18) Per Ref.08, the primary to secondary leakage of 200 gpd (TS 3.4.13) should be assumed to exist until shutdown cooling is in operation and releases from the steam generators have been terminated. Per the Emergency Operating Procedures, Shutdown Cooling (SDC) commences when the Core Exit Thermocouple (CET) temperatures are less than 300'F and when the pressurizer pressure is less than 270 psia.

(19) The breathing rates are extracted from Ref.08:

Time Breathing Rate (hours) (m3/sec) 0-8 3.5E-04 8-24 1.8E-04 24-720 2.3E-04 (20) The control room occupancy factors are extracted from Ref.08:

CA06454 Rev.OOO Page 11 of 125 Time Occupancy (hours) Factor 0-24 1.0 24-96 0.6 96-720 0.4 (21) Control room inleakage: The control room inleakages for the two trains Air Conditioning Units (ACU) 11 and 12 were measured by NUCON International Inc. via sulfur hexaflouride (SF6 ) tracer gas tests as documented in Refs.23-26 (Attachment AB). An additional inleakage test was performed by Brookhaven National Laboratory (BNL) via a perfluorocarbon tracer gas (PFT test as documented in Ref.27 (Attachment AC).

ACU 11 ACU 12 SF6 Test I/I 11/97 4300+/-300 cfm 3000+/-300 cfm SF6 Test 11/11/97 3600+/-600 cfm 2550+/-450 cfm SF6 Test 11/11/97 2900X250 cfm 2750+/-380 cfm SF 6 Test 1/18/00 2600+/-200 cfm 3000+/-250 cfm PFT Test 5/1/02 2930I185 cfm 2930+/-185 cfm The latest SF 6 and PFT tests show fairly good agreement, as indicated above. A conservative value of 3500 cfm will be utilized in this work.

The control room inleakage points were deduced from the PFT testing carried out by Brookhaven National Laboratory and include the Auxiliary Building West Road inlet (WR), the Turbine Building inlet (TB), Access Control 11 (ACI 1), Access Control 13 (AC13), the Switchgear Rooms (SWGRs), and the Main Steam Isolation Valve Rooms (MSIVs). ACI I and AC13 will be equipped with dampers and radiation monitors, which will isolate this leakage path in case of an accident. The SWGRs are in continual recirculation mode and thus are also isolated from the environment. The MSIV rooms are also isolated from the environment, except for the Main Steam Line Break Accident which occurs in these rooms, due to the thermal buoyancy of the air in these rooms and due to the J-neck exhaust. For conservatism, all of the measured inleakage will be assumed to enter the control room from the most conservative pathway of either the West Road or Turbine Building inlets.

(22) Control room recirculation flow:

Flowrate: 10000.+ 1000 cfm (Note that this value will be the result of a new modification.)

Initiation delay time: 20 minutes (Ref.29 conservatively assumes a 20 minute time delay for a manual start of the Control Room Emergency Ventilation System.)

Filter efficiencies: 90% for elemental and organic iodine species (Ref.28 and Technical Specification 5.5.11 allow a 95% filter efficiency for a 2" activated carbon bed depth; however, NRC Generic Letter 99-02 (Ref.30) requires plants that test their activated charcoal to the ASTM D3803-1989 standards to use a safety factor of two. This results in a maximum credited efficiency of 90% for accident analyses.)

Filter efficiencies: 99% for particulate iodine (Per Ref.28, an engineered-safety-feature air filtration system satisfying a filter penetration less than 0.05% at rated flow can be considered to warrant a 99% removal efficiency for particulates in accident dose evaluations.)

(23) The atmospheric dump valve (ADV) to site boundary, two-hour, atmospheric dispersion coefficient of 1.44E-4 sec/mi3 was calculated via the Gifford wake model extracted from UFSAR 2.3.6, as follows xYQ = I/[b * (Orauy + cA)] = 1.44E-4 sec/in 3

CA06454 Rev. 000 Page 12 of 125 where for 150 m exclusion area boundary distance and 5% frequency p = average wind speed = I rL/sec oy= standard deviation of the distribution in the lateral direction = 92 m (UFSAR Table 2-14) ou= standard deviation of the distribution in the vertical direction = 24 m (UFSAR Table 2-14) c= wake factor A= cross-sectional area of structure from which material is released = 0 m (24) The containment to site boundary X/Q of 1.30E-4 sec/m3 was extracted from UFSAR 2.3.6.

(25) The atmospheric dispersion coefficients from the ADV to the low population zone (2 miles)

(UFSAR Fig.2.3-3/UFSAR 14. 4.3)

Time X/Q (hours) (sec/rn3 )

0-2 3.39E-05 2-24 2.20E-06 24-720 5.40E-07 Note that the 0-2 hour value was adjusted via the Gifford wake model for a point release rather than a containment release.

(26) The atmospheric dispersion coefficients from the containment to the low population zone (2 miles)

(UFSAR Fig.2.3-3/UFSAR 14.24.3)

Time X/Q (hours) (sec/m 3) 0-2 3.30E-05 2-24 2.20E-06 24-720 5.40E-07 (27) Atmospheric dispersion coefficients from the ADV to the Control Room: (Ref. 19)

The initial secondary activity together with initial primary activity and failed fuel activity released to the primary that then leaks into the secondary will escape out of the steam generators via the ADVs. The main control room inleakage points include the west road inlets, the turbine building, and Access Controls 11 and 13 on the Auxiliary Building roof. Installation of automatic isolation dampers and radiation monitors at Access Controls 11 and 13 on the Auxiliary Building Roof are credited in this work.

Atmospheric Dispersion Coefficients (sec/rn) radvl-tb radv2-tb radvl-wr radv2-wr 0-2 hr 3.70E-03 3.83E-03 1.40E-03 1.35E-03 2-8 hr 2.78E-03 3.25E-03 1.08E-03 9.39E-04 8-24hr 1.03E-03 1.32E-03 4.73E-04 3.78E-04 1-4 days 8.24E-04 9.92E-04 3.48E-04 2.52E-04 4-30 days 6.31 E-04 7.92E-04 2.44E-04 1.66E-04 The atmospheric dispers ion coefficients corresponding to the Unit 2 ADV to the turbine building wvill be conservatively utilized in this work. Note that neither thermal buoyancy nor vertical effluent velocity are credited in this work.

(28) Atmospheric dispersion coefficients from the containment to the Control Room: (Ref.19)

The failed fuel activity released into the containment atmosphere is assumed to escape into the environment through the containment wvall. Note that leakage through containment penetrations into the auxiliary building penetration room, which has a filtered release path into the environment, is not credited for this accident. The main control room

CA06454 Rev. 00 Page 13 of 125 inleakage points include the west road inlets, the turbine building, and Access Controls I I and 13 on the Auxiliary Building roof. Installation of automatic isolation dampers and radiation monitors at Access Controls 11 and 13 on the Auxiliary Building Roof are credited in this work.

Atmospheric Dispersion Coe ficients (sec/r 3/

U1-WR U2-WR U1-TB U2-TB 0-2 hr 1.11E-03 1.04E-03 1.02E-03 1.02E-03 2-8 hr 7.29E-04 5.95E-04 7.1 0E-04 7.98E-04 8-24hr 3.19E-04 2.29E-04 2.57E-04 3.19E-04 1-4 days 2.36E-04 1.64E-04 2.19E-04 2.56E-04 4-30 days 1.98E-04 1.14E-04 1.77E-04 2.14E-04 The atmospheric dispersion coefficients corresponding to the Unit 1 containment to the wvest road inlet on the auxiliary building will be conservatively utilized in this work.

(29) Additional RADTRAD Inputs for 5 secondary release pathway cases:

(a) Failed fuel and primary iodine via the 8 hour9.259259e-5 days 0.00222 hours 1.322751e-5 weeks 3.044e-6 months secondar release pathyay:

Pathways: Iodine _ cfm 1 T rcs-env 0.0-0.25 hr 200gpd 0.10 0.001857 0.25-8.0 hr 200 gpd 0.01 0.000186 2 rcs-sg 0.0-0.25 hr 200 gpd 0.90 0.016710 0.25-8.0 hr 200 gpd 0.99 0.018381 3 sg-env 0.0-0.5 hr 109.2 cfm 0.01 1.0920 0.5-8.0 hr 49.27 cfm 0.01 0.4927 4 afw-sg 0.0-0.25 hr 1.0753

= 0.25-0.50 hr 1.0736

= 0.50-8.00 hr 0.4743 5 env-cr 3500 cfm 3500 6 cr-env 3500 cfm 3500 (b) Failed fuel and pri ary noble gas via the 8 hour9.259259e-5 days 0.00222 hours 1.322751e-5 weeks 3.044e-6 months secondary rel ease pathway:

Pathways: NG cfm 1 rcs-env 0-8 hrs 200 gpd 0.018567 2 rcs-s 0-8 hrs NA 3 sg-env 0-8 hrs NA 4 ah 0-8 hrs NA 5 env-cr 0-720 hrs 3500 cfm 3500 6 cr-env 0-720 hrs 3500 cfm 3500 (c) Failed fuel and primary iodine via the 2 hour2.314815e-5 days 5.555556e-4 hours 3.306878e-6 weeks 7.61e-7 months secondary release pathway:

Pathways: Iodine P l cfm 1 rcs-env 0.0-0.25 hr 200 gpd 0.10 0.001857 0.25-2.0 hr 200 gpd 0.01 0.000186 2 rcs-sg 0.0-0.25 hr 200 gpd 0.90 0.016710 0.25-2.0 hr 200 gpd 0.99 0.018381 3 sg-env 0.0-0.5 hr 107.28 cfm 0.01 1.0728 0.5-2.0 hr 107.28 cfm 0.01 1.0728 4 afw-sg 0.0-0.25 hr l 1.0560 0.25-0.50 hr l 1.0544 0.50-2.00 hr _ 1.0544

CA06454 Rev.OOO Page 14 of 125 l 5 l env-cr I l 3500cfm I l 3500 l 6 l cr-env I 1 3500 cfm I l 3500 (d) Failed fuel and primary noble gas via the 2 hour2.314815e-5 days 5.555556e-4 hours 3.306878e-6 weeks 7.61e-7 months secondary release pathway:

Pathways: NG cfm 1 rcs-env 0-2 hrs 200 gpd 0.018567 2 rcs-sg 0-2 hrs NA 3 sg-env 0-2 hrs NA 4 afw-sg 0-2 hrs NA S env-cr 0-720 hrs 3500 cfm 3500 6 cr-env 0-720 hrs 3500 cfm 3500 (e) Failed fuel iodine and noble gas via the containment release pathway:

Pathways 1 csp-cunsp 110000 cfm 0-720 hrs 2 cunsp-csp 110000 cfm 0-720 hrs 3 csp-env 0.16%/day l 0-24 hrs csp-env 0.08%/day 24-720 hrs 4 cunsp-env 0.16%/day 0-24 hrs l cunsp-env 0.08%/day 24-720 hrs 5 l env-cr 3500 cfm 0-720 hrs 6 l cr-env 3500 cfm 0-720 hrs

CA06454 Rev.OO Page 15 of 125

7. TECHNICAL ASSUMPTIONS The following technical assumptions were utilized in this work:

(01) The 8% of the fuel that experiences incipient centerline melting and the 2% that experiences clad failure are assumed to occur in the highest powered fuel rods.

(02) No credit is taken for the containment spray system.

(03) Two containment filters are credited at 20 minutes into the accident, consistent with manual operation.

(04) No credit is taken for deposition of the plume on the ground or decay of isotopes in transit to the site boundary.

(05) Buildup of daughter nuclides is taken into account as source term nuclides decay.

(06) Note that per the requirements of Regulatory Guide (RG) 1.183 (Ref.08), the release of fission products from the secondary system should be evaluated with the assumption of a coincident loss of offsite power (LOOP). Thus, the use of condensers can not be credited in this work.

(08) The steam generator tubes remain covered for the duration of the event, therefore the gap iodines have a partition coefficient of 100 in the steam generators. A conservative flashing fraction is assumed (10% for the first 15 minutes and 1% thereafter); however, no credit for scrubbing in the steam generator is assumed.

(09) Based on the large quantity of material ejected from the primary system during the containment release pathway, a Safety Injection Actuation Signal (SIAS) will be generated due to high containment pressure (>4.25 psig) or low pressurizer pressure (<1600 psia). This is consistent with the RG 1.183 assumption of peak accident containment pressure for the CEAEE.

CA06454 Rev.000 Page 16 of 125

8. REFERENCES (01) "Power Levels of Nuclear Power Plants", Regulatory Guide 1.49 Rev. l, 12/73.

(02) CCNPP Core Operating Limits Report for Unit I Cycle 17 Rev. I (03) CCNPP Core Operating Limits Report for Unit 2 Cycle 16 Rev.0 (04) "Primary and Secondary Isotopic Calculations", CA06422 (05) "Control Room Habitability Source Term Calculations", CA06358.

(06) "Chart of the Nuclides - Nuclides and Isotopes", GE Nuclear Energy, Fifteenth Edition.

(07) "Gas Gap Isotopic Fraction Calculations", CA0642 1.

(08) "Alternate Radiological Source Terms for Evaluating Design Basis Accidents at Nuclear Power Reactors",

Regulatory Guide 1.183 (09) Bechtel Project 6750-01, 12/1/1970, "CEA Ejection Incident for FSAR Section 14.13" (10) RAI 3/27/1987, "Unit 2 Cycle 8 Reload - Request for Additional Information" (I1) SER 6130/1987, "Revised Safety Evaluation Supporting Amendment No. 108 to Faciility Operating License No.

DPR-69.

(12) CA04817, A-CCI-FE-0101 Rev.4, "CCNPP Unit I Cycle 15 CEA Ejection" (13) "RADTRAD: A Simplified Model for Radionuclide Transport and Removal and Dose Estimation",

NUREG/CR-6604, SAND98-0272 (14) "RADTRAD: A Simplified Model for Radionuclide Transport and Removal and Dose Estimation",

NUREG/CR-6604, SAND98-0272/1, Supplement 1.

(15) "RADTRAD: A Simplified Model for Radionuclide Transport and Removal and Dose Estimation",

NUREG/CR-6604, Supplement 2 (16) "RADTRAD 3.03 Installation and Verification on PCB386", CA062IO (17) "RADTRAD 3.03 Validation", CA06207 (18) "Calculation of Distance Factors for Power and Test Reactor Sites", TID-14844, 3/23/62.

(19) CA06012: CRHVAC Atmospheric Dispersion Coefficient Calculations (20) Federal Guidance Report (FGR) I1, "Limiting Values of Radionuclide Intake and Air Concentration and Dose Conversion Factors," 1989 (21) Federal Guidance Report (FGR) 12, "External Exposure to Radionuclides in Air, Water, and Soil," 1993, (22) "Fuel Performance Analysis", Westinghouse Calculation CN-WFE-02-45, Rev.0

CA06454 Rev.000 Page 17 of 125 (23) "Control Room IIVAC Inleakage Test", ETP-97-064R Rev.0, 11/11/1997 (First Run)

(24) "Control Room HVAC Inleakage Test", ETP-97-064R Rev.0, 11/11/1997 (Third Run)

(25) "Control Room HVAC Inleakage Test", ETP-97-064R Rev.0, 11/11/1997 (Fourth Run)

(26) "Control Room LIVAC Inleakage Test", ETP-97-064R Rev.0, 1/18/2000.

(27) "Perfluorocarbon Tracer Gas Testing", ETP-01-035R Rev.0, 5/1/2002 (28) ) Regulatory Guide 1.52 Rev.2: "Design, Testing, and Maintenance Criteria for Post Accident ESF Atmosphere Cleanup System Air Filtration and Absorption Units of LWRs" (29) "Control Room Recirculation Filter Initiation Time Delay", NEU-95-026 (30) NRC Generic Letter 99-02: Laboratory Testing of Nuclear-Grade Activated Charcoal (31) ASME Steam Tables, 5th Edition, United Engineering Center, N.Y., N.Y.

(32) CA05725, WEC-222-781 I-A45: Parameter Listing for RSG Inputs for Calvert Cliffs Units I & 2 (33) CA04836, A-CCI-FE-0086 R5: UIC15 Evaluation of Non-LOCA Transient Analyses and Summary of Setpoint Analyses Inputs (34) CA05346, A-CC2-FE-0097 R3: U2C14 Evaluation of Non-LOCA Transient Analyses and Summary of Setpoint Analyses Inputs (35) CA05432, A-CC-FE-0100 Rev.1, "CCNPP Units I and 2 CEA Ejection Analysis" (36) CA05432-0001, A-CC-FE-0100 Rev.4, "CCNPP Units I and 2 CEA Ejection Analysis" (37) Regulatory Guide 1.77 "Assumptions Used for Evaluating a Control Rod Ejection Accident for PWRs" (38) SRP 15.4.8: Spectrum of Rod Ejection Accidents (PWR)

(39) Bechtel letter from A.J.Amold to C.H.Poindexter, 4/4/75, CDCC#63854.

(40) "Offsite and Control Room Doses Following a LOCA", Bechtel Calculation M-89-33 Rev.3, 7/9/91.

(41) D.A.Powers, et al, "A Simplified Model of Aerosol Removal by Natural Processes in Reactor Containments,"

NUREG/CR-6189, USNRC, July 1996.

(42) CA03516, A-CC-FE-0060 Rev. 1, "Calvert Cliffs Units I and 2 Seized Rotor Analysis" (43) SP-08 11: RSG Design Specification (44) Branch Technical Position ASB 9-2: Residual Decay Energy for LWRs for Long-Term Cooling

CA06454 Rev.000 Page 18 of 125

9. METHODS OF ANALYSIS (9.1) RADTRAD Computations The current work re-analyzes control room habitability for a CEAEE based on the alternate source term methodology of Ref.08 and control room inleakage of 3500 cfm This was accomplished by utilizing the RADTRAD computer code (Refs.13-15).

The RADTRAD computer code calculates TEDE and thyroid doses to personnel at the site boundary, low population zone, and control room per 10 CFR 50.67 resulting from any postulated accident which releases radioactivity within the containment, spent fuel pool, or within any primary or secondary system. RADTRAD models the transport of up to 63 radionuclides from the source region, through a secondary region if any, and then to the environment and to the control room. The code includes the capability to model time-dependent activity release; time-dependent spray/filtration/deposition removal processes, piping/filter/inleakage transfer mechanisms, atmospheric dispersion; and natural decay. RADTRAD is documented and benchmarked in Refs.13-17.

The CEAEE model is constructed in three parts: containment release pathway, 8-hour secondary release pathway, and 2-hour secondary release pathway. The containment release pathway model is composed of iodine and noble gas radionuclides generated from incipient centerline melted and clad ruptured failed fuel. The secondary release pathway model is composed of iodine and noble gas radionuclides generated from incipient centerline melted and clad ruptured failed fuel, iodine and noble gas radionuclides from the primary TS activity limit, and iodine radionuclides from the secondary TS activity limit.

For the containment release path scenario, the failed/melted fuel activity, resulting from a postulated CEAEE and consisting of 100% of the noble gases and 25% of the iodines contained in the fuel which is estimated to reach initiation of melting and 10% of the noble gases and iodines which are contained in the gas gaps of the fuel which experience clad failure, is released into the primary system, which is released in its entirety into the containment via the ruptured control rod drive mechanism housing. The released activity is instantaneously and uniformly mixed in the free volume of the containment and is then released at the containment TS leak rate into the environment.

Cleanup via aerosol natural deposition and containment filtration is credited, although the two containment filters are assumed to start at 20 minutes into the accident consistent with manual initiation.

For the secondary release path scenario, the failed/melted fuel activity, resulting from a postulated CEAEE and consisting of 100% of the noble gases and 50% of the iodines contained in the fuel which is estimated to reach initiation of melting and 10% of the noble gases and iodines which are contained in the gas gaps of the fuel which experience clad failure, is released into the primary system, which is then transmitted into the secondary system via the 200 gpd TS steam generator tube leakage. The condenser is assumed to be unavailable due to loss of offsite power. Environmental releases occur from both steam generators via the ADVs and MSSVs. No cleanup mechanisms are assumed in the primary or secondary systems.

The activity released to the environment is transported to the site boundary and to the control room via appropriate atmospheric dispersion coefficients. While time-dependent control room inleakage can be modeled by RADTRAD, it is a constant 3500 cfm in this work. Control room filtration is credited based on a modification to increase recirculation flow to a nominal 10000 cfm. A charcoal filter efficiency of 90% is credited for elemental and organic iodine, while a HEPA efficiency of 99% is credited for particulate iodine. The control room and site boundary doses are calculated based on appropriate breathing rates and occupancy factors and on FGR 11 and 12 dose conversion factors.

(9.2) Gas Gap, Primary, and Secondary Release Activities An EXCEL spreadsheet (CEA.XLS(CEAEE.SG) displayed in Attachment A) was developed to calculate the activity released to the primary and secondary systems post-CEAEE. Three sets of isotopic activities wvere generated:

. Iodine and noble gas activities released via fuel failure

CA06454 Rev.000 Page 19 of 125

Technical Specification Primary iodine and noble gas activities

Technical Specification Secondary iodine activities (9.2.a) Failed Fuel Release Activities The isotopic activities released from the incipient centerline melted and clad ruptured failed fuel in Ci/MWt can be calculated from the total core isotopic activities extracted from case CRCB in Ref.5. For the containment pathway, all 63 isotopic activities are stored in the nuclear inventory file CRCB63.NIF listed in Attachment G. For the secondary pathway, the 14 relevant iodine and noble gas isotopic activities are stored in the nuclear inventory file CEA14.NIF, listed in Attachment D and also in column C of Attachment A. To utilize these isotopic source terms, it is necessary to multiply them by the relevant power level in MWt and by the relevant release fractions.

(9.2.b) Primary Specific Activities The initial primary specific activities in yCi/gm consistent with the TS 3.4.15 1.0 pCilgm limit were extracted from Ref.4 and are listed in column G of Attachment A. These were converted to total primary isotopic source terms in Attachment A column H via the followving algorithm:

Ajo = ASTI

MRCS

0.000001 Ci where ASTI = Isotopic activity per unit mass (pCi/gm) (Ref.04)

MRCS = Water mass in RCS (gm)

The total primary isotopic source term was then halved in Attachment A column I to reflect that the TS 3.4.15 limit for primary activity will be reduced from 1.0 pCi/gm to 0.5 pCi'gm.

These isotopic activities were inserted into the nuclear inventory file PRI14.NIF for use by RADTRAD. The file is listed in Attachment E and consists of the 14 primary noble gas and iodine isotopes. The activities are the total primary activities and are not per unit power. Thus a power of one should be designated when employing this file.

(9.2.c) Secondary Specific Activities The initial secondary specific activities in uCi/gm consistent with the TS 3.7.14 0.1 uCi/gm limit were extracted from Ref.4 and are listed in column J of Attachment A. These were converted to total secondary isotopic source terms in Attachment A column K via the following algorithm:

Aio = ASTi

M2SG

0.000001 Ci where AST, = Isotopic activity per unit mass (uCilgm) (Ref.04)

M2SG = Water mass in both SGs (gm)

These isotopic activities were inserted into the nuclear inventory file SECO5.N[F for use by RADTRAD. The file is listed in Attachment F and consists of the 5 iodine isotopes. The activities are the total secondary activities and are not per unit power. Thus a power of one should be designated when employing this file.

(9.3) 8-Hour Secondary Steam Release Calculations The methodology for the 8 hour9.259259e-5 days 0.00222 hours 1.322751e-5 weeks 3.044e-6 months cooldovnm from HFP to SDC was extracted from Ref.42. Although it was developed for the Seized Rotor Event, it should be applicable with minor corrections to the CEAEE. The steam release from the first 1800 seconds was taken directly from a CESEC execution. The steam release from 1800 seconds to 8 hours9.259259e-5 days 0.00222 hours 1.322751e-5 weeks 3.044e-6 months is based on a simple energy balance methodology; that is, the steam released from 1800 seconds to 8 hours9.259259e-5 days 0.00222 hours 1.322751e-5 weeks 3.044e-6 months is based on the amount of steam required to remove the residual heat from the primary and secondary systems, the decay heat generated in the core, and the reactor coolant pump heat. The steam release rates in cfm calculated below are divided by the partition coefficient of 100 (RG 1. 183) and entered into RADTRAD.

CA06454 Rev.000 Page 20 of 125 Steam Release Calculations for First 1800 Seconds dt 1800 sec First 1800 sec. CESEC with no operator action from CA03516 W 204500 Ibm SG mass release, CESEC with no operator action from CA03516 dW/dt 113.6111 Ibm/sec W/dt vstp 0.016018 cf/Ibm Specific volume from Steam Tables @ 1 gm/cc (STP) per Reg Guide 1.183 dV/dt 109.1894 cfm dW/dt ^vstp * (60 sec/min)

Steam Release Calculations from 1800 Seconds to 8 Hours msg86500 Ibm SG secondary water mass @ 537.7F saturated from CA03516 cpsg 1.27 btuAbm-F SG specific heat capacity @537.7F saturated from CA03516 mprs 6630 Ibm PZR steam mass @ 658.6F and 2325.8 psia from CA03516 cpprs 3.46 btuAbm-F PZR steam specific heat @ 658.6F and 2325.8 psia from CA03516 mprw 23000 Ibm PZR water mass @ 574.OF and 2325.8 psia from CA03516 cpprw 1.31 btu/lbm-F PZR water specific heat © 574.OF and 2325.8 psia from CA03516 mrcs410000 Ibm RCS water mass @540.3F and 2332.8 psia from CA03516 cprcs 1.22 btuAbm-F RCS water specific heat @ 540.3F and 2332.8 psia from CA03516 mrcsm 4248300 Ibm RCS metal mass from CA03516 cprcsm0.12 btu/lbm-F RCS specific heat @ 540.3F and 2332.8 psia from CA03516 dT 241 F Delta RCS temperature between 541F and 300 F dt 27000 sec Delta time between 8.0 hours0 days 0 hours 0 weeks 0 months and 0.5 hours5.787037e-5 days 0.00139 hours 8.267196e-6 weeks 1.9025e-6 months Ores 10469.40 btu/sec (msg'cpsg+mprs cpprs+mprw-cpprw+mrcs cprcs+mrcsm-cprcsm)*dT/dt Prcp 17 MW Reactor coolant pump power from UFSAR Table 14.6.1 Qrcp 16112.88 btu/sec Prcp'(4 RCPs/4 RCPs)*(947.8167 btu/sec/MW) ti 1800 sec Decay heat generated between 1800-28800 sec 2 28800 sec Decay heat generated between 1800-28800 sec Po 2754 Mwt Initial power per UFSAR 3.2.1 and RG 1.49 A 0.13 Constant from CA03516 a 0.283 Constant from CA03516 Pdec 25.14 Mwt Decay heat rate Pdec=Po*Ai[t2A(1 -a)-t1(1 -an/(1-a)/(t2-t1) from CA03516 SF 1.25 CA03516 Safety Factor Odec 29789.68 btu/sec Pdec*SF-(947.8167 btu/sec/mw)

Mtot 56371.96 btu/sec Qres+Qrcp+Qdec hg 1179.7 btu/lbm Enthalpy of steam in SG @ 300 F hfw 80.0 btu/lbm Enthalpy of Aux Feed entering the SG (CA03516) dWs/dt 51.26 Ibm/sec Steam Release Rate Qtot/(hg-hfw)

Ws 1384052.96 Ibm Integrated steam release dWs/dt(t2-tl) dVs/dt 49.2661 cfm Steam Release Rate dWsdt'vstp'60 (9.4) 2-Hlour Secondary Steam Release Calculations The methodology for the 2 hour2.314815e-5 days 5.555556e-4 hours 3.306878e-6 weeks 7.61e-7 months cooldown from HFP to SDC is based on a simple energy balance methodology; that is, the steam released from 0 seconds to 2 hours2.314815e-5 days 5.555556e-4 hours 3.306878e-6 weeks 7.61e-7 months is based on the amount of steam required to remove the residual heat from the primary and secondary systems, the decay heat generated in the core, and the reactor coolant pump heat. The steam release rates in cfm calculated below are divided by the partition coefficient of 100 (RG 1.183) and entered into RADTRAD.

CA06454 Rev. 000 Page 21 of 125 Steam Release Calculations from 0 Seconds to 2 Hours msg l 275942 l Ibm SG secondary water mass @ 525.2F saturated from SP-0811 &WEC-222-7811-A45 cpsg 1.24 btu/libm-F SG specific heat capacity @ 525.2F saturated from Steam Tables Qsg 77056251.6 btu SG residual heat = msg-cpsg'(525.2-300) mprs 5765 Ibm PZR steam mass @ 6536F & 2250 psia from UFSAR Table 4.7 (900cf/0.1 5613 cf/lbm) cpprs 3.55 btu/lbm-F PZR steam specific heat @ 653F and 2250 psia from Steam Tables Qprs 7224409.75 btu PZR steam residual heat = mprs'cprs'(653-300) mprw 22198 Ibm PZR water mass @ 653F and 2250 psia from UFSAR Table 4.7 (600cf/0.02703cf/lbm)

.2... 2.119 btuAbm-F PZR water specific heat @ 653F and 2250 psia from Steam Tables Qprw 16604259.4 btu PZR water residual heat = mprw-cprw*(653-300) mrcs 432677 Ibm RCS water mass @ 574.5F and 2250 psia from Input 11 cprcs 1.335 btuAbm-F RCS water specific heat @ 574.5F and 2250 psia from Steam Tables Qrcs; 158557732 btu RCS water residual heat = mrcs-cprcs-(574.5-300) mrcsm 4248300 Ibm RCS metal mass from CA03516 cprcsm 0.12 btu/lbm-F RCS specific heat @ 574.5F from CA03516 Qrcsm 139939002 btu Reactor residual heat = mrcsm'cprcsm'(574.5-300)

Otot 399381654 btu Total residual heat = Qsg + Qprs + Qprw + Qrcs + Orcsm dt 7200 sec Delta time between 0 hours0 days 0 hours 0 weeks 0 months and 2 hours2.314815e-5 days 5.555556e-4 hours 3.306878e-6 weeks 7.61e-7 months Wres 55469.67 btu/sec Qtot.dt Prcp 17 MW Reactor coolant pump power from UFSAR Table 14.6.1 Wrcp 16112.88 btu/sec Prcp*(4 RCPs/4 RCPs)'(947.8167 btu/sec/MW) ti 0 sec Decay heat generated between 0-7200 sec t2 7200 sec Decay heat generated between 0-7200 sec Po 2754 Mwt Initial power per UFSAR 3.2.1 and RG 1.49 A 0.13 Constant from CA03516 a 0.283 Constant from CA03516 Pdec 40.44 Mwt Decay heat rate Pdec=PoA*[t2A(1 -ayt1(1-a)l/(1-a)/(t2-t1) from CA03516 SF 1.25 CA03516 Safety Factor Wdec 47906.83 btu/sec Pdec'SF*(947.8167 btulsec/mw)

Wtot 119489.38 btu/sec Wres+Wrcp+Wdec hg 1150.5 btu/lbm Enthalpy of steam in SG @ 212 F (conservative) hfw 80.0 btu/lbm Enthalpy of Aux Feed entering the SG (CA03516) dWs/dt 111.62 Ibm/sec Steam Release Rate Wtot/(hg-hfw)

Ws 803665.177 Ibm Integrated steam release dWs/dt-(t2-tl) dVs/dt 107.2759 cfm Steam Release Rate dWsdtvstp60-vstp 0.016018 cf/lbm Steam Tables @i1 gm/cc (9.5) Flashing Fraction Calculations Per Regulatory Guide 1.183 Appendix E (Ref.8), upon periods of steam generator dryout, all of the primary-to-secondary leakage is assumed to flash to vapor and be released to the environment wvith no mitigation.

Since the steam generator tubes remain covered for the duration of the event, a portion of the primary-to-secondary leakage will flash to vapor, based on the thermodynamic conditions in the primary and secondary systems. Per RG 1.183 Appendix A, the flashing fraction, FF, should be determined using a constant enthalpy, li, process:

FF =(h,, - hc,)I/hr,

CA06454 Rev.000 Page 22 of 125 where hn is the enthalpy of the primary system liquid, hr is the enthalpy of the secondary system liquid, and hr. is the heat of vaporization at secondary system conditions.

To determine the flashing fractions associated with a cooldown to shutdown cooling, it is necessary to know the temperature difference between the primary and secondary systems as a function of time. The following table lists the results of the EXCEL spreadsheet CEA.XLS(FlashingFraction). This spreadsheet calculates the temperature difference required to cool the primary system to 300MF over an 8 hour9.259259e-5 days 0.00222 hours 1.322751e-5 weeks 3.044e-6 months period.

Temperature Difference between Primary and Secondary Based on Energy Balance Time Decay Heat Decay Heat RCPs Residual SG Heat Loss delta Temp Fdec Wdec Wrcp Wres Wtot dT

% btulhr btu/hr btuthr btu/hr deg F 0 100 9397033560.00 58006380 37689840.00 9492729780.00 76.65 1 sec 7.769 730055537.28 58006380 37689840.00 825751757.28 6.67 25sec 5.471 514111706.07 58006380 37689840.00 609807926.07 4.92 50 sec 4.852 455944068.33 58006380 37689840.00 551640288.33 4.45 100 sec 4.28 402193036.37 58006380 37689840.00 497889256.37 4.02 900 sec 2.541 238778622.76 58006380 37689840.00 334474842.76 2.70 1800 sec 2.0334 191079280.41 58006380 37689840.00 286775500.41 2.32 2700 sec 1.7792 167192021.10 58006380 37689840.00 262888241.10 2.12 1 hr 1.597 150070625.95 58006380 37689840.00 245766845.95 1.98 2 hr 1.2646 118834886.40 58006380 37689840.00 214531106.40 1.73 8 hr 0.8681 81575648.33 58006380 37689840.00 177271868.33 1.43 Fdec = Decay heat fraction from BTP ASB 9-2: Residual Decay Energy for LWRs for Long-Term Cooling Wdec = Decay heat in btu/hr from BTP ASB 9-2: Residual Decay Energy for LWRs for Long-Term Cooling Wrcp = RCP power from Section 9.3 Wres = Residual power from Section 9.3 Wtot = Wdec + Wrcp + Wres Wtot = 0.266

K

dT

A / t = 123849700

dT = Total SG Heat Loss in btulhr K = Alloy Inconel 690 thermal conductivity in btu-in/ft2-hr-F (93 @ 200F, 107 @ 400F. 122 @ 600F) (Attachment C) dT = Trcs - Tsg in degrees F A = heat transfer area in ft2 (2

92008 ft2 per SP-0811 Ref.43) t = SG tube wall thickness in in (0.046 in max per SP-0811 Ref.43)

Note that at HFP the RCS hot leg (60 10F - UFSAR Figure 4-9) is -760 F hotter than the SG (525.20 F - SP-08 II).

This temperature difference drops to less than 50 F within 25 seconds post-trip. The magnitude of the temperature difference is verified by inspection of the RCS and SG cooldoxvn temperatures from Unit 2 Cycle 15 displayed in Attachment B. Based on a conservative 60F temperature difference, the flashing fractions between HZP and SDC can be calculated. Note that the flash fraction remains below 1% throughout the cooldowvn.

Flashing Fraction Based on 6 Degree F Temperature Difference Between RCS and SG during Cooldown RCS RCS SG SG SG Flash Temperature Fluid Enthalpy Temperature Fluid Enthalpy Fluid-Gas Enthalpy Fraction 544 @ 2000 psia 540.1 538 534.2 660.6 0.0089 500 @ 1700 psia 487.6 494 480.8 722.1 0.0094 400 © 1000 psia 376 394 368.6 831.6 0.0089 300 @270 psia 270.1 294 263.5 914.5 0.0072

CA06454 Rev. 00O Page 23 of 125 The flash fraction for leakage from the RCS to the SG at HFP and from the RCS to the Refueling Water Tank (RWT) are also calculated. Note that flash fraction for leakage from the RCS to the SG at IIFP is - 8.84%. Also note that the leakage from the RCS to the RWT is - 10%, which is consistent with the recommended value in RG 1.1 83 (Ref.8).

Flashing Fraction Based on HFP Conditions and RWT Leakage RCS RCS _ I l Flash Temperature Fluid Enthalpy Temperature Fluid Enthalpy Fluid-Gas Enthalpy Fraction 574.6 ( 2250 psia 578.5 l SG 525.2 Sat SG 518.4 SG 679.55 0.0884 212 @ Saturation l 180.2 l RWT 100 I RWT 68.0 l RWT 1037.1 0.1082 Based on the above data, a 10% flash fraction will be assumed during the first 15 minutes after the accident, and a 1% flash fraction will be assumed for the remaining duration of the accident.

CA06454 Rev. OOO Page 24 of 125

10. CALCULATIONS The following computations were performed in this calculational package for the CEA Ejection Event 8 hour9.259259e-5 days 0.00222 hours 1.322751e-5 weeks 3.044e-6 months steam generator release:

CEA Ejection Event Files for 8 Hour Steam Generator Release Activity Source Failed Fuel Primary Secondary Radionuclide Component Iodine Noble Gas Iodine Noble Gas Iodine Case Input Files ceaffi.psf ceaffn.psf ceapri.psf ceaprn.psf ceasec.psf Dose Conversion Factor File l fgrl4.inp fgrl4.inp fgrl4.inp fg.r14.inp fgrO5.inp Release Fraction/Timing File ceaffi.rft ceaffn.rft ceapri.rft ceaprn.rft ceasec.rft Nuclear Inventory File ceal4.nif ceaU4.nit .nif pril4.nifI secO5.nif Case Output Files ceaffi.oO ceaffn.oO ceapri.oO ceaprn.oO ceasec.oO The following computations were performed in this calculational package for the CEA Ejection Event 2 hour2.314815e-5 days 5.555556e-4 hours 3.306878e-6 weeks 7.61e-7 months steam generator release:

CEA Ejection Event Files for 2 Hour Steam Generator Release Activity Source Failed Fuel Prima Secondary Radionuclide Component Iodine Noble Gas Iodine Noble Gas Iodine Case Input Files ceaffi2.psf ceaffn2.psf ceapri2.psf ceaprn2.psf ceasec2.psf Dose Conversion Factor File fgrl4.inp fgrl4.inp fgrl4.inp fgrl4.inp fgrO5.inp Release FractionrTiming File ceaffi.rft ceaffn.rft ceapri.rft ceaprn.rft ceasec.rft Nuclear Inventory File ceal4.nif ceal4.nif priU4.nif priU4.nif secO5.nif Case Output Files ceaffi2.oO ceaffn2.oO ceapri2.oO ceaprn2.oO ceasec2.oO The following computations were performed in this calculational package for the CEA Ejection Event 720 hour0.00833 days 0.2 hours 0.00119 weeks 2.7396e-4 months containment release:

CEA Ejection Event Files for Containment Release Activity Source Containment Radionuclide Component Iodine/Noble Gas Case Input Files ceactmt.psf Dose Conversion Factor File fgr63.inp Release Fraction/Timing File ceactmt.rft Nuclear Inventory File crcb63.nif Case Output Files ceactmt.oO

CA06454 Rev.000 Page 25 of 125

11. DOCUMENTATION OF CONMPUTER CODES This work employed the RADTRAD computer code, which was verified, benchmarked, and documented in Refs.13-17 and which models the transport of halogen and noble gas isotopes from a primary containment to a secondary containment and thence to the environment and control room. The installation of RADTRAD is detailed in Ref.16 and the validation in Ref.17.

The RADTRAD computer code can calculates TEDE and thyroid doses to personnel at the site boundary, low population zone, and control room per the alternate source term methodology 10 CFR 50.67 and Regulatory Guide 1.183 or can calculates whole body and thyroid doses to personnel at the site boundary, low population zone, and control room per the standard source term methodology of TID-14844 (Ref.18) resulting from any postulated accident which releases radioactivity within the containment, spent fuel pool, or within any primary system.

RADTRAD models the transport of radioactivity from up to 63 radioisotopes from the sprayed and unsprayed regions of a primary containment or a SFP area, through the secondary containment if any, and then to the environment and to the control room. The code includes the capability to model time-dependent activity release; containment spray, filtration, and leakage; control room filtration and inleakage; primary and secondary containment purge filters; control room intake filters; atmospheric dispersion; and natural decay. Doses are calculated for individuals residing at the site boundary or low population zone and in the control room.

Some inputs for the RADTRAD computer program were generated via an EXCEL spreadsheet.

CA06454 Rev. 000 Page 26 of 125

12. RESULTS UFSAR 14.13 presents the licensing basis evaluation of the CEA Ejection Event. A CEAEE is defined as a rapid, uncontrolled, total withdrawal of a single or dual CEA, where a dual CEA is two CEAs connected to a single CEA extension shaft. The event is postulated to occur as a result of a complete instantaneous circumferential rupture of either the Control Element Drive Mechanism (CEDM) pressure housing or the CEDM nozzle from the reactor vessel closure head. The pressure of the Reactor Coolant System (RCS) causes the ejection of the extension shaft through the rupture and the movement of the CEA to a fully-withdrawn position. The most limiting CEA Ejection Event is a rapid total withdrawal of the highest worth CEA within 0.05 seconds and the breaching of the RCS pressure boundary. The immediate reactor core response is an exponential increase in nuclear power. At 112.2% (i.e.,

maximum analysis setpoint including uncertainties) of Reactor Thermal Power (RTP), a Variable High Pressure Trip (VHPT) is initiated. The negative Doppler feedback due to the increasing fuel temperature partially offsets the ejected CEA worth and terminates the power excursion. The insertion of the CEAs will terminate the event.

Although both the HFP and HZP cases were analyzed, the HFP case is more limiting with respect to dose (more failed fuel and a higher steaming potential). The design basis CEA Ejection Event accounts for extended burnup.

Additional evaluations concluded that ZIRLO, Erbia, and replacement steam generators will not significantly impact the results, and thus the current results remain bounding. The worst-case results show that no fuel rod will experience clad damage and only a small fraction will reach incipient centerline melt condition (8%). The results are wvell within the 10 CFR 100 exposure guidelines, specifically Thyroid<50 Rem and Whole Body<1.5 Rem.

Previously, power reactor licensees have typically used the U.S.A.E.C Technical Information Document TID-14844, "Calculation of Distance Factors for Power and Test Reactor Sites," (Ref.18) as the basis for Design Basis Analysis (DBA) source terms. TID-14844 is referenced in 10 CFR 100.11, the power reactor siting regulation, which contains offsite dose limits in terms of whole body and thyroid doses. In December 1999, the Nuclear Regulatory Commission (NRC) issued a new regulation, 10 CFR 50.67, "Accident Source Term," which provided a mechanism for licensed power reactors to replace the traditional accident source term used in their DBA analyses with an Alternate Source Term (AST) methodology. Regulatory guidance for the implementation of these ASTs is provided in Regulatory Guide (RG) 1.183, "Alternative Radiological Source Terms for Evaluating Design Basis Accidents at Nuclear Power Reactors" (Ref.08). Section 50.67 of 10 CFR requires a licensee seeking to use AST to apply for a license amendment and requires that the application contain an evaluation of the consequences of affected DBAs. As part of the implementation of the AST, the Total Effective Dose Equivalent (TEDE) acceptance criterion of 10 CFR 50.67 replaces the previous whole body and thyroid dose guidelines of 10 CFR 100.11 and 10 CFR 50, Appendix A, GDC-19 for the loss-of-coolant accident (LOCA), the main steam line break (MSLB), the steam generator tube rupture (SGTR), the seized rotor event (SRE), the fuel handling accident (FHA), and the control element assembly ejection accident (CEAEE). The TEDE accident dose criteria are listed in Table 6 of RG 1 183 for offsite doses and in 10 CFR 50.67 for control room doses, which limit is 5 Rem TEDE. The Nuclear Steam Supply System (NSSS) response to the CEAEE was simulated using the CESEC computer code for the eight hour accident scenario.

The current work utilizes the alternate source term methodology of 10 CFR 50.67 and Regulatory Guide 1.183 to calculate offsite and control room doses for a CEAEE. The CEAEE was evaluated for both the containment and secondary release pathways. In addition, the secondary pathway was analyzed for both a 2 hour2.314815e-5 days 5.555556e-4 hours 3.306878e-6 weeks 7.61e-7 months and an 8 hour9.259259e-5 days 0.00222 hours 1.322751e-5 weeks 3.044e-6 months time to shutdown cooling (SDC). A bounding control room inleakage value of 3500 cfm was assumed. The following modifications and TS changes are proposed to comply with regulatory requirements.

Modification of the control room emergency ventilation system to a nominal 10000 cfm flow with a 90%

filtration efficiency for elemental and organic iodine and 99% for particulate iodine was credited.

Also credited was installation of automatic isolation dampers and radiation monitors at Access Controls 11 and 13 on the Auxiliary Building Roof. This modification limits activity ingress into the control room to either the West Road Inlet or the Turbine Building, thus limiting the atmospheric dispersion coefficient value.

The Technical Specification (TS 3.4.15) limit for RCS activity was reduced from 1.0 pCi/gm to 0.5 jtCigm.

CA06454 Rev.OOO Page 27 of 125

The maximum allowable containment leakage rate La contained in the Containment Leakage Rate Testing Program of TS 5.5.16 was reduced from 0.20 percent per day at Pa to 0. 16 percent per day at Pa.

The exclusion area boundary (EAB), low population zone (LPZ), and control room (CR) doses for the 8-hour secondary pathway are presented in Attachments Q, R, S. T, and U and are detailed in the following table:

8 Hour CEAEE Results from Secondary Pathway EAB LPZ CR Rem Rem Rem Failed Fuel Iodine 1.2503E-01 3.6870E-02 4.1672E+00 Failed Fuel Noble Gas 2.0073E-01 5.0370E-02 4.1885E-01 Primary TS Activity Iodine 1.5225E-06 4.5645E-07 5.5874E-05 Primary TS Activity Noble Gas 3.6795E-05 9.9443E-06 1.5932E-04 Secondary TS Activity Iodine 3.6208E-04 9.7236E-05 8.3421 E-03 Total 0.32616 0.08735 4.59461 Regulatory Limits 6.3000 6.3000 5.0000 Note that besides the iodine and noble gases released from the failed fuel, doses resulting from the release of the primary and secondary TS activities through the steam generators was also calculated and included in the results.

Note that all values are below the regulatory limits.

The exclusion area boundary (EAB), low population zone (LPZ), and control room (CR) doses for the 2-hour secondary pathway are presented in Attachments V, W, X, Y, and Z and are detailed in the following table:

2 Hour CEAEE Results from Secondary Pathway EAB LPZ CR Rem Rem Rem Failed Fuel Iodine 1.5521E-01 3.6538E-02 1.2435E+00 Failed Fuel Noble Gas 2.0073E-01 4.7255E-02 2.0440E-01 Primary TS Activity Iodine 1.8994E-06 4.4715E-07 1.6344E-05 Primary TS Activity Noble Gas 3.6795E-05 8.6621E-06 5.2343E-05 Secondary TS Activity Iodine 6.0024E-04 1.4131 E-04 4.9484E-03 Total 0.35658 0.08394 1.45292 Regulatory Limits 6.3000 6.3000 5.0000 Note that besides the iodine and noble gases released from the failed fuel, doses resulting from the release of the primary and secondary TS activities through the steam generators was also calculated and included in the results.

Note that all values are below the regulatory limits.

The exclusion area boundary (EAB), low population zone (LPZ), and control room (CR) doses for the 30-day containment pathway are presented in Attachment AA and are detailed in the following table 30 Day CEAEE Results from Containment Pathway I EAB LPZ CR l l Rem Rem Rem Failed Fuel Iodine and Noble Gases 0.45664 0.11862 0.96789 l Regulatory Limits l 6.3000 6.3000 5.0000 Note that all values are below the regulatory limits.

CA06454 Rev.000 Page 28 of 125

13. CONCLUSION'S All CEAEE offsite and control room doses are below the regulatory limits.

Results EAB LPZ CR Rem Rem Rem 8 Hour Secondary Pathway 0.32616 0.08735 4.59461 2 Hour Secondary Pathway 0.35658 0.08394 1.45292 30 day Containment Pathway 0.4567 0.1187 0.9679 CEAEE Worst-Case Doses 0.5000 0.2000 4.6000 Regulatory Limits 6.3000 6.3000 5.0000 This work supports the following changes in plant operation:

This analysis supports a pin power peaking factor of 1.70

A time to shutdown cooling of 8 hours9.259259e-5 days 0.00222 hours 1.322751e-5 weeks 3.044e-6 months was assumed..

Containment sprays were not credited in this work.

Two containment filters were credited after a 20 minute delay, consistent with manual initiation.

This work relies on the following modifications and new methodologies:

Alternate Source Term Methodology was employed.

Modification of the control room emergency ventilation system to a nominal 10000 cfm flow with a 90%

filtration efficiency for elemental and organic iodine and a 99% efficiency for particulate iodine was credited.

Installation of automatic isolation dampers and radiation monitors at Access Controls 11 and 13 on the Auxiliary Building Roof was credited. This modification limits activity ingress into the control room to either the West Road Inlet or the Turbine Building, thus limiting the atmospheric dispersion coefficient value.

The Technical Specification (TS 3.4.15) limit for RCS activity was reduced from 1.0 pCilgm to 0.5 JCi'gm.

The maximum allowable containment leakage rate La contained in the Containment Leakage Rate Testing Program of TS 5.5.16 was reduced from 0.20 percent per day at Pa to 0.16 percent per day at Pa.

CA06454 Rev. 000 Page 29 of 125

14. ATTACHMENTS ATTACHMENT A CEA EJECTION EVENT RELEASE ACTIVITIES Calculation of CEA Ejection Event Release Activities l Halflife lambda Core SG Containment Gap l Source Release Release Release sec 1/sec Cl/MWT Fraction Fraction Fraction A B C D E F Kr-85 3.3830E+08 2.0489E-09 3.7180E+02 1.00 1.00 0.10 Kr-85m 1.6128E+04 4.2978E-05 7.9679E+03 1.00 1.00 0.10 Kr-87 4.5780E+03 1.5141 E-04 1.6208E+04 1.00 1.00 0.10 Kr-88 1.0224E+04 6.7796E-05 2.2658E+04 1.00 1.00 0.10 1-131 6.9466E+05 9.9783E-07 2.7562E+04 0.50 0.25 0.10 1-132 8.2800E+03 8.3713E-05 3.9464E+04 0.50 0.25 0.10 1-133 7.4880E+04 9.2568E-06 5.5715E+04 0.50 0.25 0.10 1-134 3.1560E+03 2.1963E-04 6.2858E+04 0.50 0.25 0.10 1-135 2.3796E+04 2.9129E-05 5.2964E+04 0.50 0.25 0.10 Xe-133 4.5317E+05 1.5296E-06 5.5707E+04 1.00 1.00 0.10 Xe-135 3.2724E+04 2.1182E-05 1.7708E+04 1.00 1.00 0.10 Xe133m 1.8922E+05 3.6632E-06 1.7354E+03 1.00 1.00 0.10 Xe135m 9.1800E+02 7.5506E-04 1.1635E+04 1.00 1.00 0.10 Xe138 8.4600E+02 8.1932E-04 4.9330E+04 1.00 1.00 0.10 1 microCi/g 1 microCii/g 0.5 microCii/g 0.1 microCi/g 0.1 microCi/g Incipient Failed Primary Primary Primary Secondary Secondary Centerline Fuel Source Source Source Source Source Melt Clad-Damage microCi/g Ci Ci microCi/g Ci Fraction Fraction G H I J K L M Kr-85 3.8761E+01 7.9975E+03 7.9975E+03 0.08 0.02 Kr-85m 2.0344E+00 4.1975E+02 4.1975E+02 0.08 0.02 Kr-87 1.1747E+00 2.4238E+02 2.4238E+02 0.08 0.02 Kr-88 3.6579E+00 7.5473E+02 7.5473E+02 0.08 0.02 1-131 7.7893E-01 1.6071 E+02 8.0357E+01 8.9260E-02 1.1172E+01 0.08 0.02 1-132 2.5868E-01 5.3372E+01 2.6686E+01 2.2758E-03 2.8485E-01 0.08 0.02 1-133 1.0972E+00 2.2638E+02 1.1319E+02 5.7417E-02 7.1866E+00 0.08 0.02 1-134 1.4798E-01 3.0532E+01 1.5266E+01 5.2168E-04 6.5297E-02 0.08 0.02 1-135 6.0207E-01 1.2422E+02 6.2112E+01 1.3584E-02 1.7003E+00 0.08 0.02 Xe-133 4.0021 E+02 8.2574E+04 8.2574E+04 0.08 0.02 Xe-135 9.5607E+00 1.9726E+03 1.9726E+03 0.08 0.02 Xe133m 5.7016E+00 1.1764E+03 1.1764E+03 0.08 0.02 Xe135m 1.2511E+00 2.5814E+02 2.5814E+02 0.08 0.02 Xe138 6.6019E-01 1.3622E+02 1.3622E+02 0.08 0.02

CA06454 Rev.000 Page 30 of 125 A Half-lives: Chart of the Nuclides Fifteenth Edition' B Decay constants: Ln(2)/A(i)

C Core source in Ci/MWt: CA06358 D SG Release Fractions RG 1.183 E Containment Release Fraction per RG 1.183 F Gap Release Fraction per RG 1.183 G Primary Source in microCi/gm: CA06422 H Primary Source in Ci for 1.0 microCi/gm total (F*Mtot*1.e-6): CA06422 I Primary Source in Ci for 0.5 microCi/gm total: CA06422 J Secondary Source in microCi/gm: CA06422 K Secondary Source in Ci for 0.1 microCi/gm total (I'M2sg'1.e-6): CA06422 L Melt Fraction SER-108 and BGE-to-NRC 3/27/87 M Failed Fuel Clad Damage Fraction III

CA06454 Rev.000 Page 31 of 125 ATTACHMENT B RCS AND SG TEMPERATURES DURING COOLDOWN FOR U2C15 time/date T15 T01 P3991 P4008 PA911 PWR incore TIC incore T/C SIG pres S/G pres SIG temp delta T MWth %

2/22/05 20:00 578.7441 566.4422 860.0844 860.9044 528 50.74 1566.43 50 2/22/05 20:15 566.002 554.975 866.2637 867.7706 529 37.00 1144.26 2/22/05 20:30 558.8608 549.1283 876.4542 878.4052 531 27.86 772.418 2/22/05 20:45 556.1724 547.0767 873.8704 875.7279 531 25.17 711.863 2/22/05 21:00 554.9191 546.7604 873.238 875.0824 531 23.92 612.762 2/22/05 21:15 553.6187 545.7773 875.0209 876.7194 531 22.62 583.02 2/22/05 21:30 528.0092 526.1494 826.0601 827.7929 524 4.01 0 RX tripped at 21:18 2/22/05 21:45 531.4954 529.6996 851.4368 852.9307 527 4.50 0 2/2210522:00 531.9566 529.9861 854.554 856.0984 528 3.96 0 2/22/05 22:15 532.7553 530.8712 861.4042 863.3385 529 3.76 0 2/22/05 22:30 537.0707 535.1683 892.9442 895.0641 533 4.07 0° 2/22/05 22:45 537.0485 535.04 893.3041 894.1574 533 4.05 0 2/22/05 23:00 536.9429 535.3205 892.8889 894.4975 533 3.94 0 2/22105 23:15 537.4091 534.8431 893.3578 894.4955 533 4.41 0 2/22/05 23:30 536.9704 535.2005 893.1202 894.6226 533 3.97 0 2/22/05 23:45 534.7727 533.3892 873.0486 874.682 530 4.77 0 started cooldown 2/23/05 0:00 507.568 506.1674 682.9695 684.3099 502 5.57 0 at 23:40 2/23/05 0:15 486.4295 485.2568 565.0845 567.0615 482 4.43 0 2123/05 0:30 477.68 475.6797 516.7318 518.6068 473 4.68 0 2/23/05 0:45 455.5023 453.9149 411.658 413.5607 451 4.50 0 2/23/05 1:00 430.1253 428.2714 312.3168 314.3121 425 5.13 0 2/23/05 1:15 413.5529 412.3058 260.2605 262.4067 409 4.55 0 2/23/05 1:30 390.885 389.1119 198.0988 200.5414 387 3.88 0 2/23/05 1:45 369.2405 368.2268 150.1976 153.0631 366 3.24 0 2/23/05 2:00 352.8415 350.7658 118.4433 121.7126 349 3.84 0 22A, 22B RCPs 2/23/05 2:15 345.1859 343.6995 105.3893 106.6911 341 4.19 0 secured at 01:56 2/23/05 2:30 333.6378 331.6456 87.99626 88.99712 329 4.64 °0 2/23/05 2:45 323.0352 321.4279 75.10741 76.11856 320 3.04 0 2/23/05 3:00 316.7439 315.2555 67.55364 68.04358 314 2.74 0 2/23/05 3:15 309.7081 307.7081 59.99987 60.46406 307 2.71 0 2/23/05 3:30 303.925 302.502 53.75203 54.16422 301 2.92 0 2/23/05 3:45 291.8372 290.0799 42.79893 42.7024 290 1.84 0 2/23/05 4:00 283.292 281.8082 37.41241 37.11428 283 0.29 0 2/23/05 4:15 284.2902 283.0165 37.65192 37.22566 284 0.29 0 2/23/05 4:30 284.2399 283.4768 37.89143 37.33705 284 0.24 0 2123/05 4:45 284.4097 282.8159 38.13094 37.44844 283 1.41 0 2/23/05 5:00 283.261 281.8333 38.00369 37.47907 283 0.26 0 2/23/05 5:15 282.609 281.2734 37.46102 36.94158 283 -0.39 0 2/23105 5:30 282.2056 280.8308 36.91834 36.40408 282 0.21 0 2/23/05 5:45 281.752 280.463 36.37567 35.86658 282 -0.25 0 2/23/05 6:00 273.5653 272.2971 31.01966 30.17249 274 -0.43 0 2/23105 6:15 260.2524 258.7529 23.95011 22.08722 262 -1.75 0

CA06454 Rev.000 Page 32 of 125 2/23/05 6:30 249.1637 247.2722 19.26105 17.22444 254 -4.84 0 2/23/05 6:45 243.2102 242.1935 16.21292 14.05667 248 -4.79 0 2/23/05 7:00 261.2776 252.1104 14.28907 12.09798 244 17.28 0 2/23/05 7:15 251.0412 247.4352 13.05073 10.81788 241 10.04 0 Shutdown cooling 2/23/05 7:30 236.9769 234.4763 13.5385 11.23184 242 -5.02 0 initiated at 07:21 2/23/05 7:45 241.9588 238.4225 13.12522 10.53991 241 0.96 0 2/23/05 8:00 226.6613 223.1887 11.31852 8.82128 237 -10.34 0 l 2/23/05 8:15 212.6437 208.8708 8.247018 5.75316 229 -16.36 0 S/G Blowdown secured

CA06454 Rev.OOO Page 33 of 125 ATTACHMENT C INCONEL ALLOY 690 DATA

Special Metals Corporation - Products - INCONELc) alloy 690 Page 1 of l c 6S ro v. a) e;5- 3Y SMECAL SEARCH METALS THE ALLO0Y E:Xf7ER l INCONEL alloy 690 INCONEL alloy 690 Is a high-chromium nickel alloy having excellent resistance to many corrosive aqueous media and temperature atmospheres. The alloy's high chromium content gives It excellent resistance to aqueous corrosion by o, acids (especially nitric acid) and salts, and to sulfidation at high-temperatures. In addition to Its corrosion resistance, 690 has high strength, good metallurgical stability, and favorable fabrication characteristics.

UNS: N06690 W.Nr.: 2.4642 Technical Bulletin (PDF, 165KB)

Available Product Forms: Pipe, tube, plate, round bar and forging stock Technical Papers Alloy Solutions to Metal Dusting Problems In the Petrochemical Industry (PDF, 1.6MB)

Performance of Commercial Alloys in Simulated Waste Incineration Environments (PDF, 1.2M The Role of Protective Scales in Enhancing Oxidation Resistance (PDF 2.34MB)

<<<Back to Previous Page

http:// www.specialmetals.com/products/inconelalloy690.htm 6/10/2005

C~t)off'Y /?syo SPECIAL a 4METALS www.specialmetalsxcom INCONEL' alloy 690 (UNS N06690AV. Nr. 2.4642) is Table 1 - Limiting Chemical Composition, %,

a high-chromium nickel alloy having excellent of INCONEL alloy 690' resistance to many corrosive aqueous media and high-temperature atmospheres. In addition to its corrosion Nickel ........ ............... 58.0 min. i -

resistance, alloy 690 has high strength, good Chromium ............................ 27.0-31.0 metallurgical stability, and favorable fabrication Iron ............................ 7.0-11.0 k14:it__..Z;-A- I characteristics. Carbon ........ ............... 0.05 max.

The chemical composition of INCONEL alloy 690 Silicon ....................... 0.50 max.

is listed in Table 1. The substantial chromium content Manganese ....................... 0.50 max.

gives the alloy outstanding resistance to oxidizing Sulfur .......... .............. 0.015 max.

chemicals and to high-temperature oxidizing gases. Copper ....................... 0.50 max.

The high level of nickel imparts resistance to stress-corrosion cracking in chloride-containing environments "Aml.endments for nuclear applications: 28-31 Cr, 0.04 max. C, 0.10 as well as to sodium hydroxide solutions. max. Co.

The properties of INCONEL alloy 690 are useful for various applications involving nitric or nitric/hydrofluoric acid solutions. Examples are tail-gas Physical Constants and Thermal reheaters used in nitric acid production and heating coils and tanks for nitric/hydrofluoric solutions used in Properties pickling of stainless steels and reprocessing of nuclear Table 2 gives melting range and some physical fuels. constants at room temperature for INCONEL alloy 690.

The alloy's resistance to sulfur-containing gases Table 3 contains values for thermal and electrical makes it an attractive material for such applications as properties over a range of temperatures. Values for coal-gasification units, burners and ducts for processing specific heat were calculated; other values were sulfuric acid, furnaces for petrochemical processing, measured. Modulus of elasticity in tension, determined recuperators, incinerators, and glass vitrification by a dynamic method,. is shown for temperatures to equipment for radioactive waste disposal. 1600'F (870'C) in Table 4. All measurements of In various types of high-temperature water, alloy physical properties were done on annealed specimens.

690 displays low corrosion rates and excellent resistance to stress-corrosion cracking. Thus, alloy 690 is widely used for steam generator tubes, baffles, tubesheets, and hardware in nuclear power generation. Table 2 - Physical Constants Density, IbAn.3 ................ 0.296 Mg/m ..................................................................... 8.19 Melting Range, 'F ................ 2450-2510

.................. 1343-1377 .1 Specific Heat, BtuAb-OF.0.1.....07............................ 0.107 J/kg-C .450 Electrical Resistivity, ohm-circ mit/ft .691 1.148 .m Permeability at 200 oersteds (15.9 Wm) .1.001 Young's Modulus, 103 ksi .30.6 GPa .211 Poisson's Ratio .0.289 Publication Number SMC-079 Copyright © Special Metals Corporation, 2003 (Oct 03)

INCONEL, INCOLOY, and MONEL are trademarks of the Special Metals Corporation group of companies.

The data contained in this publication is for informational purposes only and may be revised at any time without priornotice. The data is believed to be accurate and reliable, but Special Metals makes no representation or warranty of any kind (express or implied) and assumes no liability with respect to the accuracy or completeness of the information contained herein. Although the data is believed to be representative of the product the actual characteristics or performance of the product may vary from what is shown in this publication. Nothing contained in this publication should be construed as guaranteeing the product for a particular use or application.

cLay55' /&Vo A,5 e- 3

.NCONELI alloy 690 Table 4 - Modulus Data (Annealed)

Table 3 - Thermal and Electrical Properties Tlherl Coefficient of Specific Etcrical Temperature. Young's Modulus, Shear Modulus Poisson's Temperature Caox tivIty Expansion' Heat Resitity OF DC 103 ksi MPa 103 ksl MPa Ratio OF Bt-At-h/-` 10- ininPF Btulb-'F ohdm-ck miMt .70 .21 30.0 206.9', :311t 5 .4:7 9.3 A. -. 0.3O

.Kti.,Sj...:- . . .-- -....;691,

.:0.i07.~. ... 200 93 29.3 202.0 11.35 78.3 0.29 200 93 7.80 0.112 698 400 107 - 7.97 0.119. 1 600 316 27.6 190.3 10.5 72.4 0.31 600 122 8.11 0.126 723 i '.00 -427 :26.6 ' 'l 83.4 ZF.015 '7,'o03 ,

.800 . 136 .' 8:29 ; ~ 133: 736 1000 538 25.3 174.4 9.75 67.2 0.30 1000 151 8.53 0.140 745 FII?° 20 -619 .' - 39;;:64.

':,. 8 8it If,.5"6

'-1200 v-., '165 , 7'8.87:>.

.': ....... '0,:148 I.<.. v7

, 1400 760 22.5 155.1 8.8 60.7 0.28 1400 179 9.14 0.155 749 ^-i60*871-;

.. e. .:- . g 21.3 :.i6.9"

.. .. A

' "8;.56.5

Xs.

X, -.

- ',0.:-

.s1600: .- ..... - .194. 9 * '9.8

. , 62 ,.%:';7,3<

.,tL. 1800 982 19.8 136.5 7.35 50.7 0.33 1800 207 '-3 b -0.;1 689 760 '2000 . .,18.2 .- -1093 125:5 I. ,6.70.:6.2'. y- 0.36'.

2000: . '. 0176 - 768- Extrapolated value.

c Wrfn-C 1+/-rnm/mC J/kg-OC e (Q-m 100 13.5 14.06 471 1.162

-:.'20%200 .15.4 j 'i.-.S.

467' T 300 17.3 14.53 525 1.199 500 21.0 15.19 578 1.235 600 '22.9 .9 15.70

-. :.:i604'5, 1.239>4fi.

700 24.8 16.18 631 1.241

.0 . 26.6 . 6v.. ..2i.g.--.- 2 .

900 28.5 17 .0 1 b 684 1.255 1000 630.1'~ *.17;41 b71i _ 265 1100 17.79b 738 1.278

'Between 75F (24'C) and temperature shown.

bExtrapolated values.

Mechanical Properties INCONEL alloy 690 has high strength over a broad range of temperatures. Mechanical properties of the alloy vary with product form and temper. Alloy 690 is normally used in the annealed temper, and strength characteristics described below are representative of annealed material. The usual annealing temperature is approximately 19001F (1040'C). The effect of different annealing temperatures on the tensile properties of cold-worked material is shown under "Fabrication" in Figure 8.

Tensile Properties Fatigue Strength At room and elevated temperatures, INCONEL alloy 690 The results of low-cycle fatigue tests performed at room displays high yield and ultimate strengths along with good temperature are shown in Figure 2. The specimens were ductility. Table 5 lists results of room-temperature tensile tested under axial strain with fully reversed loading.

tests on annealed material. As indicated by the values, tensile properties may vary with product form and size. At high temperatures, alloy 690 retains a substantial level of tensile properties with temperatures of over l 0007F (5400C) required to produce significant declines in strength. Figure I shows the results of short-time tensile tests performed at temperatures to 1800'F (982'C). The curves represent average values for both cold-worked and hot-worked products in the annealed temper.

2

CA06454 Rev. 000 Page 37 of 125 ATTACHMENT D NUCLEAR INVENTORY FILE CEA14.NIF Nuclide Inventory Name:

Normalized MACCS Sample 3412 Mith PWR Core Inventory Power Level:

O.lOOOE+01 Nuclides:

14 Nuclide 001:

Kr-85 1

0.3382974720E+09 0.8500E+02 3.7180E+02 none O.OOOOE+00 none O.OOOOE+00 none 0.0000E+00 Nuclide 002:

Kr-85m 1

0.1612800000E+05 0.8500E+02 7.9679E+03 Kr-85 0.2100E+00 none O.OOOOE+00 none 0.0000E+00 Nuclide 003:

Kr-87 1

0.4578000000E+04 0.8700E+02 1.6208E+04 Rb-87 0.lOOOE+01 none O.OOOOE+00 none O.OOOOE+00 Nuclide 004:

Kr-88 1

0.1022400000E+05 0.8800E+02 2.2658E+04 Rb-88 0.lOOOE+01 none 0.0000E+00 none O.OOOOE+00 Nuclide 005:

I-131 2

0.6946560000E+06 0.1310E+03 2.7562E+04 Xe-131m 0.llOOE-01 none O.OOOOE+00

CA06454 Rev.OOO Page 38 of 125 none O.OOOOE+0o Nuclide 006:

I-132 2

0.8280000000E+04 0.1320E+03 3.9464E+04 none O.OOOOE+00 none O.OOOOE+00 none O.OOOOE+00 Nuclide 007:

I-133 2

0.7488000000E+OS 0.1330E+03 5.5715E+04 Xe-133m 0.2900E-01 Xe-133 0.9700E+00 none 0.0000E+00 Nuclide 008:

I-134 2

0.3156000000E+04 0.1340E+03 6.2858E+04 none O.OOOOE+00 none 0.OOOOE+00 none O.OOOOE+00 Nuclide 009:

I-135 2

0.2379600000E+05 0.1350E+03 5.2964E+04 Xe-135m 0.1500E+00 Xe-135 0.8500E+00 none O.OOOOE+00 Nuclide 010:

Xe-133 1

0.4531680000E+06 0.1330E+03 5.5707E+04 none O.OOOOE+00 none O.OOOOE+00 none O.OOOOE+00 Nuclide 011:

Xe-135 1

0.3272400000E+05 0.13SOE+03 1.7708E+04 Cs-135 0.1000E+01 none O.OOOOE+00

CA06454 Rev.000 Page 39 of 125 none O.OOOOE+00 Nuclide 012:

Xe-133m 1

0.1892200000E+06 0.1330E+03 1.7354E+03 Xe-133 0.1000E+01 none O.OOOOE+00 none O.OOOOE+00 Nuclide 013:

Xe-135m 1

0.9180000000E+03 0.1350E+03 1.1635E+04 Xe-135 0.1000E+01 none O.OOOOE+00 none O.OOOOE+00 Nuclide 014:

Xe-138 1

0.8460000000E+03 0.1380E+03 4.9330E+04 none O.OOOOE+00 none O.OOOOE+00 none O.OOOOE+00 End of Nuclear Inventory File

CA06454 Rev.000 Page 40 of 125 ATTACHMENT E NUCLEAR INVENTORY FILE PRI14.NIF Nuclide Inventory Name:

Normalized MACCS Sample 3412 MWth PWR Core Inventory Power Level:

O.1000E+01 Nuclides:

14 Nuclide 001:

Kr-85 1

0.3382974720E+09 0.8500E+02 7.9975E+03 none O.OOOOE+00 none O.OOOOE+00 none O.OOOOE+00 Nuclide 002:

Kr-85m 1

0.1612800000E+05 0.8500E+02 4.1975E+02 Kr-85 0.2100E+00 none O.OOOOE+00 none O.OOOOE+00 Nuclide 003:

Kr-87 1

0.4578000000E+04 0.8700E+02 2.4238E+02 Rb-87 0.lOOOE+01 none o.OOOOE+O0 none O.OOOOE+00 Nuclide 004:

Kr-88 1

0.1022400000E+05 0.8800E+02 7.5473E+02 Rb-88 0.lOOOE+01 none O.OOOOE+00 none O.OOOOE+00 Nuclide 005:

I-131 2

0.6946560000E+06 0.1310E+03 8.0357E+01 Xe-131m 0.llOOE-01 none O.OOOOE+00

CA06454 Rev.OO0 Page 41 of 125 none O.OOOOE+00 Nuclide 006:

I-132 2

0.8280000000E+04 0.1320E+03 2.6686E+01 none O.OOOOE+00 none O.OOOOE+00 none O.OOOOE+00 Nuclide 007:

I-133 2

0.7488000000E+05 0.1330E+03 1.1319E+02 Xe-133m 0.2900E-01 Xe-133 0.9700E+00 none O.OOOOE+00 Nuclide 008:

I-134 2

0.3156000000E+04 0.1340E+03 1.5266E+01 none O.OOOOE+00 none O.OOOOE+00 none O.OOOOE+00 Nuclide 009:

I-135 2

0.2379600000E+05 0.1350E+03 6.2112E+01 Xe-135m 0.1500E+00 Xe-135 0.8500E+00 none O.OOOOE+00 Nuclide 010:

Xe-133 1

0.4531680000E+06 0.1330E+03 8.2574E+04 none O.OOOOE+00 none O.OOOOE+00 none O.OOOOE+00 Nuclide 011:

Xe-135 1

0.3272400000E+05 0.1350E+03 1.9726E+03 Cs-135 0.1000E+01 none O.OOOOE+00

CA06454 Rev. 00O Page 42 of 125 none O.OOOOE+00 Nuclide 012:

Xe-133m 1

0.1892200000E+06 0.1330E+03 1.1764E+03 Xe-133 0.1000E+01 none O.OOOOE+00 none O.OOOOE+00 Nuclide 013:

Xe-135m 1

0.9180000000E+03 0.1350E+03 2.5814E+02 Xe-135 0.1000E+01 none O.OOOOE+00 none O.OOOOE+00 Nuclide 014:

Xe-138 1

0.8460000000E+03 0.1380E+03 1.3622E+02 none O.OOOOE+00 none O.OOOOE+00 none O.OOOOE+00 End of Nuclear Inventory File

CA06454 Rev.000 Page 43 of 125 ATTACHMENT F NUCLEAR INVENTORY FILE SECO5.NIF Nuclide Inventory Name:

Normalized MACCS Sample 3412 MWth PWR Core Inventory Power Level:

O.lOOOE+01 Nuclides:

05 Nuclide 001:

1-131 2

0.6946560000E+06 0.1310E+03 1.1172E+01 Xe-131m 0.11OOE-01 none O.OOOOE+00 none O.OOOOE+00 Nuclide 002:

1-132 2

0.8280000000E+04 0.1320E+03 2.8485E-01 none O.OOOOE+00 none O.OOOOE+00 none O.OOOOE+00 Nuclide 003:

I-133 2

0.7488000000E+05 0.1330E+03 7.1866E+00 Xe-133m 0.2900E-01 Xe-133 0.9700E+00 none O.OOOOE+00 Nuclide 004:

I-134 2

0.3156000000E+04 0.1340E+03 6.5297E-02 none O.OOOOE+00 none O.OOOOE+00 none O.OOOOE+00 Nuclide 005:

I-135 2

0.2379600000E+05 0.1350E+03 1.7003E+00 Xe-135m 0.1500E+00 Xe-135 0.8500E+00

CA06454 Rev.000 Page 44 of 125 none O.OOOOE+OO End of Nuclear Inventory File

CA06454 Rev.000 Page 45 of 125 ATTACHMENT G NUCLEAR INVENTORY FILE CRCB63.NIF Nuclide Inventory Name:

Normalized MACCS Sample 3412 MWth PWR Core Inventory Power Level:

O.1000E+01 Nuclides:

63 Nuclide 001:

Co-58 7

0.6117120000E+07 0.5800E+02 8.0012E+02 none O.OOOOE+00 none O.OOOOE+00 none O.OOOOE+00 Nuclide 002:

Co-60 7

0.1663401096E+09 0.6000E+02 9.8625E+02 none O.OOOOE+00 none O.OOOOE+00 none O.OOOOE+00 Nuclide 003:

Kr-85 1

0.3382974720E+09 0.8500E+02 3.7180E+02 none O.OOOOE+00 none O.OOOOE+00 none 0.OOOOE+00 Nuclide 004:

Kr-85m 1

0.1612800000E+05 0.8500E+02 7.9679E+03 Kr-85 0.2100E+00 none O.OOOOE+00 none 0.OOOOE+00 Nuclide 005:

Kr-87 1

0.4578000000E+04 0.8700E+02 1.6208E+04 Rb-87 0.1000E+01 none O.OOOOE+00

CA06454 Rev.OOO Page 46 of 125 none O.OOOOE+00 Nuclide 006:

Kr-88 1

0.1022400000E+05 0.8800E+02 2.2658E+04 Rb-88 0.1000E+01 none O.OOOOE+00 none O.OOOOE+00 Nuclide 007:

Rb-86 3

0.1612224000E+07 0.8600E+02 5.9034E+01 none O.OOOOE+00 none O.OOOOE+00 none O.OOOOE+00 Nuclide 008:

Sr-89 5

0.4363200000E+07 0.8900E+02 3.3293E+04 none O.OOOOE+00 none O.OOOOE+00 none O.OOOOE+00 Nuclide 009:

Sr-90 5

0.9189573120E+09 0.9000E+02 3.1769E+03 Y-90 0.1000E+01 none O.OOOOE+00 none O.OOOOE+00 Nuclide 010:

Sr-91 5

0.3420000000E+05 0.9100E+02 3.8931E+04 Y-91M 0.5800E+00 Y-91 0.4200E+00 none O.OOOOE+00 Nuclide 011:

Sr-92 5

0.9756000000E+04 0.9200E+02 4.0190E+04 Y-92 0.1000E+01 none O.OOOOE+00

CA06454 Rev. OOO Page 47 of 125 none O.OOOOE+00 Nuclide 012:

Y-90 9

0.2304000000E+06 0.9000E+02 3.4567E+03 none O.OOOOE+00 none O.OOOOE+00 none O.OOOOE+00 Nuclide 013:

Y-91 9

0.5055264000E+07 0.9100E+02 4.2527E+04 none O.OOOOE+00 none O.OOOOE+00 none O.OOOOE+00 Nuclide 014:

Y-92 9

0.1274400000E+05 0.9200E+02 4.0519E+04 none O.OOOOE+00 none O.OOOOE+00 none O.OOOOE+00 Nuclide 015:

Y-93 9

0.3636000000E+05 0.9300E+02 2.9622E+04 Zr-93 0.1000E+01 none o.OOOOE+00 none O.OOOOE+00 Nuclide 016:

Zr-95 9

0.5527872000E+07 0.9500E+02 5.8246E+04 Nb-95m 0.7000E-02 Nb-95 0.9900E+00 none O.OOOOE+00 Nuclide 017:

Zr-97 9

0.6084000000E+05 0.9700E+02 4.9425E+04 Nb-97m 0.9500E+00 Nb-97 0.5300E-O1

CA06454 Rev.OOO Page 48 of 125 none O.OOOOE+00 Nuclide 018:

Nb-95 9

0.3036960000E+07 0.9500E+02 6.0839E+04 none O.OOOOE+00 none O.OOOOE+00 none O.OOOOE+00 Nuclide 019:

Mo-99 7

0.2376000000E+06 0.9900E+02 5.0834E+04 Tc-99m 0.8800E+00 Tc-99 0.1200E+00 none O.OOOOE+00 Nuclide 020:

Tc-99m 7

0.2167200000E+05 0.9900E+02 4.5424E+04 Tc-99 0.1000E+01 none O.OOOOE+00 none O.OOOOE+00 Nuclide 021:

Ru-103 7

0.3393792000E+07 0.1030E+03 4.8774E+04 Rh-103m 0.1000E+01 none 0.OOOOE+00 none O.OOOOE+00 Nuclide 022:

Ru-105 7

0.1598400000E+05 0.1050E+03 3.1455E+04 Rh-105 0.1000E+01 none O.OOOOE+00 none O.OOOOE+00 Nuclide 023:

Ru-106 7

0.3181248000E+08 0.1060E+03 1.9695E+04 Rh-106 0.1000E+01 none O.OOOOE+00

CA06454 Rev.000 Page 49 of 125 none O.OOOOE+00 Nuclide 024:

Rh-105 7

0.1272960000E+06 0.1050E+03 2.8507E+04 none O.OOOOE+00 none O.OOOOE+00 none O.OOOOE+00 Nuclide 025:

Sb-127 4

0.3326400000E+06 0.1270E+03 2.4299E+03 Te-127m 0.1800E+00 Te-127 0.8200E+00 none O.OOOOE+00 Nuclide 026:

Sb-129 4

0.1555200000E+05 0.1290E+03 8.7888E+03 Te-129m 0.2200E+00 Te-129 0.7700E+00 none O.OOOOE+00 Nuclide 027:

Te-127 4

0.3366000000E+05 0.1270E+03 2.4664E+03 none O.OOOOE+00 none O.OOOOE+00 none O.OOOOE+00 Nuclide 028:

Te-127m 4

0.9417600000E+07 0.1270E+03 4.6272E+02 Te-127 0.9800E+00 none O.OOOOE+00 none O.OOOOE+00 Nuclide 029:

Te-129 4

0.4176000000E+04 0.1290E+03 8.4012E+03 I-129 0.1000E+01 none O.OOOOE+00

CA06454 Rev.000 Page 50 of 125 none O.OOOOE+00 Nuclide 030:

Te-129m 4

0.2903040000E+07 0.1290E+03 1.8872E+03 Te-129 0.6500E+00 I-129 0.3500E+00 none O.OOOOE+00 Nuclide 031:

Te-131m 4

0.1080000000E+06 0.1310E+03 5.0686E+03 Te-131 0.2200E+00 1-131 0.7800E+00 none O.OOOOE+00 Nuclide 032:

Te-132 4

0.2815200000E+06 0.1320E+03 3.8391E+04 I-132 0.1000E+01 none O.OOOOE+00 none O.OOOOE+00 Nuclide 033:

1-131 2

0.6946560000E+06 0.1310E+03 2.7562E+04 Xe-131m 0.11OOE-01 none O.OOOOE+00 none O.OOOOE+00 Nuclide 034:

I-132 2

0.8280000000E+04 0.1320E+03 3.9464E+04 none O.OOOOE+00 none O.OOOOE+00 none O.OOOOE+00 Nuclide 035:

I-133 2

0.7488000000E+05 0.1330E+03 5.5715E+04 Xe-133m 0.2900E-01 Xe-133 0.9700E+00

CA06454 Rev.OOO Page 51 of 125 none O.OOOOE+00 Nuclide 036:

I-134 2

0.3156000000E+04 0.1340E+03 6.2858E+04 none O.OOOOE+00 none O.OOOOE+00 none O.OOOOE+00 Nuclide 037:

I-135 2

0.2379600000E+05 0.1350E+03 5.2964E+04 Xe-135m 0.1500E+00 Xe-135 0.8500E+00 none O.OOOOE+00 Nuclide 038:

Xe-133 1

0.4531680000E+06 0.1330E+03 5.5707E+04 none O.OOOOE+00 none O.OOOOE+00 none O.OOOOE+00 Nuclide 039:

Xe-135 1

0.3272400000E+05 0.1350E+03 1.7708E+04 Cs-135 0.1000E+01 none O.OOOOE+00 none O.OOOOE+00 Nuclide 040:

Cs-134 3

0.6507177120E+08 0.1340E+03 7.1917E+03 none O.OOOOE+00 none O.OOOOE+00 none O.OOOOE+00 Nuclide 041:

Cs-136 3

0.1131840000E+07 0.1360E+03 1.7111E+03 none O.OOOOE+00 none O.OOOOE+00

CA06454 Rev.000 Page 52 of 125 none O.OOOOE+0O Nuclide 042:

Cs-137 3

0.9467280000E+09 0.1370E+03 4.7857E+03 Ba-137m 0.9500E+O0 none O.OOOOE+00 none O.OOOOE+00 Nuclide 043:

Ba-139 6

0.4962000000E+04 0.1390E+03 S.1001E+04 none O.OOOOE+00 none O.OOOOE+00 none O.OOOOE+00 Nuclide 044:

Ba-140 6

0.1100736000E+07 0.1400E+03 5.2928E+04 La-140 0.1000E+01 none O.OOOOE+00 none O.OOOOE+00 Nuclide 045:

La-140 9

0.1449792000E+06 0.1400E+03 5.4255E+04 none O.OOOOE+00 none O.OOOOE+00 none O.OOOOE+00 Nuclide 046:

La-141 9

0.1414800000E+05 0.1410E+03 4.6433E+04 Ce-141 0.1000E+01 none O.OOOOE+00 none O.OOOOE+00 Nuclide 047:

La-142 9

0.5550000000E+04 0.1420E+03 4.4898E+04 none O.OOOOE+00 none O.OOOOE+00

CA06454 Rev.000 Page 53 of 125 none O.OOOOE+00 Nuclide 048:

Ce-141 8

0.2808086400E+07 0.1410E+03 5.1883E+04 none O.OOOOE+00 none O.OOOOE+00 none O.OOOOE+00 Nuclide 049:

Ce-143 8

0.1188000000E+06 0.1430E+03 4.4327E+04 Pr-143 0.1000E+01 none O.OOOOE+00 none O.OOOOE+00 Nuclide 050:

Ce-144 8

0.2456352000E+08 0.1440E+03 4.2317E+04 Pr-144m 0.18OOE-01 Pr-144 0.9800E+00 none O.OOOOE+00 Nuclide 051:

Pr-143 9

0.1171584000E+07 0.1430E+03 4.6904E+04 none O.OOOOE+00 none O.OOOOE+00 none 0.OOOOE+00 Nuclide 052:

Nd-147 9

0.9486720000E+06 0.1470E+03 1.9151E+04 Pm-147 0.1000E+01 none O.OOOOE+00 none O.OOOOE+00 Nuclide 053:

Np-239 8

0.2034720000E+06 0.2390E+03 5.5833E+05 Pu-239 0.1000E+01 none O.OOOOE+00

CA06454 Rev.000 Page 54 of 125 none O.OOOOE+00 Nuclide 054:

Pu-238 8

0.2768863824E+10 0.2380E+03 1.7259E+02 U-234 0.1000E+01 none O.OOOOE+00 none O.OOOOE+00 Nuclide 055:

Pu-239 8

0.7594336440E+12 0.2390E+03 1.1469E+01 U-235 0.1000E+01 none O.OOOOE+00 none O.OOOOE+00 Nuclide 056:

Pu-240 8

0.2062920312E+12 0.2400E+03 2.0026E+01 U-236 0.1000E+01 none O.OOOOE+00 none O.OOOOE+00 Nuclide 057:

Pu-241 8

0.4544294400E+09 0.2410E+03 4.9593E+03 U-237 0.2400E-04 Am-241 0.1000E+01 none O.OOOOE+00 Nuclide 058:

Am-241 9

0.1363919472E+ll 0.2410E+03 7.3183E+00 Np-237 0.1000E+01 none O.OOOOE+00 none O.OOOOE+00 Nuclide 059:

Cm-242 9

0.1406592000E+08 0.2420E+03 2.0078E+03 Pu-238 0.1000E+01 none O.OOOOE+00

CA06454 Rev.000 Page 55 of 125 none O.OOOOE+O0 Nuclide 060:

Cm-244 9

0.571508136E+9 0.2440E+03 3.1650E+02 Pu-240 0.lOOOE+01 none O.OOOOE+00 none O.OOOOE+00 Nuclide 061:

Xe-133m 1

1.8922000000E+05 0.1330E+03 1.7354E+03 Xe-133 0.1000E+01 none O.OOOOE+00 none O.OOOOE+00 Nuclide 062:

Xe-135m 1

9.1800000000E+02 0.1350E+03 1.1635E+04 Xe-135 0.1000E+Ol none O.OOOOE+00 none O.OOOOE+00 Nuclide 063:

Xe-138 1

8.4600000000E+02 0.1380E+03 4.9330E+04 none O.OOOOE+00 none O.OOOOE+00 none O.OOOOE+00 End of Nuclear Inventory File

CA06454 Rev.000 Page 56 of 125 ATTACHMENT H RELEASE FRACTION AND TIMING FILE CEAFFI.RFT Release Fraction and Timing Name:

PWR, RG 1.183, Table 2 Section 3.2 Duration (h): Design Basis Accident O.OOOlE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 Noble Gases:

O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 Iodine:

0.0420E+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 Cesium:

O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 Tellurium:

O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 Strontium:

O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+O0 Barium:

O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 Ruthenium:

O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 Cerium:

O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 Lanthanum:

O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 Non-Radioactive Aerosols (kg):

O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 End of Release File

CA06454 Rev.000 Page 57 of 125 ATTACHMENT I RELEASE FRACTION AND TIMING FILE CEAFFN.RFT Release Fraction and Timing Name:

PWR, RG 1.183, Table 2 Section 3.2 Duration (h): Design Basis Accident O.OOO1E+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 Noble Gases:

0.0820E+OO o .OOOOE+O0 o .OOOOE+00 0.OOOOE+00 Iodine:

O.OOOOE+00 O.OOOOE+00 o .OOOOE+00 O.OOOOE+O0 Cesium:

O.OOOOE+00 o .OOOOE+00 o .OOOOE+00 0.OOOOE+O0 Tellurium:

O.OOOOE+00 O.OOOOE+O0 o .OOOOE+00 o .OOOOE+00 Strontium:

O.OOOOE+00 o.OOOOE+00 o .OOOOE+00 o .OOOOE+00 Barium:

O.OOOOE+00 o .OOOOE+00 0.OOOOE+00 o .OOOOE+O0 Ruthenium:

O.OOOOE+00 o .OOOOE+O0 o.ooooE+o0 O.OOOOE+00 Cerium:

O.OOOOE+00 0.0OOOE+00 O.OOOOE+00 0.OODOE+O0 Lanthanum:

O.OOOOE+00 O.OOOOE+00 o .OOOOE+O0 0. OOOOE+O0 Non-Radioactive Aerosols (kg):

O.OOOOE+00 O.OOOOE+00 000E0 o~oo+oO.OOOOE+00 End of Release File

CA06454 Rev.000 Page 58 of 125 A1YACHMENT J RELEASE FRACTION AND TIMING FILE CEAPRI.RFT Release Fraction and Timing Name:

PWR, RC 1.183, Table 2 Section 3.2 Duration (h): Design Basis Accident O.OOO1E+OO O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO Noble Gases:

O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO Iodine:

l.OOOOE+OO O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO Cesium:

O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO Tellurium:

O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO Strontium:

O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO Barium:

O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO Ruthenium:

O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO Cerium:

O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO Lanthanum:

O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO Non-Radioactive Aerosols (kg):

O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO End of Release File

CA06454 Rev.000 Page 59 of 125 A1TACHMENT K RELEASE FRACTION AND TIMING FILE CEAPRN.RFT Release Fraction and Timing Name:

PWR, RG 1.183, Table 2 Section 3.2 Duration (h): Design Basis Accident O.OOOlE+OO O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO Noble Gases:

l.OOOOE+OO O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO Iodine:

O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO Cesium:

O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO Tellurium:

O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO Strontium:

O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO Barium:

O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO Ruthenium:

O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO Cerium:

O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO Lanthanum:

O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO Non-Radioactive Aerosols (kg):

O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO End of Release File

CA06454 Rev. 000 Page 60 of 125 ATTACHMENT L RELEASE FRACTION AND TIMING FILE CEASEC.RFT Release Fraction and Timing Name:

PWR, RG 1.183, Table 2 Section 3.2 Duration (h): Design Basis Accident O.OOOlE+OO O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO Noble Gases:

O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO Iodine:

l.OOOOE+OO O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO Cesium:

O.OOOOE+00 O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO Tellurium:

O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO Strontium:

O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO Barium:

O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO Ruthenium:

O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO Cerium:

O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO Lanthanum:

O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO Non-Radioactive Aerosols (kg):

O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO O.OOOOE+OO End of Release File

CA06454 Rev.000 Page 61 of 125 ATTACHMENT M RELEASE FRACTION AND TIMING FILE CEACTMT.RFT Release Fraction and Timing Name:

PWR, RG 1.183, Table 2 Section 3.2 Duration (h): Design Basis Accident O.OOOlE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 Noble Gases:

0.0820E+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 Iodine:

0.0220E+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 Cesium:

O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 Tellurium:

O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 Strontium:

O.OOOOE+00O O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 Barium:

O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 Ruthenium:

O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 Cerium:

O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 Lanthanum:

O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 Non-Radioactive Aerosols (kg):

O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 End of Release File

CA06454 Rev.OOO Page 62 of 125 ATTACHMENT N CONVERSION FACTORS FILE FGR63.INP FGRDCF 10/24/95 03:24:50 beta-test version 1.10, minor FORTRAN fixes 5/4/95 Implicit daughter halflives (m) less than 90 and less than 0.100 of parent 9 ORGANS DEFINED IN THIS FILE:

GONADS BREAST LUNGS RED MARR BONE SUR THYROID REMAINDER EFFECTIVE SKIN(FGR) 63 NUCLIDES DEFINED IN THIS FILE:

Co-S8 Y Co-60 Y Kr-85 Kr-85m Kr-87 Kr-88 Rb-86 Sr-89 Sr-90 Sr-91 Including:Y-91m Sr-92 Y-90 Y-91 Y-92 Y-93 Zr-95 Zr-97 Including:Nb-97m , Including:Nb-97 Nb-95 Mo-99 Tc-99m Ru-103 Including:Rh-103m Ru-105 Ru-106 Including:Rh-106 Rh-105 Sb-127 Sb-129 Te-127 Te-127m Te-129 Te-129m Including:Te-129 Te-131m Including:Te-131 Te-132 1-131 I-132 I-133 1-134 1-135 Including:Xe-135m

CA06454 Rev. OOO Page 63 of 125 Xe-133 Xe-135 Cs-134 Cs-136 Cs-137 Including:Ba-137m Ba-139 Ba-140 La-140 La-141 La-142 Ce-141 Ce-143 Ce-144 Including:Pr-144m, Including:Pr-144 Pr-143 Nd-147 Np-239 Pu-238 Pu-239 Pu-240 Pu-241 Am-241 Cm-242 Cm-244 Xe-133m Xe-135m Xe-138 CLOUDSHINE GROUND GROUND GROUND INHALED INHALED INGESTION SHINE 8HR SHINE 7DAY SHINE RATE ACUTE CHRONIC Co-58 GONADS 4.660E-14 2.867E-11 5.828E-10 9.970E-16-1.000E+00 6.170E-10 1.040E-09 BREAST 5.300E-14 2.737E-11 5.565E-10 9.520E-16-1.000E+00 9.370E-10 1.790E-10 LUNGS 4 .640E-14 2.617E-11 5.319E-10 9.100E-16-1.OOOE+00 1.600E-08 8.530E-11 RED MARR 4 .530E-14 2.671E-11 5.430E-10 9.290E-16-1.OOOE+00 9.230E-10 2.600E-10 BONE SUR 7.410E-14 3.795E-11 7.716E-10 1.320E-15-1.000E+00 6.930E-10 1.250E-10 THYROID 4.770E-14 2.720E-l1 5.530E-1O 9.460E-16-1.000E+00 8.720E-1O 6.310E-11 REMAINDER 4.440E-14 2.585E-11 5.2S5E-10 8.990E-16-1.O00E+00 1.890E-09 1.580E-09 EFFECTIVE 4.760E-14 2.732E-11 5.553E-10 9.500E-16-1.000E+00 2.940E-09 8.090E-10 SKIN(FGR) 5.580E-14 3.278E-11 6.664E-10 1.140E-15-1.000E+00 0. 000E+00 0.OOOE+00 Co-60 GONADS 1.230E-13 7.056E-11 1.480E-09 2.450E-15-1.000E+00 4.760E-09 3.190E-09 BREAST 1.390E-13 6.739E-11 1.413E-09 2.340E-15-1.OOOE+00 1.840E-08 1.100E-09 LUNGS 1.240E-13 6.537E-11 1.371E-09 2.270E-15-1.OOOE+00 3.450E-07 8.770E-10 RED MARR 1.230E-13 6.710E-11 1.407E-09 2.330E-15-1.000E+00 1.720E-08 1.320E-09 BONE SUR 1.780E-13 8.956E-11 1.879E-09 3.110E-15-1.000E+00 1.350E-08 9.390E-10 THYROID 1.270E-13 6.480E-11 1.359E-09 2.250E-15-1.OOOE+00 1.620E-08 7. 880E-10 REMAINDER 1.200E-13 6.508E-11 1.365E-09 2.260E-15-1.OOOE+00 3.600E-08 4.970E-09 EFFECTIVE 1.260E-13 6.768E-11 1.419E-09 2.350E-15-1.OOOE+00 5.910E-08 2.770E-09 SKIN(FGR) 1.450E-13 7.948E-11 1.667E-09 2.760E-15-1.000E+00 O.OOOE+00 0.OOOE+00 Kr-85 GONADS 1.170E-16 8.121E-14 1.704E-12 2.820E-18-1.OOOE+00 0.000E+00 0. OOOE+00 BREAST 1.340E-16 7.891E-14 1.656E-12 2.740E-18-1.OOOE+00 0.OOOE+00 0.OOOE+00 LUNGS 1.140E-16 7.056E-14 1.481E-12 2.450E-18-1.000E+00 0. 000E+00 0. OOOE+00 RED MARR 1.090E-16 6.998E-14 1.469E-12 2.430E-18-1.OOOE+00 O.000E+00 0. OOOE+00 BONE SUR 2.200E-16 1.287E-13 2.702E-12 4.470E-18-1.OOOE+00 0.OOOE+00 0.OOOE+00

CA06454 Rev.000 Page 64 of 125 THYROID 1.180E-16 7.459E-14 1. 565E-12 2. 590E-1B8-1. OOOE+00 O.000E+00 0. OOOE+00 REMAINDER 1. 090E-16 6.941E-14 1.457E-12 2 .410E-18-1.OOOE+00 o.000E+00 0. OOOE+00 EFFECTIVE 1. 190E-16 7.603E-14 1. 596E-12 2 .640E-18-1.000E+00 o.000E+00 0. OOOE+00 SKIN(FGR) 1.320E-14 2.304E-11 4.835E-10 8. OOOE-16-1 . OOE+00 0. OOOE+00 0.OOOE+00 Kr-85m GONADS 7.310E-15 2.594E-12 3.653E-12 1. 570E-16-1 . OOE+00 O.OOOE+00 O.OOOE+00 BREAST 8.410E-15 2.527E-12 3.560E-12 1. 530E-16-1 .OOOE+O0 o.OOOE+00 o.OOOE+00 LUNGS 7.040E-15 2.379E-12 3.351E-12 1 .440E-16-1 .OOOE+00 o.OOOE+00 o.OOOE+00 RED MARR 6.430E-15 2.346E-12 3.304E-12 1. 420E-16-1 .OOOE+00 0.OOOE+00 o.OOOE+00 BONE SUR 1.880E-14 5.286E-12 7.446E-12 3 .200E-16-1.OOOE+00 0. OOOE+00 0.000E+00 THYROID 7.330E-15 2.395E-12 3.374E-12 1.450E-16-1.OOOE+O0 o.000E+00 o.OOOE+00 REMAINDER 6.640E-15 2.313E-12 3.257E-12 1.400E-16-1.OOOE+00 O.000E+00 0.OOOE+00 EFFECTIVE 7.480E-15 2.511E-12 3.537E-12 1. 520E-16-1. OOOE+O0 0. OOOE+00 0.OOOE+00 SKIN(FGR) 2.240E-14 2.247E-11 3.164E-11 1.360E-15-1.OOOE+00 o.OOOE+00 o.OOOE+00 Kr-87 GONADS 4.OOOE-14 4.962E-12 S. 026E-12 7 .610E-16-1.OOOE+00 0.000E+00 o.OOOE+00 BREAST 4.500E-14 4.740E-12 4. 802E-12 7.270E-16-1.OOOE+00 0. 000E+00 0. OOOE+00 LUNGS 4.040E-14 4.603E-12 4.663E-12 7. 060E-16-1 .OOOE+00 o.OOOE+00 o. OOOE+00 RED MARR 4.OOOE-14 4 .708E-12 4.769E-12 7 .220E-16-1 .OOOE+00 o.OOOE+00 o.OOOE+00 BONE SUR 6.020E-14 6.514E-12 6.598E-12 9. 990E-16-1. OOOE+00 0. OOOE+00 0.OOOE+00 THYROID 4.130E-14 4 .473E-12 4.531E-12 6.860E-16-1.OOOE+00 0. OOOE+00 0.OOOE+00 REMAINDER 3.910E-14 4.590E-12 4.650E-12 7. 040E-16-1 .OOOE+00 o.OOOE+00 0.OOOE+00 EFFECTIVE 4.120E-14 4.773E-12 4.835E-12 7 .320E-16-1 .OOOE+00 0.000E+00 0.OOOE+00 SKIN(FGR) 1.370E-13 8.802E-11 8.916E-11 1 .3S0E-14-1.OOOE+00 0. OOOE+00 o.OOOE+00 Kr-88 GONADS 9.900E-14 2.278E-11 2.655E-11 1.8BOOE-15-1 . OOE+00 0.OOOE+00 o.OOOE+00 BREAST 1.110E-13 2.177E-11 2.537E-11 1.720E-15-1 .OOOE+O0 o.000E+00 O.OOOE+00 LUNGS 1.010E-13 2.139E-11 2.493E-11 1. 690E-15-1 .OOOE+O0 o.OOOE+00 o.OOOE+00 RED MARR 1.OOOE-13 2.190E-11 2.552E-11 1.730E-15-1.OOOE+00 0.OOOE+00 o.OOOE+00 BONE SUR 1.390E-13 2.886E-11 3.363E-11 2.280E-15-1.OOOE+00 O.000E+00 0.OOOE+00 THYROID 1.030E-13 2.012E-11 2.345E-ll 1.590E-15-1.OOOE+00 O.000E+00 o.OOOE+00 REMAINDER 9.790E-14 2.139E-11 2.493E-11 1. 690E-15-1 .OOOE+00 0.OOOE+00 0.OOOE+00 EFFECTIVE 1. 020E-13 2.202E-11 2.567E-11 1. 740E-15-1 .OOOE+00 O.000E+00 o.OOOE+00 SKIN(FGR) 1.350E-13 5.607E-11 6.534E-11 4 .430E-15-1.OOOE+O0 0. 000E+00 0.OOOE+00 Rb-86 GONADS 4 .710E-15 2.788E-12 5.187E-11 9 .740E-17-1 .OOOE+00 1.340E-09 2.150E-09 BREAST 5.340E-15 2.662E-12 4.953E-11 9. 300E-17-1 . OOE+00 1.330E-09 2.140E-09 LUNGS 4.710E-15 2.553E-12 4.750E-11 8. 920E-17-1 .OOOE+00 3.300E-09 2.140E-09 RED MARR 4.640E-15 2.619E-12 4.873E-11 9.150E-17-1.OOOE+00 2.320E-09 3.720E-09 BONE SUR 7.050E-15 3.635E-12 6.764E-11 1. 270E-16-1 .OOOE+00 4 .270E-09 6.860E-09 THYROID 4 .840E-15 2.599E-12 4.836E-11 9.080E-17-1 .OOOE+O0 1.330E-09 2.140E-09 REMAINDER 4.520E-15 2.542E-12 4.729E-11 B. 880E-17-1 .OOOE+00 1.380E-09 2.330E-09 EFFECTIVE 4.810E-15 2.665E-12 4.958E-11 9 .310E-17-1 .OOOE+00 1.790E-09 2.530E-09 SKIN(FGR) 4.850E-14 2.210E-10 4.111E-09 7.720E-15-1.OOOE+00 o.OOOE+00 o.OOOE+00 Sr-89 GONADS 7.730E-17 7.155E-14 1.436E-12 2 .490E-18-1.OOOE+00 7.950E-12 8.050E-12 BREAST 9.080E-17 7.212E-14 1.447E-12 2.SlOE-18-1.OOOE+00 7.960E-12 7.980E-12 LUNGS 7.OBOE-17 5.689E-14 1.142E-12 1.980E-18-1.OOOE+00 8.350E-08 7.970E-12 RED MARR 6.390E-17 5.345E-14 1.073E-12 1.8660E-18-1 .OOOE+00 1. 070E-10 1.080E-10 BONE SUR 1.940E-16 1.560E-13 3.131E-12 S5.430E-18-1 .OO0E+00 1.590E-10 1.610E-10 THYROID 7.600E-17 6.063E-14 1.217E-12 2 .110E-18-1 .OOOE+00 7. 960E-12 7.970E-12 REMAINDER 6.710E-17 S. 603E-14 1.124E-12 1. 950E-18-1 .OOOE+00 3.970E-09 8.250E-09 EFFECTIVE 7.730E-17 6.523E-14 1.309E-12 2 .270E-18-1.OOOE+00 1.120E-08 2.500E-09 SKIN(FGR) 3.690E-14 1.914E-10 3.841E-09 6.660E-15-1.OOOE+00 O.OOOE+00 O.OOOE+00

CA06454 Rev. OOO Page 65 of 125 Sr-90 GONADS 7.780E-18 9.590E-15 2.014E-13 3.330E-19-1.OOOE+00 2.690E-10 5.040E-11 BREAST 9.490E-18 1.008E-14 2.116E-13 3.500E-19-1.OOOE+00 2.690E-10 5.040E-11 LUNGS 6.440E-18 6.307E-15 1.324E-13 2.190E-l9-l.OOOE+00 2.860E-06 5.040E-l1 RED MARR 5.440E-18 5.558E-15 1.167E-13 1.930E-19-1.OOOE+00 3.280E-08 6.450E-09 BONE SUR 2.280E-17 2.393E-14 5.025E-13 8.310E-19-1.OOOE+00 7.090E-08 1.390E-08 THYROID 7.330E-18 7.171E-15 1.506E-13 2.490E-19-1.OOOE+00 2.690E-10 5.040E-11 REMAINDER 6.110E-18 6.422E-15 1.348E-13 2.230E-19-1.OOOE+00 5.730E-09 6.700E-09 EFFECTIVE 7.530E-18 8.179E-15 1.717E-13 2.840E-19-1.OOOE+00 3.510E-07 3.230E-09 SKIN(FGR) 9.200E-15 4.032E-12 8.46SE-11 1.400E-16-1.OOOE+0O O.OOOE+00 O.OOOE+OO Sr-91 GONADS 4.819E-14 2.155E-11 5.062E-11 1.026E-15-1.OOOE+00 5.669E-11 2.520E-10 BREAST 5.477E-14 2.059E-11 4.838E-11 9.806E-16-1.OOOE+00 1.775E-11 3.676E-11 LUNGS 4.803E-14 1.970E-11 4.626E-11 9.376E-16-1.OOOE+00 2.170E-09 1.055E-11 RED MARR 4.691E-14 2.011E-11 4.722E-11 9.570E-16-1.OOOE+00 2.275E-11 5.659E-11 BONE SUR 7.674E-14 2.852E-11 6.709E-11 1.360E-15-1.OOOE+00 1.306E-11 2.070E-11 THYROID 4.938E-14 2.035E-11 4.782E-11 9.693E-16-1.OOOE+00 9.930E-12 1.968E-12 REMAINDER 4.610E-14 1.948E-11 4.573E-11 9.268E-16-1.OOOE+00 5.802E-10 2.557E-09 EFFECTIVE 4.924E-14 2.057E-11 4.832E-11 9.793E-16-1.OOOE+00 4.S47E-10 8.455E-10 SKIN(FGR) 9.938E-14 1.748E-10 3.987E-10 8.080E-15-1.OOOE+O0 O.OOOE+00 O.OOOE+00 Sr-92 GONADS 6.610E-14 1.593E-11 1.830E-11 1.300E-15-1.OOOE+00 1.020E-11 8.180E-11 BREAST 7.480E-14 1.520E-11 1.745E-11 1.240E-15-1.OOOE+00 6.490E-12 1.700E-11 LUNGS 6.670E-14 1.483E-11 1.703E-11 1.210E-15-1.OOOE+00 1.050E-09 7.220E-12 RED MARR 6.620E-14 1.520E-11 1.745E-11 1.240E-15-1.OOOE+00 6.980E-12 2.290E-11 BONE SUR 9.490E-14 2.010E-11 2.308E-11 1.640E-15-1.OOOE+00 4.360E-12 8.490E-12 THYROID 6.820E-14 1.446E-11 1.661E-11 1.180E-15-1.OOOE+00 3.920E-12 1.300E-12 REMAINDER 6.450E-14 1.471E-11 1.689E-11 1.200E-15-1.OOOE+00 2.900E-10 1.720E-09 EFFECTIVE 6.790E-14 1.532E-11 1.759E-11 1.250E-15-1.OOOE+00 2.180E-10 5.430E-10 SKIN(FGR) 8.560E-14 2.280E-11 2.618E-11 1.860E-15-1.OOOE+00 O.OOOE+OO O.OOOE+O0 Y-90 GONADS 1.890E-16 1.586E-13 1.601E-12 5.750E-18-1.OOOE+00 5.170E-13 1.430E-14 BREAST 2.200E-16 1.578E-13 1.593E-12 5.720E-18-1.OOOE+00 5.170E-13 1.270E-14 LUNGS 1.770E-16 1.313E-13 1.326E-12 4.760E-18-1.OOOE+00 9.310E-09 1.260E-14 RED MARR 1.620E-16 1.261E-13 1.273E-12 4.570E-18-1.OOOE+00 1.520E-11 3.700E-13 BONE SUR 4.440E-16 3.228E-13 3.259E-12 1.170E-17-1.OOOE+00 1.510E-11 3.670E-13 THYROID 1.870E-16 1.38SE-13 1.398E-12 5.020E-18-1.OOOE+00 5.170E-13 1.260E-14 REMAINDER 1.680E-16 1.291E-13 1.303E-12 4.680E-18-1.OOOE+00 3.870E-09 9.680E-09 EFFECTIVE 1.900E-16 1.468E-13 1.482E-12 5.320E-18-1.OOOE+00 2.280E-09 2.910E-09 SKIN(FGR) 6.240E-14 2.897E-10 2.924E-09 1.050E-14-1.OOOE+0O O.OOOE+00 O.OOOE+OO Y-91 GONADS 2.560E-16 1.756E-13 3.546E-12 6.110E-18-1.OOOE+00 8.200E-12 3.540E-12 BREAST 2.930E-16 1.713E-13 3.459E-12 5.960E-18-1.OOOE+00 8.920E-12 5.540E-13 LUNGS 2.500E-16 1.526E-13 3.082E-12 5.310E-18-1.OOOE+00 9.870E-08 2.020E-13 RED MARR 2.410E-16 1.521E-13 3.070E-12 5.290E-18-1.OOOE+00 3.190E-10 6.590E-12 BONE SUR 4.560E-16 2.903E-13 5.862E-12 1.OlOE-17-1.OOOE+00 3.180E-10 6.130E-12 THYROID 2.600E-16 1.564E-13 3.157E-12 5.440E-18-1.OOOE+00 8.500E-12 1.290E-13 REMAINDER 2.390E-16 1.509E-13 3.047E-12 5.250E-18-1.OOOE+00 4.200E-09 8.570E-09 EFFECTIVE 2.600E-16 1.650E-13 3.332E-12 5.740E-18-1.OOOE+00 1.320E-08 2.570E-09 SKIN(FGR) 3.850E-14 1.989E-10 4.016E-09 6.920E-15-1.OOOE+00 O.OOOE+O0 O.OOOE+00 Y-92 GONADS 1.270E-14 3.B55E-12 4.872E-12 2.650E-16-1.OOOE+00 2.610E-12 1.960E-11 BREAST 1.440E-14 3.680E-12 4.652E-12 2.530E-16-1.OOOE+00 1.500E-12 3.550E-12 LUNGS 1.270E-14 3.535E-12 4.468E-12 2.430E-16-1.OOOE+00 1.240E-09 1.390E-12

CA06454 Rev. 000 Page 66 of 125 RED MARR 1.250E-14 3.608E-12 4.560E-12 2.480E-16-1.OOOE+00 2.070E-12 4.910E-12 BONE SUR 1.950E-14 5.091E-12 6.435E-12 3.500E-16-1.OOOE+00 1.510E-12 1.750E-12 THYROID 1.300E-14 3.579E-12 4.523E-12 2.460E-16-1.OOOE+00 1.050E-12 1.770E-13 REMAINDER 1.220E-14 3.506E-12 4.431E-12 2.410E-16-1.OOOE+00 2.030E-10 1.700E-09 EFFECTIVE 1.300E-14 3.680E-12 4.652E-12 2.530E-16-1.OOOE+00 2.110E-10 5.150E-10 SKIN(FGR) 1.140E-13 2.022E-10 2.5S6E-10 1.390E-14-1.OOOE+OO O.OOOE+OO O.OOOE+OO Y-93 GONADS 4.670E-15 2.108E-12 4.989E-12 9.510E-17-1.OOOE+00 5.310E-12 2.200E-11 BREAST 5.300E-15 2.026E-12 4.794E-12 9.140E-17-1.OOOE+00 1.740E-12 3.130E-12 LUNGS 4.680E-1S 1.937E-12 4.58SE-12 8.740E-17-1.OOOE+00 2.520E-09 8.670E-13 RED MARR 4.580E-15 1.972E-12 4.669E-12 8.900E-17-1.OOOE+00 4.040E-12 4.930E-12 BONE SUR 7.580E-15 2.948E-12 6.977E-12 1.330E-16-1.OOOE+00 3.140E-12 1.730E-12 THYROID 4.790E-15 1.908E-12 4.516E-12 8.610E-17-1.OOOE+00 9.260E-13 1.260E-13 REMAINDER 4.510E-15 1.919E-12 4.543E-12 8.660E-17-1.OOOE+00 9.250E-10 4.090E-09 EFFECTIVE 4.800E-15 2.021E-12 4.784E-12 9.120E-17-1.OOOE+00 5.820E-10 1.230E-09 SKIN(FGR) 8.500E-14 2.726E-10 6.452E-10 1.230E-14-1.OOOE+OO O.OOOE+OO O.OOOE+OO Zr-95 GONADS 3.530E-14 2.182E-11 4.421E-10 7.590E-16-1.OOOE+00 1.880E-09 8.160E-10 BREAST 4.010E-14 2.084E-11 4.223E-10 7.250E-16-1.OOOE+OO 1.910E-09 1.050E-10 LUNGS 3.510E-14 1.989E-11 4.030E-10 6.920E-16-1.OOOE+00 2.170E-09 2.340E-11 RED MARE 3.430E-14 2.030E-11 4.112E-10 7.060E-16-1.OOOE+00 1.300E-08 2.140E-10 BONE SUR 5.620E-14 2.875E-11 5.824E-10 1.OOOE-15-1.OOOE+00 1.030E-07 4.860E-10 THYROID 3.610E-14 2.076E-11 4.205E-10 7.220E-16-1.OOOE+00 1.440E-09 8.270E-12 REMAINDER 3.360E-14 1.963E-11 3.978E-10 6.830E-16-1.OOOE+00 2.280E-09 2.530E-09 EFFECTIVE 3.600E-14 2.078E-11 4.211E-10 7.230E-16-1.OOOE+00 6.390E-09 1.020E-09 SKIN(FGR) 4.500E-14 2.561E-11 5.190E-10 8.910E-16-1.OOOE+OO O.OOOE+OO O.OOOE+OO Zr-97 GONADS 4.331E-14 2.179E-11 7.799E-11 9.253E-16-1.OOOE+00 1.840E-10 6.228E-10 BREAST 4.928E-14 2.083E-11 7.455E-11 8.846E-16-1.OOOE+00 4.706E-11 8.137E-11 LUNGS 4.322E-14 1.992E-11 7.127E-11 8.456E-16-1.OOOE+00 4.108E-09 1.770E-11 RED MARR 4.224E-14 2.034E-11 7.279E-11 8.634E-16-1.OOOE+00 6.376E-11 1.302E-10 BONE SUR 6.897E-14 2.881E-11 1.031E-10 1.224E-15-1.OOOE+00 3.504E-11 4.558E-11 THYROID 4.443E-14 2.061E-11 7.377E-11 8.755E-16-1.OOOE+00 2.315E-11 2.671E-12 REMAINDER 4.139E-14 1.966E-11 7.035E-11 8.34SE-16-l.OOOE+00 2.041E-09 6.990E-09 EFFECTIVE 4.432E-14 2.078E-11 7.438E-11 8.824E-16-1.OOOE+00 1.171E-09 2.283E-09 SKIN(FGR) 9.835E-14 2.281E-10 8.148E-10 9.587E-15-1.OOOE+OO O.OOOE+OO O.OOOE+OO Nb-95 GONADS 3.660E-14 2.253E-11 4.43SE-10 7.850E-16-1.OOOE+00 4.320E-10 8.050E-10 BREAST 4.160E-14 2.150E-11 4.231E-10 7.490E-16-1.OOOE+00 4.070E-10 1.070E-10 LUNGS 3.650E-14 2.055E-11 4.04SE-10 7.160E-16-1.OOOE+00 8.320E-09 2.740E-11 RED MARR 3.560E-14 2.101E-11 4.13SE-10 7.320E-16-1.OOOE+00 4.420E-10 1.990E-10 BONE SUR 5.790E-14 2.957E-11 5.819E-10 1.030E-15-l.OOOE+00 5.130E-10 2.940E-10 THYROID 3.750E-14 2.144E-11 4.220E-10 7.470E-16-1.OOOE+00 3.580E-10 1.180E-11 REMAINDER 3.490E-14 2.032E-11 4.000E-10 7.080E-16-1.000E+00 1.070E-09 1.470E-09 EFFECTIVE 3.740E-14 2.147E-11 4.226E-10 7.480E-16-1.000E+00 1.570E-09 6.950E-10 SKIN(FGR) 4.300E-14 2.598E-11 5.112E-10 9.050E-16-1.OOOE+00 O.OOOE+00 0.000E+00 Mo-99 GONADS 7.130E-15 4.282E-12 4.403E-11 1.550E-16-1.OOOE+00 9.510E-11 2.180E-10 BREAST 8.130E-15 4.116E-12 4.233E-11 1.490E-16-1.OOOE+00 2.750E-11 3.430E-11 LUNGS 7.060E-15 3.867E-12 3.977E-11 1.400E-16-l.000E+00 4.290E-09 1.510E-11 RED MARR 6.820E-15 3.923E-12 4.034E-11 1.420E-16-1.OOOE+00 5.240E-11 8.320E-11 BONE SUR 1.240E-14 6.105E-12 6.278E-11 2.210E-16-1.OOOE+00 4.130E-11 6.320E-11 THYROID 7.270E-15 4.033E-12 4.147E-11 1.460E-16-1.OOOE+00 1.520E-11 1.030E-11 REMAINDER 6.740E-15 3.812E-12 3.920E-11 1.380E-16-1.OOOE+00 1.740E-09 4.280E-09

CA06454 Rev. 000 Page 67 of 125 EFFECTIVE 7.280E-15 4.061E-12 4.176E-11 1.470E-16-1.OOOE+00 1.070E-09 1.360E-09 SKIN(FGR) 3.140E-14 1.039E-10 1.06BE-09 3.760E-15-1.OOOE+00 O.OOOE+00 O.OOOE+00 Tc-99m GONADS 5.750E-15 2.334E-12 3.877E-12 1.240E-16-1.OOOE+00 2.770E-12 9.750E-12 BREAST 6.650E-15 2.258E-12 3.752E-12 1.200E-16-1.OOOE+00 2.150E-12 3.570E-12 LUNGS 5.490E-15 2.127E-12 3.533E-12 1.130E-16-1.OOOE+00 2.280E-11 3.140E-12 RED MARR 4.910E-15 2.070E-12 3.439E-12 1.100E-16-1.OOOE+00 3.360E-12 6.290E-12 BONE SUR 1.630E-14 5.383E-12 8.942E-12 2.860E-16-1.OOOE+00 2.620E-12 4.060E-12 THYROID 5.750E-15 2.145E-12 3.564E-12 1.140E-16-1.OOOE+00 5.010E-11 8.460E-11 REMAINDER 5.150E-15 2.070E-12 3.439E-12 1.100E-16-1.OOOE+00 1.020E-11 3.340E-11 EFFECTIVE 5.890E-15 2.277E-12 3.783E-12 1.210E-16-1.OOOE+00 8.800E-12 1.680E-11 SKIN(FGR) 7.140E-15 2.710E-12 4.502E-12 1.440E-16-1.OOOE+00 O.OOOE+00 O.OOOE+00 Ru-103 GONADS 2.191E-14 1.404E-11 2.783E-10 4.892E-16-1.OOOE+00 3.070E-10 S.720E-10 BREAST 2.512E-14 1.350E-11 2.677E-10 4.705E-16-1.OOOE+00 3.110E-10 1.200E-10 LUNGS 2.180E-14 1.273E-11 2.522E-10 4.432E-16-1.OOOE+00 1.561E-08 7.310E-11 RED MARR 2.100E-14 1.287E-11 2.551E-10 4.483E-16-1.000E+00 3.190E-10 1.660E-10 BONE SUR 3.892E-14 1.958E-11 3.882E-10 6.823E-16-1.OOOE+00 2.370E-10 9.631E-11 THYROID 2.241E-14 1.331E-11 2.639E-10 4.638E-16-1.000E+00 2.570E-10 6.250E-11 REMAINDER 2.080E-14 1.248E-11 2.472E-10 4.346E-16-1.OOOE+00 1.250E-09 2.110E-09 EFFECTIVE 2.251E-14 1.332E-11 2.641E-10 4.642E-16-1.OOOE+00 2.421E-09 8.271E-10 SKIN(FGR) 2.774E-14 1.78SE-11 3.543E-10 6.229E-16-1.OOOE+00 O.OOOE+OO O.OOOE+00 Ru-105 GONADS 3.720E-14 1.327E-11 1.861E-11 8.070E-16-1.OOOE+00 1.590E-11 9.670E-11 BREAST 4.240E-14 1.271E-11 1.783E-11 7.730E-16-1.OOOE+00 6.610E-12 1.590E-11 LUNGS 3.700E-14 1.210E-11 1.697E-11 7.360E-16-1.OOOE+00 5.730E-10 6.210E-12 RED MARR 3.590E-14 1.230E-11 1.725E-11 7.480E-16-1.000E+00 7.700E-12 2.350E-11 BONE SUR 6.280E-14 1.809E-11 2.537E-11 1.100E-15-1.OOOE+00 4.620E-12 8.890E-12 THYROID 3.800E-14 1.260E-11 1.766E-11 7.660E-16-1.OOOE+00 4.150E-12 1.820E-12 REMAINDER 3.540E-14 1.189E-11 1.667E-11 7.230E-16-1.OOOE+00 1.610E-10 8.540E-10 EFFECTIVE 3.810E-14 1.265E-11 1.773E-11 7.690E-16-1.OOOE+00 1.230E-10 2.870E-10 SKIN(FGR) 6.730E-14 7.368E-11 1.033E-10 4.480E-15-1.OOOE+00 O.OOOE+00 O.OOOE+00 Ru-106 GONADS 1.010E-14 6.411E-12 1.340E-10 2.230E-16-1.OOOE+00 1.300E-09 1.640E-09 BREAST 1.160E-14 6.152E-12 1.286E-10 2.140E-16-1.OOOE+00 1.780E-09 1.440E-09 LUNGS 1.010E-14 5.836E-12 1.220E-10 2.030E-16-1.OOOE+00 1.040E-06 1.420E-09 RED MARR 9.750E-15 5.893E-12 1.232E-10 2.050E-16-1.OOOE+00 1.760E-09 1.460E-09 BONE SUR 1.720E-14 8.883E-12 1.856E-10 3.090E-16-1.OOOE+00 1.610E-09 1.430E-09 THYROID 1.030E-14 6.066E-12 1.268E-10 2.110E-16-1.OOOE+00 1.720E-09 1.410E-09 REMAINDER 9.630E-15 5.721E-12 1.196E-10 1.990E-16-1.OOOE+00 1.200E-08 2.110E-08 EFFECTIVE 1.040E-14 6.095E-12 1.274E-10 2.120E-16-1.000E+00 1.290E-07 7.400E-09 SKIN(FGR) 1.090E-13 4.082E-10 8.531E-09 1.420E-14-1.OOOE+00 O.OOOE+00 O.OOOE+00 Rh-105 GONADS 3.640E-15 2.127E-12 1.411E-11 7.980E-17-1.000E+00 2.110E-11 5.800E-11 BREAST 4.160E-15 2.063E-12 1.369E-11 7.740E-17-1.OOOE+00 5.610E-12 8.970E-12 LUNGS 3.570E-15 1.935E-12 1.284E-11 7.260E-17-1.OOOE+00 9.580E-10 3.860E-12 RED MARR 3.380E-15 1.946E-12 1.291E-11 7.300E-17-1.OOOE+00 7.770E-12 1.470E-11 BONE SUR 7.530E-1S 3.332E-12 2.210E-11 1.250E-16-1.OOOE+00 4.460E-12 6.750E-12 THYROID 3.680E-15 1.983E-12 1.316E-11 7.440E-17-1.OOOE+00 2.880E-12 2.910E-12 REMAINDER 3.390E-15 1.885E-12 1.250E-11 7.070E-17-1.OOOE+00 4.530E-10 1.270E-09 EFFECTIVE 3.720E-15 2.031E-12 1.347E-11 7.620E-17-1.OOOE+00 2.580E-10 3.990E-10 SKIN(FGR) 1.070E-14 4.691E-12 3.112E-11 1.760E-16-1.000E+0O O.OOOE+00 0.OOOE+00 Sb-127 GONADS 3.260E-14 1.985E-11 2.441E-10 7.100E-16-1.000E+00 2.520E-10 6.140E-10

CA06454 Rev.OOO Page 68 of 125 BREAST 3.720E-14 1.904E-11 2.341E-10 6.810E-16-1.OOOE+00 9.120E-11 7.600E-11 LUNGS 3.240E-14 1.809E-11 2.224E-10 6.470E-16-1.OOOE+00 6.940E-09 1.570E-11 RED MARR 3.140E-14 1.834E-11 2.255E-10 6.560E-16-1.OOOE+00 1.610E-10 1.330E-10 BONE SUR 5.520E-14 2.720E-11 3.345E-10 9.730E-16-1.OOOE+00 1.340E-10 5.240E-11 THYROID 3.330E-14 1.884E-11 2.317E-10 6.740E-16-1.OOOE+00 6.150E-11 4.640E-12 REMAINDER 3.090E-14 1.775E-11 2.183E-10 6.350E-16-1.OOOE+00 2.330E-09 5.870E-09 EFFECTIVE 3.330E-14 1.890E-11 2.324E-10 6.760E-16-1.OOOE+00 1.630E-09 1.950E-09 SKIN(FGR) 5.580E-14 7.967E-11 9.799E-10 2.850E-15-1.OOOE+OO O.OOOE+OO O.OOOE+OO Sb-129 GONADS 6.970E-14 2.336E-11 3.231E-11 1.440E-15-1.OOOE+00 2.150E-11 1.510E-10 BREAST 7.910E-14 2.222E-11 3.074E-11 1.370E-15-1.OOOE+00 1.280E-11 2.560E-11 LUNGS 6.980E-14 2.141E-11 2.962E-11 1.320E-15-1.OOOE+00 8.980E-10 9.390E-12 RED MARR 6.860E-14 2.190E-11 3.029E-11 1.350E-15-1.OOOE+00 1.700E-11 3.670E-11 BONE SUR 1.070E-13 3.033E-11 4.196E-11 1.870E-15-1.OOOE+00 1.460E-11 1.340E-11 THYROID 7.160E-14 2.174E-11 3.007E-11 1.340E-15-1.OOOE+00 9.720E-12 1.470E-12 REMAINDER 6.710E-14 2.125E-11 2.939E-11 1.310E-15-1.OOOE+00 1.870E-10 1.450E-09 EFFECTIVE 7.140E-14 2.238E-11 3.096E-11 1.380E-15-1.OOOE+00 1.740E-10 4.840E-10 SKIN(FGR) 1.050E-13 8.273E-11 1.144E-10 S.100E-15-1.OOOE+OO O.OOOE+OO O.OOOE+OO Te-127 GONADS 2.370E-16 1.191E-13 2.661E-13 5.480E-18-1.OOOE+00 2.020E-12 4.020E-12 BREAST 2.730E-16 1.158E-13 2.588E-13 5.330E-18-1.OOOE+00 1.880E-12 3.OOOE-12 LUNGS 2.320E-16 1.060E-13 2.370E-13 4.880E-18-1.OOOE+00 4.270E-10 2.890E-12 RED MARR 2.210E-16 1.058E-13 2.365E-13 4.870E-18-1.OOOE+00 4.090E-12 6.570E-12 BONE SUR 4.650E-16 1.862E-13 4.162E-13 8.570E-18-1.OOOE+00 4.090E-12 6.460E-12 THYROID 2.400E-16 1.106E-13 2.472E-13 5.090E-18-1.OOOE+00 1.840E-12 2.860E-12 REMAINDER 2.210E-16 1.036E-13 2.316E-13 4.770E-18-1.OOOE+OO 1.11OE-10 6.130E-10 EFFECTIVE 2.420E-16 1.125E-13 2.515E-13 5.180E-18-1.OOOE+00 8.600E-11 1.870E-10 SKIN(FGR) 1.140E-14 1.173E-11 2.622E-11 5.400E-16-1.OOOE+OO O.OOOE+OO O.OOOE+OO Te-127m GONADS 1.900E-16 4.689E-13 9.642E-12 1.630E-17-1.OOOE+OO 1.100E-10 1.250E-10 BREAST 2.690E-16 5.150E-13 1.OS9E-11 1.790E-17-1.OOOE+OO 1.100E-10 9.740E-11 LUNGS 7.620E-17 1.602E-13 3.295E-12 5.570E-18-1.OOOE+00 3.340E-08 9.620E-11 RED MARR 6.430E-17 1.249E-13 2.567E-12 4.340E-18-1.OOOE+00 5.360E-09 5.430E-09 BONE SUR 3.940E-16 9.005E-13 1.852E-11 3.130E-17-1.OOOE+00 2.040E-08 2.070E-08 THYROID 1.500E-16 2.779E-13 5.714E-12 9.660E-18-1.OOOE+00 9.660E-11 9.430E-11 REMAINDER 8.640E-17 1.999E-13 4.111E-12 6.950E-18-1.OOOE+00 1.660E-09 2.980E-09 EFFECTIVE 1.470E-16 3.251E-13 6.684E-12 1.130E-17-1.OOOE+00 5.810E-09 2.230E-09 SKIN(FGR) 8.490E-16 1.496E-12 3.076E-11 5.200E-17-1.OOOE+OO O.OOOE+OO O.OOOE+OO Te-129 GONADS 2.710E-15 3.889E-13 3.922E-13 6.510E-17-1.OOOE+00 5.050E-13 1.590E-12 BREAST 3.120E-15 3.800E-13 3.832E-13 6.360E-17-1.OOOE+00 5.390E-13 6.050E-13 LUNGS 2.640E-15 3.298E-13 3.326E-13 5.520E-17-1.OOOE+00 1.530E-10 4.910E-13 RED MARR 2.540E-15 3.298E-13 3.326E-13 5.520E-17-1.OOOE+00 6.190E-13 7.640E-13 BONE SUR 4.880E-15 5.753E-13 5.802E-13 9.630E-17-1.OOOE+00 6.220E-13 5.400E-13 THYROID 2.740E-15 3.525E-13 3.555E-13 5.900E-17-1.OOOE+00 5.090E-13 3.360E-13 REMAINDER 2.520E-15 3.262E-13 3.289E-13 5.460E-17-1.OOOE+00 7.280E-12 1.790E-10 EFFECTIVE 2.750E-15 3.590E-13 3.621E-13 6.010E-17-1.OOOE+00 2.090E-11 5.450E-11 SKIN(FGR) 3.570E-14 3.429E-11 3.458E-11 5.740E-15-1.OOOE+OO O.OOOE+OO O.OOOE+OO Te-129m GONADS 3.321E-15 2.206E-12 4.799E-11 8.561E-17-1.OOOE+00 1.783E-10 2.420E-10 BREAST 3.838E-15 2.181E-12 4.739E-11 8.454E-17-1.OOOE+00 1.694E-10 1.664E-10 LUNGS 3.176E-15 1.741E-12 3.815E-11 6.808E-17-1.OOOE+00 4.040E-08 1.593E-10 RED MARR 3.071E-15 1.729E-12 3.793E-11 6.768E-17-1.OOOE+00 3.100E-09 3.500E-09 BONE SUR 5.772E-15 3.287E-12 7.147E-11 1.275E-16-1.OOOE+00 7.050E-09 7.990E-09

CA06454 Rev.000 Page 69 of 125 THYROID 3.341E-15 1.923E-12 4.201E-11 7.495E-17-1.OOOE+00 1.563E-10 1.572E-10 REMAINDER 3.048E-15 1.746E-12 3.822E-11 6.819E-17-1.OOOE+00 3.275E-09 7.196E-09 EFFECTIVE 3.337E-15 1.974E-12 4.308E-11 7.686E-17-1.OOOE+00 6.484E-09 2.925E-09 SKIN(FGR) 3.811E-14 1.501E-10 3.360E-09 6.001E-15-1.OOOE+OO O.OOOE+OO O.OOOE+OO Te-131m GONADS 7.292E-14 4.020E-11 2.343E-10 1.535E-15-1.OOOE+00 2.345E-10 7.415E-10 BREAST 8.286E-14 3.853E-11 2.246E-10 1.472E-15-1.OOOE+00 9.309E-11 1.361E-10 LUNGS 7.265E-14 3.657E-11 2.131E-10 1.397E-15-1.OOOE+00 2.296E-09 6.335E-11 RED MARR 7.097E-14 3.736E-11 2.178E-10 1.427E-15-1.OOOE+00 1.417E-10 2.435E-10 BONE SUR 1.174E-13 5.467E-11 3.189E-10 2.090E-15-1.OOOE+00 2.276E-10 3.248E-10 THYROID 7.471E-14 3.741E-11 2.181E-10 1.429E-15-1.OOOE+00 3.669E-08 4.383E-08 REMAINDER 6.965E-14 3.626E-11 2.113E-10 1.385E-15-1.OOOE+00 9.509E-10 3.153E-09 EFFECTIVE 7.463E-14 3.825E-11 2.229E-10 1.461E-15-1.OOOE+00 1.758E-09 2.514E-09 SKIN(FGR) 1.038E-13 1.033E-10 6.188E-10 4.056E-15-1.OOOE+OO O.OOOE+OO O.OOOE+OO Te-132 GONADS 1.020E-14 6.812E-12 7.706E-11 2.450E-16-1.OOOE+00 4.150E-10 5.410E-10 BREAST 1.180E-14 6.756E-12 7.643E-11 2.430E-16-1.OOOE+00 3.630E-10 3.500E-10 LUNGS 9.650E-15 5.727E-12 6.479E-11 2.060E-16-1.OOOE+00 1.670E-09 3.300E-10 RED MARR 8.950E-15 5.588E-12 6.322E-11 2.010E-16-1.OOOE+00 4.270E-10 4.440E-10 BONE SUR 2.420E-14 1.273E-11 1.441E-10 4.580E-16-1.OOOE+00 7.120E-10 8.300E-10 THYROID 1.020E-14 5.978E-12 6.762E-11 2.150E-16-1.OOOE+00 6.280E-08 5.950E-08 REMAINDER 9.160E-15 5.644E-12 6.385E-11 2.030E-16-1.OOOE+00 7.890E-10 1.490E-09 EFFECTIVE 1.030E-14 6.339E-12 7.171E-11 2.280E-16-1.OOOE+00 2.550E-09 2.540E-09 SKIN(FGR) 1.390E-14 8.313E-12 9.405E-11 2.990E-16-1.OOOE+OO O.OOOE+OO O.OOOE+OO I-131 GONADS 1.780E-14 1.119E-11 1.789E-10 3.940E-16-1.OOOE+00 2.530E-11 4.070E-11 BREAST 2.040E-14 1.082E-11 1.730E-10 3.810E-16-1.OOOE+00 7.880E-11 1.210E-10 LUNGS 1.760E-14 1.016E-11 1.626E-10 3.580E-16-1.OOOE+00 6.570E-10 1.020E-10 RED MARR 1.680E-14 1.022E-11 1.635E-10 3.600E-16-1.OOOE+00 6.260E-11 9.440E-11 BONE SUR 3.450E-14 1.675E-11 2.679E-10 5.900E-16-1.OOOE+00 5.730E-11 8.720E-11 THYROID 1.810E-14 1.053E-11 1.685E-10 3.710E-16-1.OOOE+00 2.920E-07 4.760E-07 REMAINDER 1.670E-14 9.908E-12 1.585E-10 3.490E-16-1.OOOE+00 8.030E-11 1.570E-10 EFFECTIVE 1.820E-14 1.067E-11 1.707E-10 3.760E-16-1.OOOE+00 8.890E-09 1.440E-08 SKIN(FGR) 2.980E-14 1.825E-11 2.920E-10 6.430E-16-1.OOOE+OO O.OOOE+OO O.OOOE+OO I-132 GONADS 1.090E-13 2.523E-11 2.771E-11 2.320E-15-1.OOOE+00 9.950E-12 2.330E-11 BREAST 1.240E-13 2.414E-11 2.652E-11 2.220E-15-1.OOOE+00 1.410E-11 2.520E-11 LUNGS 1.090E-13 2.305E-11 2.532E-11 2.120E-15-1.OOOE+00 2.710E-10 2.640E-11 RED MARR 1.070E-13 2.360E-11 2.592E-11 2.170E-15-1.OOOE+00 1.400E-11 2.460E-11 BONE SUR 1.730E-13 3.327E-11 3.655E-11 3.060E-15-1.OOOE+00 1.240E-11 2.190E-11 THYROID 1.120E-13 2.381E-11 2.616E-11 2.190E-15-1.OOOE+00 1.740E-09 3.870E-09 REMAINDER 1.050E-13 2.283E-11 2.509E-11 2.100E-15-1.OOOE+00 3.780E-11 1.650E-10 EFFECTIVE 1.120E-13 2.403E-11 2.640E-11 2.210E-15-1.OOOE+00 1.030E-10 1.820E-10 SKIN(FGR) 1.580E-13 8.199E-11 9.007E-11 7.540E-15-1.OOOE+OO O.OOOE+OO O.OOOE+OO I-133 GONADS 2.870E-14 1.585E-11 6.748E-11 6.270E-16-1.OOOE+00 1.950E-11 3.630E-11 BREAST 3.280E-14 1.519E-11 6.468E-11 6.010E-16-1.OOOE+00 2.940E-11 4.680E-11 LUNGS 2.860E-14 1.446E-11 6.156E-11 5.720E-16-1.OOOE+00 8.200E-10 4.530E-11 RED MARR 2.770E-14 1.466E-11 6.242E-11 5.800E-16-1.OOOE+00 2.720E-11 4.300E-11 BONE SUR 4.870E-14 2.161E-11 9.202E-11 8.550E-16-1.OOOE+00 2.520E-11 4.070E-11 THYROID 2.930E-14 1.502E-11 6.393E-11 5.940E-16-1.OOOE+00 4.860E-08 9.100E-08 REMAINDER 2.730E-14 1.418E-11 6.038E-11 5.610E-16-1.OOOE+00 5.000E-11 1.550E-10 EFFECTIVE 2.940E-14 1.509E-11 6.425E-11 5.970E-16-1.OOOE+00 1.580E-09 2.800E-09 SKIN(FGR) 5.830E-14 1.150E-10 4.897E-10 4.550E-15-1.OOOE+OO O.OOOE+OO O.OOOE+OO

CA06454 Rev.000 Page 70 of 125 I-134 GONADS 1.270E-13 1.200E-11 1.202E-11 2.640E-15-1.OOOE+00 4.250E-12 1.100E-11 BREAST 1.440E-13 1.145E-11 1.147E-11 2.S20E-15-1.OOOE+00 6.170E-12 1.170E-11 LUNGS 1.270E-13 1.100E-11 1.102E-11 2.420E-15-1.OOOE+00 1.430E-10 1.260E-11 RED MARR 1.250E-13 1.127E-11 1.129E-11 2.480E-15-1.OOOE+00 6.080E-12 1.090E-11 BONE SUR 1.960E-13 1.568E-11 1.571E-11 3.450E-15-1.OOOE+00 5.310E-12 9.320E-12 THYROID 1.300E-13 1.127E-11 1.129E-11 2.480E-15-l.OOOE+00 2.880E-10 6.210E-10 REMAINDER 1.220E-13 1.091E-11 1.093E-11 2.400E-15-1.OOOE+00 2.270E-11 1.340E-10 EFFECTIVE 1.300E-13 1.150E-11 1.152E-11 2.530E-15-1.OOOE+00 3.550E-11 6.660E-11 SKIN(FGR) 1.870E-13 4.477E-11 4.485E-11 9.850E-15-1.OOOE+00 O.OOOE+00 O.OOOE+00 I-135 GONADS 8.078E-14 3.113E-11 5.489E-11 1.599E-15-1.OOOE+00 1.700E-11 3.610E-11 BREAST 9.143E-14 2.971E-11 5.240E-11 1.526E-15-1.OOOE+00 2.340E-11 3.850E-11 LUNGS 8.145E-14 2.886E-11 5.089E-11 1.482E-15-1.OOOE+00 4.410E-10 3.750E-11 RED MARR 8.054E-14 2.965E-11 5.228E-11 1.523E-15-1.OOOE+00 2.240E-11 3.650E-11 BONE SUR 1.184E-13 3.983E-11 7.024E-11 2.046E-15-1.OOOE+00 2.010E-11 3.360E-11 THYROID 8.324E-14 2.852E-11 5.030E-11 1.465E-15-1.000E+00 8.460E-09 1.790E-08 REMAINDER 7.861E-14 2.883E-11 5.084E-11 1.481E-15-1.OOOE+00 4.700E-11 1.540E-10 EFFECTIVE 8.294E-14 2.989E-11 5.271E-11 1.535E-15-1.OOOE+00 3.320E-10 6.080E-10 SKIN(FGR) 1.156E-13 9.826E-11 1.733E-10 5.047E-15-1.000E+00 O.OOOE+00 O.OOOE+00 Xe-133 GONADS 1.610E-15 1.465E-12 2.052E-11 5.200E-17-1.OOOE+00 O.OOOE+00 O.OOOE+00 BREAST 1.960E-15 1.505E-12 2.107E-11 5.340E-17-1.OOOE+00 O.OOOE+00 O.OOOE+00 LUNGS 1.320E-15 1.045E-12 1.464E-11 3.710E-17-1.OOOE+00 O.OOOE+00 0.000E+00 RED MARR 1.070E-15 8.791E-13 1.231E-11 3.120E-17-1.OOOE+00 O.OOOE+00 O.OOOE+00 BONE SUR 5.130E-15 4.254E-12 5.958E-11 1.510E-16-1.OOOE+00 O.OOOE+00 O.OOOE+00 THYROID 1.510E-15 1.181E-12 1.653E-11 4.190E-17-1.OOOE+00 O.OOOE+00 O.OOOE+00 REMAINDER 1.240E-15 1.042E-12 1.460E-11 3.700E-17-1.OOOE+00 O.OOOE+00 O.OOOE+00 EFFECTIVE 1.560E-15 1.299E-12 1.819E-11 4.610E-17-1.OOOE+00 O.OOOE+00 O.OOOE+00 SKIN(FGR) 4.970E-15 1.953E-12 2.734E-11 6.930E-17-1.OOOE+00 0.OOOE+00 O.OOOE+00 Xe-135 GONADS 1.170E-14 5.455E-12 1.194E-11 2.530E-16-1.OOOE+00 O.OOOE+00 O.OOOE+00 BREAST 1.330E-14 5.325E-12 1.166E-11 2.470E-16-1.OOOE+00 O.OOOE+00 O.OOOE+00 LUNGS 1.130E-14 4.959E-12 1.086E-11 2.300E-16-1.OOOE+00 O.OOOE+00 O.OOOE+00 RED MARR 1.070E-14 4.959E-12 1.086E-11 2.300E-16-1.OOOE+00 O.OOOE+00 O.OOOE+00 BONE SUR 2.570E-14 9.120E-12 1.997E-11 4.230E-16-1.OOOE+00 O.OOOE+00 O.OOOE+00 THYROID 1.180E-14 5.023E-12 1.100E-11 2.330E-16-l.000E+00 O.OOOE+00 0.000E+00 REMAINDER 1.080E-14 4.829E-12 1.058E-11 2.240E-16-1.OOOE+00 O.OOOE+00 O.OOOE+00 EFFECTIVE 1.190E-14 5.217E-12 1.142E-11 2.420E-16-1.OOOE+00 O.OOOE+00 O.OOOE+00 SKIN(FGR) 3.120E-14 4.506E-11 9.867E-11 2.090E-15-1.000E+00 O.OOOE+00 O.OOOE+00 Cs-134 GONADS 7.400E-14 4.607E-11 9.646E-10 1.600E-15-1.000E+00 1.300E-08 2.060E-08 BREAST 8.430E-14 4.406E-11 9.224E-10 1.530E-15-1.OOOE+00 1.080E-08 1.720E-08 LUNGS 7.370E-14 4.204E-11 8.802E-10 1.460E-15-1.OOOE+00 1.180E-08 1.760E-08 RED MARR 7.190E-14 4.262E-11 8.922E-10 1.480E-15-1.OOOE+00 1.180E-08 1.870E-08 BONE SUR 1.200E-13 6.105E-11 1.278E-09 2.120E-15-1.OOOE+00 1.100E-08 1.740E-08 THYROID 7.570E-14 4.377E-11 9.163E-10 1.520E-15-1.OOOE+00 1.110E-08 1.760E-08 REMAINDER 7.060E-14 4.147E-11 8.681E-10 1.440E-15-1.OOOE+00 1.390E-08 2.210E-08 EFFECTIVE 7.570E-14 4.377E-11 9.163E-10 1.520E-15-1.OOOE+00 1.250E-08 1.980E-08 SKIN(FGR) 9.450E-14 6.249E-11 1.308E-09 2.170E-15-1.OOOE+00 O.OOOE+00 O.OOOE+00 Cs-136 GONADS 1.040E-13 6.223E-11 1.102E-09 2.180E-15-1.OOOE+00 1.880E-09 3.040E-09 BREAST 1.180E-13 5.966E-11 1.056E-09 2.090E-15-1.OOOE+00 1.670E-09 2.650E-09 LUNGS 1.040E-13 5.710E-l l.0115E-09 2.000E-15-1.OOOE+00 2.320E-09 2.620E-09

CA06454 Rev.000 Page 71 of 125 RED MARR 1.OlOE-13 5.824E-11 1.031E-09 2.040E-15-1.OOOE+00 1.860E-09 2.950E-09 BONE SUR 1.660E-13 8.422E-11 1.491E-09 2.950E-15-1.OOOE+00 1.700E-09 2.710E-09 THYROID 1.070E-13 5.852E-11 1.036E-09 2.050E-15-1.OOOE+00 1.730E-09 2.740E-09 REMAINDER 9.950E-14 5.652E-11 1.OO1E-09 1.980E-15-1.OOOE+00 2.190E-09 3.520E-09 EFFECTIVE 1.060E-13 5.966E-11 1.056E-09 2.090E-15-1.OOOE+00 1.980E-09 3.040E-09 SKIN(FGR) 1.250E-13 7.251E-11 1.284E-09 2.540E-15-1.OOOE+OO O.OOOE+O0 O.OOOE+OO Cs-137 GONADS 2.669E-14 1.669E-11 3.530E-10 5.840E-16-1.OOOE+00 8.760E-09 1.390E-08 BREAST 3.047E-14 1.596E-11 3.376E-10 5.585E-16-1.OOOE+00 7.840E-09 1.240E-08 LUNGS 2.649E-14 1.517E-11 3.209E-10 5.309E-16-1.OOOE+00 8.820E-09 1.270E-08 RED MARR 2.583E-14 1.542E-11 3.260E-10 5.394E-16-1.OOOE+00 8.300E-09 1.320E-08 BONE SUR 4.382E-14 2.238E-11 4.734E-10 7.832E-16-1.OOOE+00 7.940E-09 1.260E-08 THYROID 2.725E-14 1.588E-11 3.358E-10 5.556E-16-1.OOOE+00 7.930E-09 1.260E-08 REMAINDER 2.536E-14 1.490E-11 3.152E-10 5.215E-16-1.OOOE+00 9.120E-09 1.450E-08 EFFECTIVE 2.725E-14 1.585E-11 3.353E-10 5.546E-16-1.OOOE+00 8.630E-09 1.350E-08 SKIN(FGR) 4.392E-14 5.253E-11 1.110E-09 1.836E-15-1.OOOE+00 O.OOOE+OO O.OOOE+00 Ba-139 GONADS 2.130E-15 3.368E-13 3.429E-13 4.790E-17-1.OOOE+00 2.560E-12 1.560E-12 BREAST 2.450E-15 3.297E-13 3.357E-13 4.690E-17-1.OOOE+00 2.460E-12 5.170E-13 LUNGS 2.030E-15 3.002E-13 3.057E-13 4.270E-17-1.OOOE+00 2.530E-10 3.890E-13 RED MARR 1.870E-15 2.932E-13 2.985E-13 4.170E-17-1.OOOE+00 3.410E-12 8.590E-13 BONE SUR 5.290E-15 6.841E-13 6.965E-13 9.730E-17-1.OOOE+00 2.490E-12 4.380E-13 THYROID 2.130E-15 3.044E-13 3.100E-13 4.330E-17-1.OOOE+00 2.400E-12 2.660E-13 REMAINDER 1.920E-15 2.932E-13 2.985E-13 4.170E-17-1.OOOE+00 4.820E-11 3.570E-10 EFFECTIVE 2.170E-15 3.227E-13 3.286E-13 4.590E-17-1.OOOE+00 4.640E-11 1.080E-10 SKIN(FGR) 6.160E-14 7.241E-11 7.373E-11 1.030E-14-1.OOOE+00 O.OOOE+00 O.OOOE+O0 Ba-140 GONADS 8.410E-15 5.451E-12 9.607E-11 1.910E-16-1.OOOE+00 4.300E-10 9.960E-10 BREAST 9.640E-15 5.280E-12 9.305E-11 1.850E-16-1.OOOE+00 2.870E-10 1.590E-10 LUNGS 8.270E-15 4.852E-12 8.550E-11 1.700E-16-1.OOOE+00 1.660E-09 6.630E-11 RED MARR 7.930E-15 4.880E-12 8.601E-11 1.710E-16-1.OOOE+00 1.290E-09 4.390E-10 BONE SUR 1.550E-14 8.020E-12 1.413E-10 2.810E-16-1.OOOE+00 2.410E-09 5.530E-10 THYROID 8.530E-15 5.109E-12 9.003E-11 1.790E-16-1.OOOE+00 2.560E-10 5.250E-11 REMAINDER 7.890E-15 4.766E-12 8.399E-11 1.670E-16-1.OOOE+00 1.410E-09 7.370E-09 EFFECTIVE 8.580E-15 5.137E-12 9.053E-11 1.800E-16-1.OOOE+00 1.010E-09 2.560E-09 SKIN(FGR) 2.520E-14 5.565E-11 9.808E-10 1.950E-15-1.OOOE+00 O.OOOE+OO O.OOOE+O0 La-140 GONADS 1.140E-13 6.027E-11 4.425E-10 2.240E-15-1.OOOE+00 4.540E-10 1.340E-09 BREAST 1.290E-13 5.758E-11 4.228E-10 2.140E-15-1.OOOE+00 1.450E-10 1.800E-10 LUNGS 1.150E-13 5.596E-11 4.109E-10 2.080E-15-1.OOOE+00 4.210E-09 4.010E-11 RED MARR 1.140E-13 5.731E-11 4.208E-10 2.130E-15-1.OOOE+00 2.140E-10 2.810E-10 BONE SUR 1.690E-13 7.776E-11 5.709E-10 2.890E-15-1.000E+00 1.410E-10 9.770E-11 THYROID 1.180E-13 5.462E-11 4.010E-10 2.030E-15-1.OOOE+00 6.870E-11 6.400E-12 REMAINDER 1.110E-13 5.569E-11 4.089E-10 2.070E-15-1.OOOE+00 2.120E-09 6.260E-09 EFFECTIVE 1.170E-13 5.812E-11 4.267E-10 2.160E-15-1.OOOE+00 1.310E-09 2.280E-09 SKIN(FGR) 1.660E-13 2.217E-10 1.628E-09 8.240E-15-1.OOOE+00 O.OOOE+00 O.OOOE+0O La-141 GONADS 2.330E-15 7.315E-13 9.675E-13 4.740E-17-1.OOOE+00 1.O1OE-11 3.770E-12 BREAST 2.640E-15 7.007E-13 9.267E-13 4.540E-17-1.OOOE+00 9.840E-12 7.070E-13 LUNGS 2.340E-15 6.713E-13 8.879E-13 4.350E-17-1.OOOE+00 6.460E-10 2.720E-13 RED MARR 2.310E-15 6.852E-13 9.063E-13 4.440E-17-1.OOOE+00 2.930E-11 1.070E-12 BONE SUR 3.490E-15 9.923E-13 1.312E-12 6.430E-17-1.OOOE+00 1.200E-10 6.060E-13 THYROID 2.390E-15 6.590E-13 8.716E-13 4.270E-17-1.OOOE+00 9.400E-12 5.290E-14 REMAINDER 2.260E-15 6.682E-13 8.83BE-13 4.330E-17-1.OOOE+00 2.280E-10 1.240E-09

CA06454 Rev.000 Page 72 of 125 EFFECTIVE 2.390E-15 7.007E-13 9.267E-13 4.540E-17-1.OOOE+00 1.570E-10 3.740E-10 SKIN(FGR) 6.580E-14 1.667E-10 2.204E-10 1.080E-14-1.OOOE+OO O.OOOE+OO O.OOOE+OO La-142 GONADS 1.400E-13 1.978E-11 2.034E-11 2.540E-15-1.OOOE+00 1.660E-11 6.990E-11 BREAST 1.570E-13 1.885E-11 1.938E-11 2.420E-15-1.OOOE+00 1.130E-11 1.540E-11 LUNGS 1.420E-13 1.846E-11 1.898E-11 2.370E-15-1.OOOE+00 3.010E-10 8.400E-12 RED MARR 1.420E-13 1.900E-11 1.954E-11 2.440E-15-1.OOOE+00 1.360E-11 1.930E-11 BONE SUR 1.950E-13 2.484E-11 2.554E-11 3.190E-15-1.OOOE+OO 1.11OE-11 7.400E-12 THYROID 1.450E-13 1.768E-11 1.818E-11 2.270E-15-1.OOOE+00 8.740E-12 1.160E-12 REMAINDER 1.380E-13 1.853E-11 1.906E-11 2.380E-15-1.OOOE+00 8.070E-11 5.200E-10 EFFECTIVE 1.440E-13 1.916E-11 1.970E-11 2.460E-15-1.OOOE+00 6.840E-11 1.790E-10 SKIN(FGR) 2.160E-13 9.111E-11 9.368E-11 1.170E-14-1.OOOE+OO O.OOOE+OO O.OOOE+OO Ce-141 GONADS 3.380E-15 2.213E-12 4.332E-11 7.710E-17-1.OOOE+00 5.540E-11 1.080E-10 BREAST 3.930E-15 2.170E-12 4.247E-11 7.560E-17-1.OOOE+00 4.460E-11 1.11OE-11 LUNGS 3.170E-15 1.951E-12 3.820E-11 6.800E-17-1.OOOE+00 1.670E-08 1.430E-12 RED MARR 2.830E-15 1.860E-12 3.641E-11 6.480E-17-1.OOOE+00 8.960E-11 3.390E-11 BONE SUR 9.410E-15 5.166E-12 1.O11E-10 1.800E-16-1.OOOE+00 2.540E-10 2.300E-11 THYROID 3.350E-15 2.003E-12 3.922E-11 6.980E-17-1.OOOE+00 2.550E-11 1.800E-13 REMAINDER 2.980E-15 1.894E-12 3.708E-11 6.600E-17-1.OOOE+00 1.260E-09 2.500E-09 EFFECTIVE 3.430E-15 2.118E-12 4.146E-11 7.380E-17-1.OOOE+00 2.420E-09 7.830E-10 SKIN(FGR) 1.020E-14 3.788E-12 7.416E-11 1.320E-16-1.OOOE+OO O.OOOE+OO O.OOOE+OO Ce-143 GONADS 1.280E-14 7.900E-12 4.958E-11 2.980E-16-1.OOOE+00 7.530E-11 2.120E-10 BREAST 1.470E-14 7.688E-12 4.825E-11 2.900E-16-1.OOOE+00 1.660E-11 2.320E-11 LUNGS 1.230E-14 6.893E-12 4.325E-11 2.600E-16-1.OOOE+00 3.880E-09 3.820E-12 RED MARR 1.170E-14 6.787E-12 4.259E-11 2.560E-16-1.OOOE+00 2.960E-11 5.070E-11 BONE SUR 2.520E-14 1.323E-11 8.302E-11 4.990E-16-1.OOOE+00 1.640E-11 1.610E-11 THYROID 1.280E-14 7.211E-12 4.525E-11 2.720E-16-1.OOOE+00 6.230E-12 4.350E-13 REMAINDER 1.170E-14 6.734E-12 4.226E-11 2.540E-16-1.OOOE+00 1.420E-09 3.890E-09 EFFECTIVE 1.290E-14 7.396E-12 4.642E-11 2.790E-16-1.OOOE+00 9.160E-10 1.230E-09 SKIN(FGR) 3.960E-14 1.058E-10 6.638E-10 3.990E-15-1.OOOE+OO O.OOOE+OO O.OOOE+OO Ce-144 GONADS 2.725E-15 6.328E-13 1.319E-11 6.088E-17-1.OOOE+00 2.390E-10 6.987E-11 BREAST 3.129E-15 6.274E-13 1.307E-11 5.922E-17-1.OOOE+00 3.480E-10 1.223E-11 LUNGS 2.639E-15 5.228E-13 1.089E-11 5.362E-17-1.OOOE+00 7.911E-07 6.551E-12 RED MARR 2.507E-15 4.755E-13 9.907E-12 5.247E-17-1.OOOE+00 2.880E-09 8.923E-l1 BONE SUR 5.441E-15 1.646E-12 3.429E-11 1.127E-16-1.OOOE+00 4.720E-09 1.280E-10 THYROID 2.753E-15 5.529E-13 1.152E-11 5.418E-17-1.OOOE+00 2.920E-10 5.154E-12 REMAINDER 2.534E-15 5.086E-13 1.060E-11 5.283E-17-1.OOOE+OO 1.910E-08 1.890E-08 EFFECTIVE 2.773E-15 5.909E-13 1.231E-11 5.766E-17-1.OOOE+OO 1.OlOE-07 5.711E-09 SKIN(FGR) 8.574E-14 7.648E-13 1.594E-11 1.250E-14-1.OOOE+OO O.OOOE+OO O.OOOE+OO Pr-143 GONADS 2.130E-17 2.264E-14 4.032E-13 7.930E-19-1.OOOE+00 4.370E-18 8.990E-18 BREAST 2.550E-17 2.330E-14 4.149E-13 8.160E-19-1.OOOE+00 2.220E-18 1.090E-18 LUNGS 1.860E-17 1.642E-14 2.923E-13 5.750E-19-1.OOOE+00 1.330E-08 1.910E-19 RED MARR 1.620E-17 1.493E-14 2.659E-13 5.230E-19-1.OOOE+00 1.480E-11 1.030E-12 BONE SUR 5.930E-17 5.454E-14 9.711E-13 1.910E-18-1.OOOE+00 1.490E-11 1.030E-12 THYROID 2.050E-17 1.802E-14 3.208E-13 6.310E-19-1.OOOE+00 1.680E-18 2.660E-20 REMAINDER 1.760E-17 1.642E-14 2.923E-13 5.750E-19-1.OOOE+00 1.970E-09 4.220E-09 EFFECTIVE 2.100E-17 2.002E-14 3.564E-13 7.010E-19-1.OOOE+00 2.190E-09 1.270E-09 SKIN(FGR) 1.760E-14 5.711E-11 1.017E-09 2.OOOE-15-1.OOOE+OO O.OOOE+OO O.OOOE+OO Nd-147 GONADS 6.130E-15 4.218E-12 7.235E-11 1.480E-16-1.OOOE+00 8.410E-11 1.790E-10

CA06454 Rev. 000 Page 73 of 125 BREAST 7.120E-15 4.132E-12 7.088E-11 1.450E-16-1.OOOE+00 3.450E-11 1.870E-11 LUNGS 5.820E-15 3.648E-12 6.257E-11 1.280E-16-1.OOOE+00 1.060E-08 2.440E-12 RED MARR 5.400E-15 3.505E-12 6.013E-11 1.230E-16-1.OOOE+00 9.190E-11 5.050E-11 BONE SUR 1.320E-14 8.265E-12 1.418E-10 2.900E-16-1.OOOE+00 3.260E-10 2.220E-11 THYROID 6.120E-15 3.876E-12 6.648E-11 1.360E-16-1.OOOE+00 1.820E-11 2.640E-13 REMAINDER 5.530E-15 3.562E-12 6.111E-11 1.250E-16-1.OOOE+00 1.760E-09 3.760E-09 EFFECTIVE 6.190E-15 3.961E-12 6.795E-11 1.390E-16-1.OOOE+00 1.850E-09 1.180E-09 SKIN(FGR) 1.950E-14 3.135E-11 5.377E-10 1.200E-15-2.OOGE+OO O.OOOE+OO O.OOOE+OO Np-239 GONADS 7.530E-15 4.691E-12 4.380E-11 1.710E-16-1.OOOE+00 7.450E-11 1.620E-10 BREAST 8.730E-15 4.636E-12 4.329E-11 1.690E-16-1.OOOE+00 1.630E-11 1.720E-11 LUNGS 7.180E-15 4.115E-12 3.842E-11 1.SOOE-16-1.OOOE+00 2.360E-09 2.400E-12 RED MARR 6.500E-15 4.005E-12 3.740E-11 1.460E-16-1.OOOE+00 2.080E-10 4.660E-11 BONE SUR 2.OOOE-14 1.OO1E-11 9.349E-11 3.650E-16-1.OOOE+00 2.030E-09 3.590E-11 THYROID 7.520E-15 4.197E-12 3.919E-11 1.530E-16-1.OOOE+00 7.620E-12 2.070E-13 REMAINDER 6.760E-15 4.005E-12 3.740E-11 1.460E-16-1.OOOE+00 9.590E-10 2.770E-09 EFFECTIVE 7.690E-15 4.471E-12 4.175E-11 1.630E-16-1.OOOE+00 6.780E-10 8.820E-10 SKIN(FGR) 1.600E-14 7.215E-12 6.737E-11 2.630E-16-1.OOOE+OO O.OOOE+OO O.OOOE+OO Pu-238 GONADS 6.560E-18 4.291E-14 9.011E-13 1.490E-18-1.OOOE+00 1.040E-05 2.330E-09 BREAST 1.270E-17 5.558E-14 1.167E-12 1.930E-18-1.OOOE+00 4.400E-10 1.800E-13 LUNGS 1.060E-18 2.267E-15 4.759E-14 7.870E-20-1.OOOE+00 3.200E-04 8.640E-14 RED MARR 1.680E-18 5.587E-15 1.173E-13 1.940E-19-1.OOOE+00 5.800E-05 1.270E-08 BONE SUR 9.300E-18 3.514E-14 7.378E-13 1.220E-18-1.OOOE+00 7.250E-04 1.580E-07 THYROID 4.010E-18 9.792E-15 2.056E-13 3.400E-19-1.OOOE+00 3.860E-10 7.990E-14 REMAINDER 1.990E-18 9.216E-15 1.935E-13 3.200E-19-1.OOOE+00 2.740E-05 2.180E-08 EFFECTIVE 4.880E-18 2.413E-14 5.068E-13 8.380E-19-1.OOOE+00 7.790E-05 1.340E-08 SKIN(FGR) 4.090E-17 2.776E-13 5.830E-12 9.640E-18-1.OOOE+OO O.OOOE+OO O.OOOE+OO Pu-239 GONADS 4.840E-18 1.768E-14 3.713E-13 6.140E-19-1.OOOE+00 1.200E-05 2.640E-09 BREAST 7.550E-18 2.238E-14 4.699E-13 7.770E-19-1.OOOE+00 3.990E-10 1.210E-13 LUNGS 2.650E-18 2.267E-15 4.760E-14 7.870E-20-1.OOOE+00 3.230E-04 7.890E-14 RED MARR 2.670E-18 3.456E-15 7.258E-14 1.200E-19-1.OOOE+00 6.570E-05 1.410E-08 BONE SUR 9.470E-18 1.673E-14 3.514E-13 5.810E-19-1.OOOE+00 8.210E-04 1.760E-07 THYROID 3.S80E-18 S.126E-15 1.077E-13 1.780E-19-l.OOOE+00 3.750E-10 7.500E-14 REMAINDER 2.860E-18 4.838E-15 1.016E-13 1.680E-19-1.OOOE+00 3.020E-05 2.120E-08 EFFECTIVE 4.240E-18 1.057E-14 2.220E-13 3.670E-l9-1.OOOE+00 8.330E-05 1.400E-08 SKIN(FGR) 1.860E-17 1.057E-13 2.220E-12 3.670E-18-1.OOOE+OO O.OOOE+OO O.OOOE+OO Pu-240 GONADS 6.360E-18 4.11BE-14 8.649E-13 1.430E-18-1.OOOE+00 1.200E-05 2.640E-09 BREAST 1.230E-17 5.328E-14 1.119E-12 1.850E-18-1.OOOE+00 4.330E-10 1.730E-13 LUNGS 1.090E-18 2.249E-15 4.723E-14 7.810E-20-1.OOOE+00 3.230E-04 8.220E-14 RED MARR 1.650E-18 5.386E-15 1.131E-13 1.870E-19-1.OOOE+00 6.570E-05 1.410E-08 BONE SUR 9.260E-18 3.398E-14 7.137E-13 1.180E-18-1.OOOE+00 8.210E-04 1.760E-07 THYROID 3.920E-18 9.446E-15 1.984E-13 3.280E-19-1.OOOE+00 3.760E-10 7.510E-14 REMAINDER 1.960E-18 8.870E-15 1.863E-13 3.080E-19-1.OOOE+00 3.020E-05 2.130E-08 EFFECTIVE 4.750E-18 2.313E-14 4.857E-13 8.030E-19-1.OOOE+00 8.330E-05 1.400E-08 SKIN(FGR) 3.920E-17 2.644E-13 5.552E-12 9.180E-18-1.OOOE+00 O.OOOE+OO O.OOOE+00 Pu-241 GONADS 7.190E-20 6.653E-17 1.396E-15 2.310E-21-1.OOOE+00 2.760E-07 5.660E-11 BREAST 8.670E-20 7.229E-17 1.517E-15 2.510E-21-1.OOOE+00 2.140E-11 2.790E-15 LUNGS 6.480E-20 4.090E-17 8.584E-16 1.420E-21-1.OOOE+00 3.180E-06 4.480E-15 RED MARR 5.630E-20 4.003E-17 8.403E-16 1.390E-21-1.OOOE+00 1.430E-06 2.780E-10 BONE SUR 2.190E-19 1.385E-16 2.908E-15 4.810E-21-1.OOOE+00 1.780E-05 3.480E-09

CA06454 Rev.000 Page 74 of 125 THYROID 6.980E-20 4.522E-17 9.491E-16 1.570E-21-1.OOOE+00 9.150E-12 1.OlOE-15 REMAINDER 6.090E-20 4.291E-17 9.007E-16 1.490E-21-1.OOOE+00 6.020E-07 1.850E-10 EFFECTIVE 7.250E-20 5.55BE-17 1.167E-15 1.930E-21-1.OOOE+00 1.340E-06 2.070E-10 SKIN(FGR) 1.170E-19 2.033E-16 4.268E-1S 7.060E-21-1.OOOE+OO O.OOOE+OO O.OOOE+OO Am-241 GONADS 8.580E-16 9.360E-13 1.966E-11 3.250E-17-1.OOOE+00 3.250E-05 2.700E-07 BREAST 1.070E-15 1.014E-12 2.129E-11 3.520E-17-1.OOOE+00 2.670E-09 2.620E-11 LUNGS 6.740E-16 5.789E-13 1.216E-11 2.010E-17-1.OOOE+00 1.840E-05 3.360E-11 RED MARR 5.210E-16 4.838E-13 1.016E-11 1.680E-17-1.OOOE+00 1.740E-04 1.450E-06 BONE SUR 2.870E-15 2.678E-12 5.625E-11 9.300E-17-1.OOOE+00 2.170E-03 1.810E-05 THYROID 7.830E-16 6.36SE-13 1.337E-11 2.210E-17-1.OOOE+00 1.600E-09 1.320E-11 REMAINDER 6.340E-16 5.933E-13 1.246E-11 2.060E-17-1.OOOE+00 7.820E-05 6.660E-07 EFFECTIVE 8.180E-16 7.920E-13 1.663E-11 2.750E-17-1.OOOE+00 1.200E-04 9.840E-07 SKIN(FGR) 1.280E-15 2.396E-12 5.032E-11 8.320E-17-1.OOOE+OO O.OOOE+OO O.OOOE+OO Cm-242 GONADS 7.830E-18 4.893E-14 1.013E-12 1.700E-18-1.OOOE+00 5.700E-07 5.200E-09 BREAST 1.480E-17 6.159E-14 1.275E-12 2.140E-18-1.OOOE+00 9.440E-10 8.950E-12 LUNGS 1.130E-18 3.022E-15 6.257E-14 1.050E-19-1.OOOE+00 1.550E-05 8.840E-12 RED MARR 1.890E-18 6.562E-15 1.359E-13 2.280E-19-1.OOOE+00 3.900E-06 3.570E-08 BONE SUR 1.060E-17 4.231E-14 8.759E-13 1.470E-18-1.OOOE+00 4.870E-05 4.460E-07 THYROID 4.910E-18 1.261E-14 2.610E-13 4.380E-19-1.OOOE+00 9.410E-10 8.820E-12 REMAINDER 2.270E-18 1.079E-14 2.235E-13 3.750E-19-1.OOOE+00 2.450E-06 4.020E-08 EFFECTIVE 5.690E-18 2.751E-14 5.697E-13 9.560E-19-1.OOOE+00 4.670E-06 3.100E-08 SKIN(FGR) 4.290E-17 2.700E-13 5.589E-12 9.380E-18-1.OOOE+OO O.OOOE+OO O.OOOE+OO Cm-244 GONADS 6.900E-18 4.522E-14 9.492E-13 1.570E-18-1.OOOE+00 1.590E-05 1.330E-07 BREAST 1.330E-17 5.702E-14 1.197E-12 1.980E-18-1.OOOE+00 1.040E-09 8.820E-12 LUNGS 7.080E-19 2.592E-15 5.441E-14 9.OOOE-20-1.OOOE+00 1.930E-05 8.810E-12 RED MARR 1.460E-18 5.87SE-15 1.233E-13 2.040E-19-1.OOOE+00 9.380E-05 7.820E-07 BONE SUR 8.820E-18 3.859E-14 8.101E-13 1.340E-18-1.OOOE+00 1.170E-03 9.770E-06 THYROID 4.190E-18 1.146E-14 2.406E-13 3.980E-19-1.OOOE+OO 1.OlOE-09 8.440E-12 REMAINDER 1.810E-18 9.821E-15 2.062E-13 3.410E-19-1.OOOE+00 4.780E-05 4.150E-07 EFFECTIVE 4.910E-18 2.529E-14 5.308E-13 8.780E-19-1.OOOE+00 6.700E-05 5.450E-07 SKIN(FGR) 3.910E-17 2.506E-13 5.260E-12 8.700E-18-1.OOOE+OO O.OOOE+OO O.OOOE+OO Xe-133m GONADS 1.420E-1S O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO BREAST 1.700E-15 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO LUNGS 1.190E-15 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO RED MARR 1.100E-15 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO BONE SUR 3.230E-15 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO THYROID 1.360E-15 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO REMAINDER 1.150E-15 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO EFFECTIVE 1.370E-15 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO SKIN(FGR) 1.040E-14 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO Xe-135m GONADS 2.OOOE-14 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO BREAST 2.290E-14 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO LUNGS 1.980E-14 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO RED MARR 1.910E-14 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO BONE SUR 3.500E-14 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO THYROID 2.040E-14 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO REMAINDER 1.890E-14 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO EFFECTIVE 2.040E-14 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO SKIN(FGR) 2.970E-14 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO

CA06454 Rev.000 Page 75 of 125 Xe-138 GONADS 5.590E-14 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+00 O.OOOE+OO O.OOOE+OO BREAST 6.320E-14 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO LUNGS 5.660E-14 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO RED MARR 5.600E-14 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO BONE SUR 8.460E-14 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO THYROID 5.770E-14 O.OOOE+0O O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO REMAINDER 5.490E-14 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO EFFECTIVE 5.770E-14 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO SKIN(FGR) 1.070E-13 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO

CA06454 Rev. 000 Page 76 of 125 A1TACHMENT 0 CONVERSION FACTORS FILE FGR14.INP FGRDCF 10/24/95 03:24:50 beta-test version 1.10, minor FORTRAN fixes 5/4/95 Implicit daughter halflives (m) less than 90 and less than 0.100 of parent 9 ORGANS DEFINED IN THIS FILE:

GONADS BREAST LUNGS RED MARR BONE SUR THYROID REMAINDER EFFECTIVE SKIN(FGR) 14 NUCLIDES DEFINED IN THIS FILE:

Kr-85 Kr-85m Kr-87 Kr-88 I-131 D I-132 D I-133 D 1-134 D 1-135 D Including:Xe-135m Xe-133 Xe-135 Xe-133m Xe-135m Xe-138 CLOUDSHINE GROUND GROUND GROUND INHALED INHALED INGESTION SHINE 8HR SHINE 7DAY SHINE RATE ACUTE CHRONIC Kr-85 GONADS 1.170E-16 8.121E-14 1. 704E-12 2.820E-18-1.O00E+00 O.OOOE+O0 O.000E+00 BREAST 1.34OE-16 7.891E-14 1.656E-12 2.740E-18-1.OOOE+O0 O.OOOE+00 O.OOOE+00 LUNGS 1.14OE-16 7.056E-14 1.481E-12 2.450E-18-1.OOOE+00 0.OOOE+00 0.OOOE+00 RED MARR 1.090E-16 6.998E-14 1.469E-12 2.430E-18-1.OOOE+00 0.OOOE+00 0.OOOE+00 BONE SUR 2.200E-16 1.287E-13 2.702E-12 4.470E-18-1.OO0E+00 0.OOOE+00 0.OOOE+00 THYROID 1.180E-16 7.459E-14 1.565E-12 2.590E-18-1.OOOE+00 0.OOOE+00 0.OOOE+00 REMAINDER 1.090E-16 6.941E-14 1.457E-12 2.410E-18-1.000E+00 0.OOOE+00 0.000E+00 EFFECTIVE 1.190E-16 7.603E-14 1.596E-12 2.640E-18-1.OO0E+00 O.OOOE+00 O.O00E+00 SKIN(FGR) 1.320E-14 2.304E-11 4 .835E-1l 8.000E-16-1.000E+00 0.OOOE+00 0.OOOE+0D Kr-85m GONADS 7.310E-15 2.594E-12 3.653E-12 1.570E-16-1.OOOE+00 0.000E+00 0.OOOE+00 BREAST 8.410E-15 2.527E-12 3.560E-12 1.530E-16-1.OOOE+00 0.OOOE+00 0.OOOE+00 LUNGS 7.040E-15 2.379E-12 3.351E-12 1.440E-16-1.OOOE+00 0.OOOE+00 0.OOOE+00 RED MARR 6.430E-15 2.346E-12 3.304E-12 1.420E-16-1.OOOE+00 0.OOOE+00 0.OOOE+00 BONE SUR 1.880E-14 5.286E-12 7.446E-12 3.200E-16-1.OOOE+00 0.OOOE+00 O.OOOE+00 THYROID 7.330E-15 2.395E-12 3.374E-12 1.450E-16-1.OOOE+00 0.000E+00 0.OOOE+00 REMAINDER 6.640E-15 2.313E-12 3.257E-12 1.400E-16-1.OOOE+00 0.OOOE+00 0.OOOE+00 EFFECTIVE 7.480E-15 2.511E-12 3.537E-12 1.520E-16-1.OOOE+00 O.OOOE+00 0.OOOE+00 SKIN(FGR) 2.240E-14 2.247E-11 3.164E-11 1.360E-15-1.OOOE+00 0.OOOE+00 0.OOOE+00 Kr-87

CA06454 Rev.OOO Page 77 of 125 GONADS 4.OOOE-14 4.962E-12 5.026E-12 7.610E-16-1.OOOE+OO O.OOOE+OO O.OOOE+OO BREAST 4.500E-14 4.740E-12 4.802E-12 7.270E-16-1.OOOE+OO O.OOOE+OO O.OOOE+OO LUNGS 4.040E-14 4.603E-12 4.663E-12 7.060E-16-1.OOOE+OO O.OOOE+OO O.OOOE+OO RED MARR 4.OOOE-14 4.708E-12 4.769E-12 7.220E-16-1.OOOE+OO O.OOOE+OO O.OOOE+OO BONE SUR 6.020E-14 6.514E-12 6.598E-12 9.990E-16-1.OOOE+OO O.OOOE+OO O.OOOE+OO THYROID 4.130E-14 4.473E-12 4.531E-12 6.860E-16-1.OOOE+OO O.OOOE+OO O.OOOE+OO REMAINDER 3.910E-14 4.590E-12 4.650E-12 7.040E-16-1.OOOE+OO O.OOOE+OO O.OOOE+OO EFFECTIVE 4.120E-14 4.773E-12 4.835E-12 7.320E-16-1.OOOE+OO O.OOOE+OO O.OOOE+OO SKIN(FGR) 1.370E-13 8.802E-11 8.916E-11 1.350E-14-1.OOOE+OO O.OOOE+OO O.OOOE+OO Kr-88 GONADS 9.900E-14 2.278E-11 2.655E-11 1.800E-15-1.OOOE+OO O.OOOE+OO O.OOOE+OO BREAST 1.11OE-13 2.177E-11 2.537E-11 1.720E-15-1.OOOE+OO O.OOOE+OO O.OOOE+OO LUNGS 1.010E-13 2.139E-11 2.493E-11 1.690E-15-1.OOOE+OO O.OOOE+OO O.OOOE+OO RED MARR 1.OOOE-13 2.190E-11 2.552E-11 1.730E-15-1.OOOE+OO O.OOOE+OO O.OOOE+OO BONE SUR 1.390E-13 2.886E-11 3.363E-11 2.280E-15-1.OOOE+OO O.OOOE+OO O.OOOE+OO THYROID 1.030E-13 2.012E-11 2.345E-11 1.590E-15-1.OOOE+OO O.OOOE+OO O.OOOE+OO REMAINDER 9.790E-14 2.139E-11 2.493E-11 1.690E-15-1.OOOE+OO O.OOOE+OO O.OOOE+OO EFFECTIVE 1.020E-13 2.202E-11 2.567E-11 1.740E-15-1.OOOE+OO O.OOOE+OO O.OOOE+OO SKIN(FGR) 1.350E-13 5.607E-11 6.534E-11 4.430E-15-1.OOOE+OO O.OOOE+OO O.OOOE+OO I-131 GONADS 1.780E-14 1.119E-11 1.789E-10 3.940E-16-1.OOOE+00 2.530E-11 4.070E-11 BREAST 2.040E-14 1.082E-11 1.730E-10 3.810E-16-1.OOOE+00 7.880E-11 1.210E-10 LUNGS 1.760E-14 1.016E-11 1.626E-10 3.580E-16-1.OOOE+00 6.570E-10 1.020E-10 RED MARR 1.680E-14 1.022E-11 1.635E-10 3.600E-16-1.OOOE+00 6.260E-11 9.440E-11 BONE SUR 3.450E-14 1.675E-11 2.679E-10 5.900E-16-1.OOOE+00 5.730E-11 8.720E-11 THYROID 1.810E-14 1.053E-11 1.685E-10 3.710E-16-1.OOOE+00 2.920E-07 4.760E-07 REMAINDER 1.670E-14 9.908E-12 1.585E-10 3.490E-16-1.OOOE+00 8.030E-11 1.570E-10 EFFECTIVE 1.820E-14 1.067E-11 1.707E-10 3.760E-16-1.OOOE+00 8.890E-09 1.440E-08 SKIN(FGR) 2.980E-14 1.825E-11 2.920E-10 6.430E-16-1.OOOE+OO O.OOOE+OO O.OOOE+OO I-132 GONADS 1.090E-13 2.523E-11 2.771E-11 2.320E-15-1.OOOE+00 9.950E-12 2.330E-11 BREAST 1.240E-13 2.414E-11 2.652E-11 2.220E-15-1.OOOE+00 1.410E-11 2.520E-11 LUNGS 1.090E-13 2.305E-11 2.532E-11 2.120E-15-1.OOOE+00 2.710E-10 2.640E-11 RED MARR 1.070E-13 2.360E-11 2.592E-11 2.170E-15-1.OOOE+00 1.400E-11 2.460E-11 BONE SUR 1.730E-13 3.327E-11 3.655E-11 3.060E-15-1.OOOE+00 1.240E-11 2.190E-11 THYROID 1.120E-13 2.381E-11 2.616E-11 2.190E-15-1.OOOE+00 1.740E-09 3.870E-09 REMAINDER 1.050E-13 2.283E-11 2.509E-11 2.100E-15-1.OOOE+00 3.780E-11 1.650E-10 EFFECTIVE 1.120E-13 2.403E-11 2.640E-11 2.210E-15-1.OOOE+00 1.030E-10 1.820E-10 SKIN(FGR) 1.580E-13 8.199E-11 9.007E-11 7.540E-15-1.OOOE+OO O.OOOE+OO O.OOOE+OO I-133 GONADS 2.870E-14 1.585E-11 6.748E-11 6.270E-16-1.OOOE+00 1.950E-11 3.630E-11 BREAST 3.280E-14 1.519E-11 6.468E-11 6.010E-16-1.OOOE+00 2.940E-11 4.680E-11 LUNGS 2.860E-14 1.446E-11 6.156E-11 5.720E-16-1.OOOE+00 8.200E-10 4.530E-11 RED MARR 2.770E-14 1.466E-11 6.242E-11 5.800E-16-1.OOOE+00 2.720E-11 4.300E-11 BONE SUR 4.870E-14 2.161E-11 9.202E-11 8.550E-16-1.OOOE+00 2.520E-11 4.070E-11 THYROID 2.930E-14 1.502E-11 6.393E-11 5.940E-16-1.OOOE+00 4.860E-08 9.100E-08 REMAINDER 2.730E-14 1.418E-11 6.038E-11 5.610E-16-1.OOOE+00 5.OOOE-11 1.550E-10 EFFECTIVE 2.940E-14 1.509E-11 6.425E-11 5.970E-16-1.OOOE+00 1.580E-09 2.800E-09 SKIN(FGR) 5.830E-14 1.150E-10 4.897E-10 4.550E-15-1.OOOE+OO O.OOOE+OO O.OOOE+OO I-134 GONADS 1.270E-13 1.200E-11 1.202E-11 2.640E-15-1.OOOE+00 4.250E-12 1.100E-11 BREAST 1.440E-13 1.145E-11 1.147E-11 2.520E-15-1.OOOE+00 6.170E-12 1.170E-11 LUNGS 1.270E-13 1.100E-11 1.102E-11 2.420E-15-1.OOOE+00 1.430E-10 1.260E-11 RED MARR 1.250E-13 1.127E-11 1.129E-11 2.480E-15-1.OOOE+00 6.080E-12 1.090E-11

CA06454 Rev.000 Page 78 of 125 BONE SUR 1.960E-13 1.568E-11 1.571E-11 3.450E-15-1.OOOE+00 5.310E-12 9.320E-12

CA06454 Rev.000 Page 79 of 125 SKIN(FGR) 2.970E-14 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO Xe-138 GONADS 5.590E-14 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+00 O.OOOE+OO O.OOOE+OO BREAST 6.320E-14 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO LUNGS 5.660E-14 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO RED MARR 5.600E-14 O.OOOE+OO O.OOOE+OO O.OOOE+OO-l.OOOE+OO O.OOOE+OO O.OOOE+OO BONE SUR 8.460E-14 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO THYROID 5.770E-14 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO REMAINDER 5.490E-14 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO EFFECTIVE 5.770E-14 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO SKIN(FGR) 1.070E-13 O.OOOE+OO O.OOOE+OO O.OOOE+OO-1.OOOE+OO O.OOOE+OO O.OOOE+OO

CA06454 Rev.000 Page 80 of 125 ATTACHMENT P CONVERSION FACTORS FILE FGRO5.INP FGRDCF 10/24/95 03:24:50 beta-test version 1.10, minor FORTRAN fixes 5/4/95 Implicit daughter halflives (m) less than 90 and less than 0.100 of parent 9 ORGANS DEFINED IN THIS FILE:

GONADS BREAST LUNGS RED MARR BONE SUR THYROID REMAINDER EFFECTIVE SKIN(FGR) 05 NUCLIDES DEFINED IN THIS FILE:

I-131 D I-132 D I-133 D I-134 D 1-135 D Including:Xe-135m CLOUDSHINE GROUND GROUND GROUND INHALED INHALED INGESTION SHINE 8HR SHINE 7DAY SHINE RATE ACUTE CHRONIC I-131 GONADS 1.780E-14 1.119E-11 1.789E-10 3.940E-16-1.OOOE+00 2.530E-11 4.070E-il BREAST 2.040E-14 1.082E-11 1.730E-10 3.810E-16-1.OOOE+00 7.880E-11 1.210E-10 LUNGS 1.760E-14 1.016E-11 1.626E-10 3.580E-16-1.OOOE+00 6.570E-10 1.020E-10 RED MARR 1.680E-14 1.022E-11 1.635E-10 3.600E-16-l.OOOE+00 6.260E-11 9.440E-li BONE SUR 3.450E-14 1.675E-11 2.679E-10 5.900E-16-l.OOOE+00 5.730E-11 8.720E-il THYROID 1.810E-14 1.053E-11 1.685E-10 3.710E-16-1.OOOE+00 2.920E-07 4.760E-07 REMAINDER 1.670E-14 9.908E-12 1.585E-10 3.490E-16-1.OOOE+00 8.030E-11 1.570E-10 EFFECTIVE 1.820E-14 1.067E-11 1.707E-10 3.760E-16-1.OOOE+00 8.890E-09 1.440E-08 SKIN(FGR) 2.980E-14 1.825E-11 2.920E-10 6.430E-16-l.OOOE+00 O.OOOE+00 O.OOOE+00 I-132 GONADS l.090E-13 2.523E-11 2.771E-11 2.320E-15-1.OOOE+00 9.950E-12 2.330E-1l BREAST 1.240E-13 2.414E-11 2.652E-11 2.220E-15-l.OOOE+00 1.410E-11 2.520E-il LUNGS l.090E-13 2.305E-11 2.532E-11 2.120E-15-l.OOOE+00 2.710E-10 2.640E-ll RED MARR 1.070E-13 2.360E-11 2.592E-11 2.170E-15-1.OOOE+00 1.400E-11 2.460E-1l BONE SUR 1.730E-13 3.327E-11 3.655E-11 3.060E-15-1.OOOE+00 1.240E-11 2.190E-il THYROID 1.120E-13 2.381E-11 2.616E-i1 2.190E-15-1.OOOE+00 1.740E-09 3.870E-09 REMAINDER 1.050E-13 2.283E-11 2.509E-11 2.100E-15-1.OOOE+00 3.780E-11 1.650E-10 EFFECTIVE 1.120E-13 2.403E-11 2.640E-11 2.210E-15-1.OOOE+00 1.030E-10 1.820E-10 SKIN(FGR) 1.580E-13 8.199E-11 9.007E-11 7.540E-15-1.OOOE+00 O.OOOE+00 0.OOOE+00 I-133 GONADS 2.870E-14 1.585E-11 6.748E-11 6.270E-16-l.OOOE+00 1.950E-11 3.630E-li BREAST 3.280E-14 1.519E-11 6.468E-11 6.010E-16-1.OOOE+00 2.940E-11 4.680E-li LUNGS 2.860E-14 1.446E-11 6.156E-11 5.720E-16-l.OOOE+00 8.200E-10 4.530E-li RED MARR 2.770E-14 1.466E-11 6.242E-11 5.800E-16-l.OOOE+00 2.720E-11 4.300E-il BONE SUR 4.870E-14 2.161E-11 9.202E-11 8.550E-16-l.OOOE+00 2.520E-11 4.070E-li THYROID 2.930E-14 1.502E-11 6.393E-11 5.940E-16-l.OOOE+00 4.860E-08 9.100E-08 REMAINDER 2.730E-14 1.418E-11 6.038E-11 5.610E-16-l.OOOE+00 5.000E-11 1.550E-10 EFFECTIVE 2.940E-14 1.509E-11 6.425E-11 5.970E-16-1.OOOE+00 1.580E-09 2.800E-09 SKIN(FGR) 5.830E-14 1.150E-10 4.897E-10 4.550E-15-l.OOOE+00 O.OOOE+00 O.OOOE+00

CA06454 Rev. 000 Page 81 of 125 I-134 GONADS 1.270E-13 1.200E-11 1.202E-11 2.640E-15-1.OOOE+00 4.250E-12 1.100E-11 BREAST 1.440E-13 1.145E-11 1.147E-11 2.520E-15-1.OOOE+00 6.170E-12 1.170E-11 LUNGS 1.270E-13 1.100E-11 1.102E-11 2.420E-15-1.OOOE+00 1.430E-10 1.260E-11 RED MARR 1.250E-13 1.127E-11 1.129E-11 2.480E-15-1.OOOE+00 6.080E-12 1.090E-11 BONE SUR 1.960E-13 1.568E-11 1.571E-11 3.450E-15-1.OOOE+00 5.310E-12 9.320E-12 THYROID 1.300E-13 1.127E-11 1.129E-11 2.480E-15-1.OOOE+00 2.880E-10 6.210E-10 REMAINDER 1.220E-13 1.091E-11 1.093E-11 2.400E-15-1.OOOE+00 2.270E-11 1.340E-10 EFFECTIVE 1.300E-13 1.150E-11 1.152E-11 2.530E-15-1.OOOE+00 3.550E-11 6.660E-11 SKIN(FGR) 1.870E-13 4.477E-11 4.485E-11 9.850E-15-1.OOOE+OO O.OOOE+OO O.OOOE+OO 1-135 GONADS 8.078E-14 3.113E-11 5.489E-11 1.599E-15-1.OOOE+00 1.700E-11 3.610E-11 BREAST 9.143E-14 2.971E-11 5.240E-11 1.526E-15-1.OOOE+00 2.340E-11 3.850E-11 LUNGS 8.145E-14 2.886E-11 5.089E-11 1.482E-15-1.OOOE+00 4.410E-10 3.750E-11 RED MARR 8.054E-14 2.965E-11 5.228E-11 1.523E-15-l.OOOE+00 2.240E-11 3.650E-11 BONE SUR 1.184E-13 3.983E-11 7.024E-11 2.046E-15-1.OOOE+00 2.010E-11 3.360E-11 THYROID 8.324E-14 2.852E-11 5.030E-11 1.465E-15-1.OOOE+00 8.460E-09 1.790E-08 REMAINDER 7.861E-14 2.883E-11 5.084E-11 1.481E-15-1.OOOE+00 4.700E-11 1.540E-10 EFFECTIVE 8.294E-14 2.989E-11 5.271E-11 1.535E-15-1.OOOE+00 3.320E-10 6.080E-10 SKIN(FGR) 1.156E-13 9.826E-11 1.733E-10 5.047E-15-1.OOOE+OO O.OOOE+OO O.OOOE+OO

CA06454 Rev.OOO Page 82 of 125 ATTACHMENT Q CEAFFI OUTPUT FILE Cumulative Dose Summary eab lpz cr Time Thyroid TEDE Thyroid TEDE Thyroid TEDE (hr) (rem) (rem) (rem) (rem) (rem) (rem) 0.000 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 0.250 1.6065E+00 5.8302E-02 3.7820E-01 1.3725E-02 3.6197E+00 1.1535E-01 0.333 1.6797E+00 6.0934E-02 3.9543E-01 1.4345E-02 5.9654E+00 l.9001E-01 0.500 1.8449E+00 6.6841E-02 4.3433E-01 1.5736E-02 1.0045E+01 3.1973E-01 0.800 2.1107E+00 7.6244E-02 4.9688E-01 1.7949E-02 1.5210E+01 4.8368E-01 1.100 2.4120E+00 8.6783E-02 5.6782E-01 2.0430E-02 1.8883E+01 6.0002E-01 1.400 2.7486E+00 9.8438E-02 6.4706E-01 2.3174E-02 2.1980E+01 6.9798E-01 1.700 3.1200E+00 l.1119E-01 7.3449E-01 2.6176E-02 2.4945E+01 7.9157E-01 2.000 3.5258E+00 1.2503E-01 8.3004E-01 2.9433E-02 2.7987E+01 8.8750E-01 2.300 3.5258E+00 1.2503E-01 8.3676E-01 2.9661E-02 3.1058E+01 9.8422E-01 2.600 3.5258E+00 1.2503E-01 8.4400E-01 2.9905E-02 3.4147E+01 1.0814E+00 2.900 3.5258E+00 1.2503E-01 8.5175E-01 3.0165E-02 3.7363E+01 1.1825E+00 3.200 3.5258E+00 1.2503E-01 8.6000E-01 3.0440E-02 4.0755E+01 1.2890E+00 3.500 3.5258E+00 1.2503E-01 8.6876E-01 3.0732E-02 4.4349E+01 1.4017E+00 3.800 3.5258E+00 1.2503E-01 8.7801E-01 3.1038E-02 4.8153E+01 1.5210E+00 4.100 3.5258E+00 1.2503E-01 8.8775E-01 3.1360E-02 5.2173E+01 1.6470E+00 4.400 3.5258E+00 1.2503E-01 8.9797E-01 3.1697E-02 5.6408E+01 1.7796E+00 4.700 3.5258E+00 1.2503E-01 9.0868E-01 3.2049E-02 6.0859E+01 1.9188E+00 5.000 3.5258E+00 1.2503E-01 9.1986E-01 3.2416E-02 6.5523E+01 2.0647E+00 5.300 3.5258E+00 1.2503E-01 9.3152E-01 3.2798E-02 7.0399E+01 2.2171E+00 5.600 3.5258E+00 1.2503E-01 9.4364E-01 3.3194E-02 7.5485E+01 2.3761E+00 5.900 3.5258E+00 1.2503E-01 9.5623E-01 3.3605E-02 8.0780E+01 2.5414E+00 6.200 3.5258E+00 1.2503E-01 9.6927E-01 3.4030E-02 8.6281E+01 2.7131E+00 6.500 3.5258E+00 1.2503E-01 9.8277E-01 3.4469E-02 9.1987E+01 2.8912E+00 6.800 3.5258E+00 1.2503E-01 9.9672E-01 3.4922E-02 9.7895E+01 3.07S5E+00 7.100 3.5258E+00 1.2503E-01 1.0111E+00 3.5389E-02 1.0400E+02 3.2659E+00 7.400 3.5258E+00 1.2503E-01 1.0260E+00 3.5869E-02 1.1031E+02 3.4625E+00 7.700 3.5258E+00 1.2503E-01 1.0412E+00 3.6364E-02 1.1682E+02 3.6652E+00 8.000 3.5258E+00 1.2503E-01 1.0570E+00 3.6871E-02 1.2352E+02 3.8739E+00 8.300 3.5258E+00 1.2503E-01 1.0570E+00 3.6871E-02 1.2838E+02 4.0252E+00 8.600 3.5258E+00 1.2503E-01 1.0570E+00 3.6871E-02 1.3073E+02 4.0984E+00 8.900 3.5258E+00 1.2503E-01 1.0570E+00 3.6871E-02 1.3187E+02 4.1338E+00 9.200 3.5258E+00 1.2503E-01 1.0570E+00 3.6871E-02 1.3242E+02 4.1510E+00 9.500 3.5258E+00 1.2503E-01 1.0570E+00 3.6871E-02 1.3269E+02 4.1593E+00 9.800 3.5258E+00 1.2503E-01 1.0570E+00 3.6871E-02 1.3282E+02 4.1633E+00 10.100 3.5258E+00 1.2503E-01 1.0570E+00 3.6871E-02 1.3288E+02 4.1653E+00 10.400 3.5258E+00 1.2503E-01 1.0570E+00 3.6871E-02 1.3291E+02 4.1663E+00 24.000 3.5258E+00 1.2503E-01 1.0570E+00 3.6871E-02 1.3294E+02 4.1672E+00 96.000 3.5258E+00 1.2503E-01 1.0570E+00 3.6871E-02 1.3294E+02 4.1672E+00 720.000 3.5258E+00 1.2503E-01 1.0570E+00 3.6871E-02 1.3294E+02 4.1672E+00 Worst Two-Hour Doses

CA06454 Rev.000 Page 83 of 125 eab Time Whole Body Thyroid TEDE (hr) (rem) (rem) (rem) 0.0 1.3920E-02 3.5258E+00 1.2503E-01

CA06454 Rev.OOO Page 84 of 125 ATTACHMENT R CEAFFN OUTPUT FILE Cumulative Dose Summary

ii#if#ifiifiifiifiifiifiifiifiifi#if#ififi#i#ifi#ifiifiifi#ififiififiifif##ifiiffiifiiffi#####i#

eab lpz cr Time Thyroid TEDE Thyroid TEDE Thyroid TEDE (hr) (rem) (rem) (rem) (rem) (rem) (rem) 0.000 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 0.333 O.OOOOE+00 5.7185E-02 O.OOOOE+00 1.3462E-02 O.OOOOE+00 9.4344E-03 0.500 O.OOOOE+00 7.8304E-02 O.OOOOE+00 1.8434E-02 O.OOOOE+00 1.8143E-02 0.800 O.OOOOE+00 1.0995E-01 O.OOOOE+00 2.5885E-02 O.OOOOE+00 3.6895E-02 1.100 O.OOOOE+00 1.3653E-01 O.OOOOE+00 3.2143E-02 O.OOOOE+00 5.7856E-02 1.400 O.OOOOE+00 1.6000E-01 O.OOOOE+00 3.7666E-02 O.OOOOE+00 8.0048E-02 1.700 O.OOOOE+00 1.8124E-01 O.OOOOE+00 4.2667E-02 O.OOOOE+00 1.0283E-01 2.000 O.OOOOE+00 2.0073E-01 O.OOOOE+00 4.7255E-02 O.OOOOE+00 1.2570E-01 2.300 O.OOOOE+00 2.0073E-01 O.OOOOE+00 4.7530E-02 O.OOOOE+00 1.4786E-01 2.600 0.0000E+00 2.0073E-01 O.OOOOE+00 4.7785E-02 O.OOOOE+00 1.6878E-01 2.900 O.OOOOE+00 2.0073E-01 O.OOOOE+00 4.8022E-02 O.OOOOE+00 1.8851E-Ol 3.200 O.OOOOE+00 2.0073E-01 O.OOOOE+00 4.8242E-02 O.OOOOE+00 2.0710E-01 3.500 O.OOOOE+00 2.0073E-01 O.OOOOE+OO 4.8448E-02 O.OOOOE+00 2.2459E-01 3.800 O.OOOOE+00 2.0073E-01 O.OOOOE+00 4.8640E-02 O.OOOOE+00 2.4104E-01 4.100 O.OOOOE+00 2. 0073E-01 O.OOOOE+00 4.8819E-02 O.OOOOE+00 2.5650E-01 4.400 O.OOOOE+00 2.0073E-01 O.OOOOE+00 4.8987E-02 O.OOOOE+00 2.7104E-01 4.700 O.OOOOE+00 2.0073E-01 O.OOOOE+00 4.9144E-02 O.OOOOE+00 2.8472E-01 5.000 O.OOOOE+00 2.0073E-01 O.OOOOE+00 4.9292E-02 O.OOOOE+00 2.9758E-01 5.300 O.OOOOE+OO 2.0073E-01 O.OOOOE+00 4.9430E-02 O.OOOOE+00 3.0970E-01 5.600 O.OOOOE+00 2.0073E-01 O.OOOOE+00 4.9560E-02 O.OOOOE+00 3.2110E-01 5.900 O.OOOOE+00 2.0073E-01 O.OOOOE+00 4.9683E-02 O.OOOOE+00 3.3185E-01 6.200 O.OOOOE+00 2.0073E-01 O.OOOOE+00 4.9798E-02 O.OOOOE+00 3.4200E-01 6.500 O.OOOOE+00 2.0073E-01 O.OOOOE+00 4.9907E-02 O.OOOOE+00 3.5157E-01 6.800 O.OOOOE+00 2.0073E-01 O.OOOOE+00 5.0010E-02 O.OOOOE+00 3.6061E-01 7.100 O.OOOOE+00 2.0073E-01 O.OOOOE+00 5.0107E-02 O.OOOOE+00 3.6917E-01 7.400 O.OOOOE+OO 2.0073E-01 O.OOOOE+00 5.0199E-02 O.OOOOE+00 3.7726E-01 7.700 O.OOOOE+00 2.0073E-01 O.OOOOE+00 5.0286E-02 O.OOOOE+00 3.8493E-01 8.000 O.OOOOE+00 2.0073E-01 O.OOOOE+00 5.0368E-02 O.OOOOE+00 3.9221E-01 8.300 O.OOOOE+00 2. 0073E-01 O.OOOOE+00 5.0368E-02 O.OOOOE+00 3.9842E-01 8.600 O.OOOOE+00 2.0073E-01 O.OOOOE+00 5.0368E-02 O.OOOOE+00 4 .0316E-01 8.900 O.OOOOE+00 2.0073E-01 O.OOOOE+00 5.0368E-02 O.OOOOE+00 4.0679E-01 9.200 O.OOOOE+00 2.0073E-01 O.OOOOE+00 5.0368E-02 O.OOOOE+00 4.0957E-01 9.500 O.OOOOE+00 2.0073E-01 O.OOOOE+00 5.0368E-02 O.OOOOE+00 4.1170E-01 9.800 O.OOOOE+00 2.0073E-01 O.OOOOE+00 5.0368E-02 O.OOOOE+00 4 .1333E-01 10.100 O.OOOOE+00 2.0073E-01 0.OOOOE+00 5.0368E-02 O.OOOOE+00 4.1459E-01 10.400 O.OOOOE+00 2.0073E-01 O.OOOOE+00 5.0368E-02 O.OOOOE+00 4.1555E-01 24.000 O.OOOOE+00 2.0073E-01 O.OOOOE+00 5.0368E-02 O.OOOOE+00 4.1885E-01 96.000 O.OOOOE+00 2.0073E-01 O.OOOOE+00 5.0368E-02 O.OOOOE+00 4.1885E-01 720.000 O.OOOOE+00 2.0073E-01 O.OOOOE+00 5.0368E-02 O.OOOOE+00 4.1885E-01 Worst Two-Hour Doses

1. 1. 1. 1. iffiifiiffiffi#################################################ifiififfiffifiifiifi

CA06454 Rev.000 Page 85 of 125 eab Time Whole Body Thyroid TEDE (hr) (rem) (rem) (rem) 0.0 2.0073E-0l O.OOOOE+00 2.0073E-01

CA06454 Rev. 000 Page 86 of 125 ATITACHMENT S CEAPRI OUTPUT FILE Cumulative Dose Summary eab lpz cr Time Thyroid TEDE Thyroid TEDE Thyroid TEDE (hr) (rem) (rem) (rem) (rem) (rem) (rem) 0.000 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 0.250 2.1387E-05 6.9436E-07 5.0349E-06 1.6346E-07 4.8199E-05 1.5002E-06 0.333 2.2362E-05 7.2597E-07 5.2645E-06 1.7091E-07 7.9459E-05 2.4729E-06 0.500 2.4566E-05 7.9735E-07 5.7833E-06 1.8771E-07 1.3387E-04 4.1655E-06 0.800 2.8114E-05 9.1207E-07 6.6186E-06 2.1472E-07 2.0283E-04 6.3101E-06 1.100 3.2145E-05 1.0421E-06 7.5674E-06 2.4533E-07 2.5195E-04 7.8371E-06 1.400 3.6653E-05 1.1873E-06 8.6288E-06 2.7951E-07 2.9345E-04 9.1264E-06 1.700 4.1636E-05 1.3475E-06 9.8018E-06 3.1722E-07 3.3321E-04 1.0361E-05 2.000 4.7089E-05 1.5225E-06 1.1085E-05 3.5842E-07 3.7409E-04 1.1630E-05 2.300 4.7089E-05 1.5225E-06 1.1176E-05 3.6131E-07 4.1540E-04 1.2912E-05 2.600 4.7089E-05 1.5225E-06 1.1273E-05 3.6443E-07 4.5701E-04 1.4203E-05 2.900 4.7089E-05 1.5225E-06 1.1378E-05 3.6778E-07 5.0038E-04 1.5548E-05 3.200 4.7089E-05 1.5225E-06 1.1489E-05 3.7133E-07 5.4619E-04 1.6969E-05 3.500 4.7089E-05 1.5225E-06 1.1608E-05 3.7511E-07 5.9477E-04 1.8474E-05 3.800 4.7089E-05 1.5225E-06 1.1733E-05 3.7910E-07 6.4626E-04 2.0070E-05 4.100 4.7089E-05 1.5225E-06 1.1865E-05 3.8330E-07 7.0073E-04 2.1757E-05 4.400 4.7089E-05 1.5225E-06 1.2004E-05 3.8771E-07 7.5818E-04 2.3536E-05 4 .700 4.7089E-05 1.5225E-06 1.2149E-OS 3.9233E-07 8.1861E-04 2.5407E-05 5.000 4.7089E-05 1.5225E-06 1.2301E-05 3.9716E-07 8.8201E-04 2.7370E-05 5.300 4.7089E-05 1.5225E-06 1.2460E-05 4.0220E-07 9.4836E-04 2.9423E-05 5.600 4.7089E-05 1.5225E-06 1.2625E-05 4.0743E-07 1.0176E-03 3.1567E-05 5.900 4.7089E-05 1.5225E-06 1.2796E-05 4.1287E-07 1.0898E-03 3.3800E-05 6.200 4.7089E-05 1.5225E-06 1.2974E-05 4.1851E-07 1.1649E-03 3.6121E-05 6.500 4.7089E-05 1.5225E-06 1.3159E-05 4.2435E-07 1.2428E-03 3.8531E-05 6.800 4.7089E-05 1.5225E-06 1.3349E-05 4.3038E-07 1.3236E-03 4.1028E-05 7.100 4.7089E-05 1.5225E-06 1.3546E-05 4.3661E-07 1.4072E-03 4.3612E-05 7.400 4.7089E-05 1.5225E-06 1.3750E-05 4.4303E-07 1.4936E-03 4.6282E-05 7.700 4.7089E-05 1.5225E-06 1.3959E-05 4.4965E-07 1.5828E-03 4.9037E-05 8.000 4.7089E-05 1.5225E-06 1.4175E-05 4.5645E-07 1.6747E-03 5.1877E-05 8.300 4.7089E-05 1.5225E-06 1.4175E-05 4.5645E-07 1.7414E-03 5.3938E-05 8.600 4.7089E-05 1.5225E-06 1.4175E-05 4.5645E-07 1.7737E-03 5.4936E-05 8.900 4.7089E-05 1.5225E-06 1.4175E-05 4.5645E-07 1.7894E-03 5.5419E-05 9.200 4.7089E-05 1.5225E-06 1.4175E-05 4.5645E-07 1.7970E-03 5.5653E-OS 9.500 4.7089E-05 1.5225E-06 1.4175E-05 4.5645E-07 1.8006E-03 5.5767E-05 9.800 4.7089E-05 1.5225E-06 1.417SE-05 4.5645E-07 1.8024E-03 5.5822E-05 10.100 4.7089E-05 1.5225E-06 1.4175E-OS 4.5645E-07 1.8033E-03 5.5849E-05 10.400 4.7089E-05 1.5225E-06 1.4175E-05 4.5645E-07 1.8037E-03 5.5862E-05 24.000 4.7089E-05 1.5225E-06 1.4175E-OS 4.5645E-07 1.8041E-03 5.5874E-05 96.000 4.7089E-05 1.5225E-06 1.4175E-05 4.5645E-07 1.8041E-03 5.5874E-05 720.000 4.7089E-05 1.5225E-06 1.4175E-OS 4.5645E-07 1.8041E-03 5.5874E-05 Worst Two-Hour Doses

CA06454 Rev.OOO Page 87 of 125 eab Time Whole Body Thyroid TEDE (hr) (rem) (rem) (rem) 0.0 6.1845E-08 4.7089E-05 1.5225E-06

CA06454 Rev.OOO Page 88 of 125 ATTACHMENT T CEAPRN OUTPUT FILE Cumulative Dose Summary eab lpz cr Time Thyroid TEDE Thyroid TEDE Thyroid TEDE (hr) (rem) (rem) (rem) (rem) (rem) (rem) 0.000 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 0.333 O.OOOOE+00 6.8281E-06 0.OOOOE+00 1.6075E-06 O.OOOOE+00 1.1967E-06 0.500 O.OOOOE+00 1.0087E-05 O.OOOOE+00 2.3746E-06 O.OOOOE+00 2.5448E-06 0.800 O.OOOOE+00 1.5768E-05 O.OOOOE+00 3.7121E-06 O.OOOOE+00 5.9264E-06 1.100 O.OOOOE+00 2.1253E-05 O.OOOOE+00 5.0033E-06 O.OOOOE+00 1.0260E-05 1.400 O.OOOOE+00 2.6574E-0S O.OOOOE+00 6.2559E-06 O.OOOOE+00 1.5297E-05 1.700 O.OOOOE+00 3.17S0E-05 O.OOOOE+00 7.4744E-06 O.OOOOE+00 2.0849E-05 2.000 O.OOOOE+00 3.6795E-05 O.OOOOE+00 8.6621E-06 O.OOOOE+00 2.6772E-05 2.300 O.OOOOE+00 3.6795E-05 O.OOOOE+00 8.7373E-06 O.OOOOE+00 3.2836E-05 2.600 O.OOOOE+00 3.679SE-05 O.OOOOE+00 8.8109E-06 O.OOOOE+00 3.8875E-05 2.900 O.OOOOE+00 3.6795E-OS O.OOOOE+00 8.8829E-06 O.OOOOE+00 4.4873E-05 3.200 O.OOOOE+00 3.6795E-05 O.OOOOE+00 8.9534E-06 O.OOOOE+00 5.0818E-05 3.500 O.OOOOE+00 3.6795E-05 O.OOOOE+00 9.0225E-06 O.OOOOE+00 5.6703E-05 3.800 O.OOOOE+00 3.6795E-05 O.OOOOE+00 9.0904E-06 O.OOOOE+00 6.2524E-05 4.100 O.OOOOE+00 3.6795E-05 O.OOOOE+00 9.1571E-06 O.OOOOE+00 6.8276E-05 4.400 O.OOOOE+00 3.6795E-05 O.OOOOE+00 9.2227E-06 O.OOOOE+00 7.3960E-05 4.700 O.OOOOE+00 3.6795E-05 O.OOOOE+00 9.2873E-06 O.OOOOE+00 7.9575E-05 5.000 O.OOOOE+00 3.6795E-05 O.OOOOE+00 9.3509E-06 O.OOOOE+00 8.5122E-05 5.300 O.OOOOE+00 3.679SE-05 O.OOOOE+00 9.4135E-06 O.OOOOE+00 9.0603E-05 5.600 O.OOOOE+00 3.6795E-05 O.OOOOE+00 9.4754E-06 O.OOOOE+00 9.6020E-05 5.900 O.OOOOE+00 3.6795E-05 O.OOOOE+00 9.5364E-06 O.OOOOE+00 1.0137E-04 6.200 O.OOOOE+00 3.6795E-OS O.OOOOE+00 9.5966E-06 O.OOOOE+00 1.0667E-04 6.500 O.OOOOE+00 3.6795E-05 O.OOOOE+00 9.6561E-06 O.OOOOE+00 1.1190E-04 6.800 O.OOOOE+00 3.6795E-05 O.OOOOE+00 9.7150E-06 O.OOOOE+00 1.1708E-04 7.100 O .OOOOE+00 3.6795E-05 O.OOOOE+00 9.7732E-06 O.OOOOE+00 1.2221E-04 7.400 O.OOOOE+00 3.6795E-0S O.OOOOE+00 9.8308E-06 O.OOOOE+00 1.2729E-04 7.700 O.OOOOE+00 3.6795E-05 O.OOOOE+00 9.8878E-06 O.OOOOE+00 1.3232E-04 8.000 O.OOOOE+00 3.6795E-05 0.0000E+00 9.9443E-06 O.OOOOE+00 1.3730E-04 8.300 O.OOOOE+00 3.6795E-05 O.OOOOE+00 9.9443E-06 O.OOOOE+00 1.4174E-04 8.600 O.OOOOE+00 3.6795E-05 O.OOOOE+00 9.9443E-06 O.OOOOE+00 1.4528E-04 8.900 O.OOOOE+00 3.6795E-05 0.0000E+00 9.9443E-06 O.OOOOE+00 1.4810E-04 9.200 O.OOOOE+00 3.6795E-OS O.OOOOE+00 9.9443E-06 O.OOOOE+00 1.5035E-04 9.500 O.OOOOE+00 3.6795E-05 O.OOOOE+00 9.9443E-06 O.OOOOE+00 1.5215E-04 9.800 O.OOOOE+00 3.6795E-05 O.OOOOE+00 9.9443E-06 O.OOOOE+00 1.5359E-04 10.100 O.OOOOE+00 3.6795E-05 O.OOOOE+00 9.9443E-06 O.OOOOE+00 1.5473E-04 10.400 O.OOOOE+00 3.679SE-05 O.OOOOE+00 9.9443E-06 O.OOOOE+00 1.5565E-04 24.000 O.OOOOE+00 3.6795E-05 O.OOOOE+00 9.9443E-06 O.OOOOE+00 1.5932E-04 96.000 O.OOOOE+00 3.6795E-05 O.OOOOE+00 9.9443E-06 O.OOOOE+00 1.5932E-04 720.000 O.OOOOE+00 3.6795E-05 O.OOOOE+00 9.9443E-06 O.OOOOE+00 1.5932E-04 Worst Two-Hour Doses

CA06454 Rev. OOO Page 89 of 125 eab Time Whole Body Thyroid TEDE (hr) (rem) (rem) (rem) 0.0 3.679SE-05 O.OOOOE+00 3.6795E-05

CA06454 Rev.000 Page 90 of 125 ATTACHMENT U CEASEC OUTPUT FILE Cumulative Dose Summary eab lpz cr Time Thyroid TEDE Thyroid TEDE Thyroid TEDE (hr) (rem) (rem) (rem) (rem) (rem) (rem) 0.000 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 0.333 3.3296E-03 1.0371E-04 7.8385E-04 2.4416E-05 9.8724E-03 3.0318E-04 0.500 4.9862E-03 1.5530E-04 1.1738E-03 3.6560E-05 2.0033E-02 6.1517E-04 0.800 6.3261E-03 1.9701E-04 1.4893E-03 4.6380E-05 3.6923E-02 1.1338E-03 1.100 7.6607E-03 2.3855E-04 1.8035E-03 5.6158E-05 5.0624E-02 1.5544E-03 1.400 8.9899E-03 2.7990E-04 2.1164E-03 6.5894E-05 6.2755E-02 1.9268E-03 1.700 1.0314E-02 3.2108E-04 2.4280E-03 7.5587E-05 7.4105E-02 2.2752E-03 2.000 1.1632E-02 3.6208E-04 2.7384E-03 8.5240E-05 8.5053E-02 2.6112E-03 2.300 1.1632E-02 3.6208E-04 2.7585E-03 8.5864E-05 9.5331E-02 2.9267E-03 2.600 1.1632E-02 3.6208E-04 2.7785E-03 8.6485E-05 1.0490E-01 3.2202E-03 2.900 1.1632E-02 3.6208E-04 2.7984E-03 8.7103E-05 1.1410E-01 3.5027E-03 3.200 1.1632E-02 3.6208E-04 2.8182E-03 8.7719E-05 1.2311E-01 3.7791E-03 3.500 1.1632E-02 3.6208E-04 2.8380E-03 8.8332E-05 1.3201E-01 4.0521E-03 3.800 1.1632E-02 3.6208E-04 2.8576E-03 8.8943E-05 1.4084E-01 4.3229E-03 4.100 1.1632E-02 3.6208E-04 2.8772E-03 8.9551E-05 1.4961E-01 4.5920E-03 4.400 1.1632E-02 3.6208E-04 2.8967E-03 9.0157E-05 1.5834E-01 4.8598E-03 4.700 1.1632E-02 3.6208E-04 2.9162E-03 9. 0760E-05 1.6703E-01 5.1263E-03 5.000 1.1632E-02 3.6208E-04 2.9355E-03 9.1361E-05 1.7569E-01 5.3918E-03 5.300 1.1632E-02 3.6208E-04 2.9548E-03 9.1959E-05 1.8431E-01 5.6561E-03 5.600 1.1632E-02 3.6208E-04 2.9740E-03 9.2555E-05 1.9290E-01 5.9194E-03 5.900 1.1632E-02 3.6208E-04 2.9932E-03 9.3149E-05 2.0145E-01 6.1817E-03 6.200 1.1632E-02 3.6208E-04 3.0122E-03 9.3740E-05 2.0997E-01 6.4429E-03 6.500 1.1632E-02 3.6208E-04 3.0312E-03 9.4328E-05 2.1846E-01 6.7030E-03 6.800 1.1632E-02 3.6208E-04 3.0501E-03 9.4914E-05 2.2691E-01 6.9622E-03 7.100 1.1632E-02 3.6208E-04 3.0690E-03 9.5498E-05 2.3534E-01 7.2203E-03 7.400 1.1632E-02 3.6208E-04 3.0877E-03 9.6080E-05 2.4372E-01 7.4774E-03 7.700 1.1632E-02 3.6208E-04 3.1064E-03 9.6659E-05 2.5208E-01 7.7335E-03 8.000 1.1632E-02 3.6208E-04 3.1251E-03 9.7236E-05 2.6041E-01 7.9886E-03 8.300 1.1632E-02 3.6208E-04 3.1251E-03 9.7236E-05 2.6635E-01 8.1707E-03 8.600 1.1632E-02 3.6208E-04 3.1251E-03 9.7236E-05 2.6923E-01 8.2590E-03 8.900 1.1632E-02 3.6208E-04 3.1251E-03 9.7236E-05 2.7063E-01 8.3018E-03 9.200 1.1632E-02 3.6208E-04 3.1251E-03 9.7236E-05 2.7130E-01 8.3225E-03 9.500 1.1632E-02 3.6208E-04 3.1251E-03 9.7236E-05 2.7163E-01 8.3326E-03 9.800 1.1632E-02 3.6208E-04 3.1251E-03 9.7236E-05 2.7179E-01 8.337SE-03 10.100 1.1632E-02 3.6208E-04 3.1251E-03 9.7236E-05 2.7187E-01 8.3398E-03 10.400 1.1632E-02 3.6208E-04 3.1251E-03 9.7236E-05 2.7191E-01 8.3410E-03 24.000 1.1632E-02 3.6208E-04 3.1251E-03 9.7236E-05 2.7194E-01 8.3421E-03 96.000 1.1632E-02 3.6208E-04 3.1251E-03 9.7236E-05 2.7194E-01 8.3421E-03 720.000 1.1632E-02 3.6208E-04 3.1251E-03 9.7236E-05 2.7194E-01 8.3421E-03

1. 1. 1. 1. To#########oe#####################################

Worst Two-Hour Doses

1. 1. 1. 1. f########M###############f###########f####~###########f###########

CA06454 Rev.000 Page 91 of 125 eab Time Whole Body Thyroid TEDE (hr) (rem) (rem) (rem) 0.0 5.2494E-06 1.1632E-02 3.6208E-04

CA06454 Rev.OOO Page 92 of 125 ATTACHMENT V CEAFFI2 OUTPUT FILE

1. M####################################################U############

Cumulative Dose Summary eab lpz cr Time Thyroid TEDE Thyroid TEDE Thyroid TEDE (hr) (rem) (rem) (rem) (rem) (rem) (rem) 0.000 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 0.250 1.6061E+00 5.8286E-02 3.7809E-01 1.3721E-02 3.6189E+00 1.1532E-01 0.333 1.6789E+00 6.0905E-02 3.9524E-01 1.4338E-02 5.9637E+00 1.8995E-01 0.500 1.8431E+00 6.6774E-02 4.3389E-01 1.5720E-02 1.0040E+01 3.1957E-01 0.800 2.2002E+00 7.9410E-02 5.1796E-01 1.8694E-02 1.5395E+01 4.8955E-01 1.100 2.6355E+00 9.4634E-02 6.2044E-01 2.2278E-02 1.9634E+01 6.2385E-01 1.400 3.1479E+00 1.1238E-01 7.4107E-01 2.6456E-02 2.3655E+01 7.5097E-01 1.700 3.7364E+00 1.3259E-01 8.7962E-01 3.1213E-02 2.7884E+01 8.8452E-01 2.000 4.4000E+00 1.5521E-01 1.0358E+00 3.6538E-02 3.2527E+01 1.0309E+00 2.300 4.4000E+00 1.5521E-01 1.0358E+00 3.6538E-02 3.6016E+01 1.1408E+00 2.600 4.4000E+00 1.5521E-01 1.0358E+00 3.6538E-02 3.7703E+01 1.1939E+00 2.900 4.4000E+00 l.5521E-01 1.0358E+00 3.6538E-02 3.8519E+01 1.2195E+00 3.200 4.4000E+00 1.5521E-01 1.0358E+00 3.6538E-02 3.8914E+01 1.2319E+00 3.500 4.4000E+00 1.5521E-01 1.0358E+00 3.6538E-02 3.9105E+01 1.2379E+00 3.800 4.4000E+00 1.5521E-01 1.0358E+00 3.6538E-02 3.9197E+01 1.2408E+00 4.100 4.4000E+00 1.5521E-01 1.0358E+00 3.6538E-02 3.9242E+01 1.2422E+00 4.400 4.4000E+00 1.5521E-01 1.0358E+00 3.6538E-02 3.9263E+01 1.2429E+00 4.700 4.4000E+00 1.5521E-01 1.0358E+00 3.6538E-02 3.9274E+01 1.2432E+00 5.000 4.4000E+00 1.5521E-01 1.0358E+00 3.6538E-02 3.9279E+01 1.2434E+00 5.300 4.4000E+00 1.5521E-01 1.0358E+00 3.6538E-02 3.9281E+01 1.2435E+00 5.600 4.4000E+00 1.5521E-01 1.0358E+00 3.6538E-02 3.9282E+01 1.2435E+00 5.900 4.4000E+00 1.5521E-01 1.0358E+00 3.6538E-02 3.9283E+01 1.2435E+00 6.200 4.4000E+00 1.5521E-01 1.0358E+00 3.6538E-02 3.9283E+01 1.2435E+00 6.500 4.4000E+00 1.5521E-01 1.0358E+00 3.6538E-02 3.9283E+01 1.2435E+00 6.800 4.4000E+00 1.5521E-01 1.0358E+00 3.6538E-02 3.9283E+01 1.2435E+00 7.100 4.4000E+00 1.5521E-01 1.0358E+00 3.6538E-02 3.9283E+01 1.2435E+00 7.400 4.4000E+00 1.5521E-01 1.0358E+00 3.6538E-02 3.9283E+01 1.2435E+00 7.700 4.4000E+00 1.5521E-01 1.0358E+00 3.6538E-02 3.9283E+01 1.2435E+00 8.000 4.4000E+00 1.5521E-01 1.0358E+00 3.6538E-02 3.9283E+01 1.2435E+00 8.300 4.4000E+00 1.5521E-01 1.0358E+00 3.6538E-02 3.9283E+01 1.2435E+00 8.600 4.4000E+00 1.5521E-01 1.0358E+00 3.6538E-02 3.9283E+01 1.2435E+00 8.900 4.4000E+00 1.5521E-01 1.0358E+00 3.6538E-02 3.9283E+01 1.2435E+00 9.200 4.4000E+00 1.5521E-01 1.0358E+00 3.6538E-02 3.9283E+01 1.2435E+00 9.500 4.4000E+00 1.5521E-01 1.0358E+00 3.6538E-02 3.9283E+01 1.2435E+00 9.800 4.4000E+00 1.5521E-01 1.0358E+00 3.6538E-02 3.9283E+01 1.2435E+00 10.100 4.4000E+00 1.5521E-01 1.0358E+00 3.6538E-02 3.9283E+01 1.2435E+00 10.400 4.4000E+00 1.5521E-01 1.0358E+00 3.6538E-02 3.9283E+01 1.2435E+00 24.000 4.4000E+00 1.5521E-01 1.0358E+00 3.6538E-02 3.9283E+01 1.2435E+00 96.000 4.4000E+00 1.5521E-01 1.0358E+00 3.6538E-02 3.9283E+01 1.2435E+00 720.000 4.4000E+00 1.5521E-01 1.0358E+00 3.6538E-02 3.9283E+01 1.2435E+00

1. 1. UMU#########U###################################u#####U##

Worst Two-Hour Doses

CA06454 Rev.OOO Page 93 of 125 eab Time Whole Body Thyroid TEDE (hr) (rem) (rem) (rem) 0.0 1.6638E-02 4.4000E+00 1.5521E-01

CA06454 Rev.OOO Page 94 of 125 ATTACHMENT W CEAFFN2 OUTPUT FILE Cumulative Dose Summary eab lpz cr Time Thyroid TEDE Thyroid TEDE Thyroid TEDE (hr) (rem) (rem) (rem) (rem) (rem) (rem) 0.000 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 0.333 O.OOOOE+00 5.7185E-02 O.OOOOE+00 1.3462E-02 O.OOOOE+00 9.4344E-03 0.500 O.OOOOE+00 7.8304E-02 O.OOOOE+00 1.8434E-02 O.OOOOE+00 1.8143E-02 0.800 O.OOOOE+00 1.0995E-01 O.OOOOE+00 2.5885E-02 O.OOOOE+00 3.6895E-02 1.100 O.OOOOE+00 1.3653E-01 O.OOOOE+00 3.2143E-02 O.OOOOE+00 5.7856E-02 1.400 O.OOOOE+00 1.6000E-01 O.OOOOE+00 3.7666E-02 O.OOOOE+00 8.0048E-02 1.700 O.OOOOE+00 1.8124E-01 O.OOOOE+00 4.2667E-02 O.OOOOE+00 1.0283E-01 2.000 O.OOOOE+00 2.0073E-01 O.OOOOE+00 4.7255E-02 O.OOOOE+00 1.2570E-01 2.300 O.OOOOE+00 2.0073E-01 O.OOOOE+00 4.7255E-02 O.OOOOE+00 1.4543E-01 2.600 O.OOOOE+00 2.0073E-01 O.OOOOE+00 4.7255E-02 O.OOOOE+00 1.6014E-01 2.900 O.OOOOE+00 2.0073E-01 O.OOOOE+00 4.7255E-02 O.OOOOE+00 1.7113E-01 3.200 O.OOOOE+00 2.0073E-01 O.OOOOE+00 4.7255E-02 O.OOOOE+00 1.7936E-01 3.500 O.OOOOE+00 2.0073E-01 O.OOOOE+00 4.7255E-02 O.OOOOE+00 1.8553E 01 3.800 O.OOOOE+00 2.0073E-01 O.OOOOE+00 4.7255E-02 O.OOOOE+00 1.9017E-01 4.100 O.OOOOE+00 2.0073E-01 O.OOOOE+00 4.7255E-02 O.OOOOE+00 1.9365E-01 4.400 O.OOOOE+00 2.0073E-01 O.OOOOE+00 4.7255E-02 O.OOOOE+00 1.9627E-01 4.700 O.OOOOE+00 2.0073E-01 O.OOOOE+00 4.7255E-02 O.OOOOE+00 1.9825E-01 5.000 O.OOOOE+00 2.0073E-01 O.OOOOE+00 4.7255E-02 O.OOOOE+00 1.9974E-01 5.300 O.OOOOE+00 2.0073E-01 0.OOOOE+00 4.7255E-02 O.OOOOE+00 2.0086E-01 5.600 O.OOOOE+00 2.0073E-01 O.OOOOE+00 4.7255E-02 0.0000E+00 2.0171E-01 5.900 O.OOOOE+00 2.0073E-01 O.OOOOE+00 4.7255E-02 O.OOOOE+00 2.0236E-01 6.200 O.OOOOE+00 2.0073E-01 O.OOOOE+00 4.7255E-02 O.OOOOE+00 2.0285E-01 6.500 O.OOOOE+00 2.0073E-01 O.OOOOE+00 4.7255E-02 O.OOOOE+00 2.0322E-01 6.800 O.OOOOE+00 2.0073E-01 0.0000E+00 4.7255E-02 0.0000E+00 2.0350E-01 7.100 O.OOOOE+00 2.0073E-01 O.OOOOE+00 4.7255E-02 O.OOOOE+00 2.0371E-01 7.400 O.OOOOE+00 2.0073E-01 O.OOOOE+00 4.7255E-02 O.OOOOE+00 2.0387E-01 7.700 O.OOOOE+00 2.0073E-01 O.OOOOE+00 4.7255E-02 O.OOOOE+00 2.0400E-01 8.000 O.OOOOE+00 2.0073E-01 O.OOOOE+00 4.7255E-02 O.OOOOE+00 2.0409E-01 8.300 O.OOOOE+00 2.0073E-01 O.OOOOE+00 4.7255E-02 O.OOOOE+00 2.0416E-01 8.600 O.OOOOE+00 2.0073E-01 O.OOOOE+00 4.7255E-02 O.OOOOE+00 2.0422E-01 8.900 O.OOOOE+00 2.0073E-01 O.OOOOE+00 4.7255E-02 O.OOOOE+00 2.0426E-01 9.200 O.OOOOE+00 2.0073E-01 O.OOOOE+00 4.7255E-02 O.OOOOE+00 2.0429E-01 9.500 O.OOOOE+00 2.0073E-01 O.OOOOE+00 4.7255E-02 O.OOOOE+00 2.0432E-01 9.800 O.OOOOE+00 2.0073E-01 O.OOOOE+00 4.7255E-02 O.OOOOE+00 2.0434E-01 10.100 O.OOOOE+00 2.0073E-01 O.OOOOE+00 4.7255E-02 O.OOOOE+00 2.0435E-01 10.400 O.OOOOE+00 2.0073E-01 O.OOOOE+00 4.7255E-02 O.OOOOE+00 2.0436E-01 24.000 O.OOOOE+00 2.0073E-01 O.OOOOE+00 4.7255E-02 O.OOOOE+00 2.0440E-01 96.000 O.OOOOE+00 2.0073E-01 O.OOOOE+00 4.7255E-02 O.OOOOE+00 2.0440E-01 720.000 O.OOOOE+00 2.0073E-01 O.OOOOE+00 4.7255E-02 O.OOOOE+00 2.0440E-01 Worst Two-Hour Doses

1. 1. 1. 1. iffiffiffiffiffiffiffiffiffiffiff i

CA06454 Rev.OOO Page 95 of 125 eab Time Whole Body Thyroid TEDE (hr) (rem) (rem) (rem) 0.0 2.0073E-01 O.OOOOE+00 2.0073E-01

CA06454 Rev.OOO Page 96 of 125 ATTACHMENT X CEAPRI2 OUTPUT FILE Cumulative Dose Summary eab lpz cr Time Thyroid TEDE Thyroid TEDE Thyroid TEDE (hr) (rem) (rem) (rem) (rem) (rem) (rem) 0.000 O.OOOOE+00 O.OOOOE+00 0.0000E+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 0.250 2.1381E-05 6.9416E-07 5.0335E-06 1.6342E-07 4.8189E-05 1.4999E-06 0.333 2.2351E-05 7.2562E-07 5.2619E-06 1.7082E-07 7.9437E-05 2.4722E-06 0.500 2.4541E-05 7.9654E-07 5.7774E-06 1.8752E-07 1.3380E-04 4.1634E-06 0.800 2.9309E-05 9.5070E-07 6.8999E-06 2.2381E-07 2.0530E-04 6.3870E-06 1.100 3.5131E-05 1.1385E-06 8.2705E-06 2.6803E-07 2.6200E-04 8.1494E-06 1.400 4.1995E-05 1.3596E-06 9.8863E-06 3.2006E-07 3.1585E-04 9.8225E-06 1.700 4.9889E-05 1.6133E-06 1.1745E-05 3.7980E-07 3.7259E-04 1.1585E-05 2.000 5.8803E-05 1.8994E-06 1.3843E-05 4.4715E-07 4.3495E-04 1.3521E-05 2.300 5.8803E-05 1.8994E-06 1.3843E-05 4.4715E-07 4.8187E-04 1.4977E-05 2.600 5.8803E-05 1.8994E-06 1.3843E-05 4.4715E-07 5.0459E-04 1.5682E-05 2.900 5.8803E-05 1.8994E-06 1.3843E-05 4.4715E-07 5.1560E-04 1.6023E-05 3.200 5.8803E-05 1.8994E-06 1.3843E-05 4.4715E-07 5.2093E-04 1.6188E-05 3.500 5.8803E-05 1.8994E-06 1.3843E-05 4.4715E-07 5.2351E-04 1.6268E-05 3.800 5.8803E-05 1.8994E-06 1.3843E-05 4.4715E-07 5.2476E-04 1.6307E-05 4.100 5.8803E-05 1.8994E-06 1.3843E-05 4.4715E-07 5.2536E-04 1.6326E-05 4.400 5.8803E-05 1.8994E-06 1.3843E-05 4.4715E-07 5.2565E-04 1.6335E-05 4.700 5.8803E-05 1.8994E-06 1.3843E-05 4.4715E-07 5.2580E-04 1.6339E-05 5.000 5.8803E-05 1.8994E-06 1.3843E-05 4.4715E-07 5.2587E-04 1.6342E-05 5.300 5.8803E-05 1.8994E-06 1.3843E-05 4.4715E-07 5.2590E-04 1.6343E-05 5.600 5.8803E-05 1.8994E-06 1.3843E-05 4.4715E-07 5.2592E-04 1.6343E-05 5.900 5.8803E-05 1.8994E-06 1.3843E-05 4.4715E-07 5.2592E-04 1.6343E-05 6.200 5.8803E-05 1.8994E-06 1.3843E-05 4.4715E-07 5.2593E-04 1.6343E-05 6.500 5.8803E-05 1.8994E-06 1.3843E-05 4.4715E-07 5.2593E-04 1.6343E-05 6.800 5.8803E-05 1.8994E-06 1.3843E-05 4.4715E-07 5.2593E-04 1.6344E-05 7.100 5.8803E-05 1.8994E-06 1.3843E-05 4.4715E-07 5.2593E-04 1.6344E-05 7.400 5.8803E-05 1.8994E-06 1.3843E-05 4.4715E-07 5.2593E-04 1.6344E-05 7.700 5.8803E-05 1.8994E-06 1.3843E-05 4.4715E-07 5.2593E-04 1.6344E-05 8.000 5.8803E-05 1.8994E-06 1.3843E-05 4.4715E-07 5.2593E-04 1.6344E-05 8.300 5.8803E-05 1.8994E-06 1.3843E-05 4.4715E-07 5.2593E-04 1.6344E-05 8.600 5.8803E-05 1.8994E-06 1.3843E-05 4.4715E-07 5.2593E-04 1.6344E-05 8.900 5.8803E-05 1.8994E-06 1.3843E-05 4.4715E-07 5.2593E-04 1.6344E-05 9.200 5.8803E-05 1.8994E-06 1.3843E-05 4.4715E-07 5.2593E-04 1.6344E-05 9.500 5.8803E-05 1.8994E-06 1.3843E-05 4.4715E-07 5.2593E-04 1.6344E-05 9.800 5.8803E-05 1.8994E-06 1.3843E-05 4.4715E-07 5.2593E-04 1.6344E-05 10.100 5.8803E-05 1.8994E-06 1.3843E-05 4.4715E-07 5.2593E-04 1.6344E-05 10.400 5.8803E-05 1.8994E-06 1.3843E-05 4.4715E-07 5.2593E-04 1.6344E-05 24.000 5.8803E-05 1.8994E-06 1.3843E-05 4.4715E-07 5.2593E-04 1.6344E-05 96.000 5.8803E-05 1.8994E-06 1.3843E-05 4.4715E-07 5.2593E-04 1.6344E-05 720.000 5.8803E-05 1.8994E-06 1.3843E-05 4.4715E-07 5.2593E-04 1.6344E-05 Worst Two-Hour Doses

CA06454 Rev.000 Page 97 of 125 if ifif if ififif if ifif ifififififif if if ifif ififif if ifif ifififif if if ifif if ifif ififif ifififififififif if ifif ifif if if if ifif ifif ifif if ifif if if if eab Time Whole Body Thyroid TEDE (hr) (rem) (rem) (rem) 0.0 7.5742E-08 5.8803E-05 1.8994E-06

CA06454 Rev.OOO Page 98 of 125 ATTACHMENT Y CEAPRN2 OUTPUT FILE Cumulative Dose Summary eab lpz Time Thyroid TEDE Thyroid TEDE Thyroid TEDE (hr) (rem) (rem) (rem) (rem) (rem) (rem) 0.000 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 0.333 O.OOOOE+00 6.8281E-06 O.OOOOE+00 1.6075E-06 O.OOOOE+00 1.1967E-06 0.500 O.OOOOE+00 1.0087E-05 O.OOOOE+00 2.3746E-06 O.OOOOE+00 2.5448E-06 0.800 O.OOOOE+00 1.5768E-05 O.OOOOE+00 3.7121E-06 O.OOOOE+00 5.9264E-06 1.100 O.OOOOE+00 2.1253E-05 O.OOOOE+00 5.0033E-06 O.OOOOE+00 1.0260E-05 1.400 O.OOOOE+00 2.6574E-05 O.OOOOE+00 6.2559E-06 O.OOOOE+00 1.5297E-05 1.700 O.OOOOE+00 3.1750E-05 O.OOOOE+00 7.4744E-06 O.OOOOE+00 2.0849E-05 2.000 O.OOOOE+00 3.6795E-05 O.OOOOE+00 8.6621E-06 O.OOOOE+00 2.6772E-05 2.300 O.OOOOE+00 3.6795E-05 O.OOOOE+00 8.6621E-06 O.OOOOE+00 3.2167E-05 2.600 O.OOOOE+00 3.6795E-05 O.OOOOE+00 8.6621E-06 O.OOOOE+00 3.6408E-05 2.900 O.OOOOE+00 3.6795E-05 O.OOOOE+00 8.6621E-06 O.OOOOE+00 3.9747E-05 3.200 O.OOOOE+00 3.6795E-05 O.OOOOE+00 8.6621E-06 O.OOOOE+00 4.2377E-05 3.500 O.OOOOE+00 3.6795E-05 O.OOOOE+00 8.6621E-06 O.OOOOE+00 4.4452E-05 3.800 O.OOOOE+00 3.6795E-05 O.OOOOE+00 8.6621E-06 O.OOOOE+00 4.6090E-05 4.100 O.OOOOE+00 3.6795E-05 O.OOOOE+00 8.6621E-06 O.OOOOE+00 4.7385E-05 4.400 O.OOOOE+00 3.6795E-05 O.OOOOE+00 8.6621E-06 O.OOOOE+00 4.8409E-05 4.700 O.OOOOE+00 3.6795E-05 O.OOOOE+00 8.6621E-06 O.OOOOE+00 4.9219E-05 5.000 O.OOOOE+00 3.6795E-05 O.OOOOE+00 8.6621E-06 O.OOOOE+00 4.9861E-05 5.300 O.OOOOE+00 3.6795E-05 O.OOOOE+00 8.6621E-06 O.OOOOE+00 5.0370E-05 5.600 O.OOOOE+00 3.6795E-05 O.OOOOE+00 8.6621E-06 O.OOOOE+00 5.0774E-05 5.900 O.OOOOE+00 3.6795E-05 O.OOOOE+00 8.6621E-06 O.OOOOE+00 5.1094E-05 6.200 O.OOOOE+00 3.6795E-05 O.OOOOE+00 8.6621E-06 O.OOOOE+00 5.1349E-05 6.500 O.OOOOE+00 3.6795E-05 O.OOOOE+00 8.6621E-06 O.OOOOE+00 5.1551E-05 6.800 O.OOOOE+00 3.6795E-05 O.OOOOE+00 8.6621E-06 O.OOOOE+00 5.1712E-05 7.100 O.OOOOE+00 3.6795E-05 O.OOOOE+00 8.6621E-06 O.OOOOE+00 5.1840E-05 7.400 O.OOOOE+00 3.6795E-05 O.OOOOE+00 8.6621E-06 O.OOOOE+00 5.1942E-05 7.700 O.OOOOE+00 3.6795E-05 O.OOOOE+00 8.6621E-06 O.OOOOE+00 5.2023E-05 8.000 O.OOOOE+00 3.6795E-05 O.OOOOE+00 8.6621E-06 O.OOOOE+00 5.2087E-05 8.300 O.OOOOE+00 3.6795E-05 O.OOOOE+00 8.6621E-06 O.OOOOE+00 5.2139E-05 8.600 O.OOOOE+00 3.6795E-05 O.OOOOE+00 8.6621E-06 O.OOOOE+00 5.2180E-05 8.900 O.OOOOE+00 3.6795E-05 O.OOOOE+00 8.6621E-06 O.OOOOE+00 5.2213E-05 9.200 O.OOOOE+00 3.6795E-05 O.OOOOE+00 8.6621E-06 O.OOOOE+00 5.2239E-05 9.500 O.OOOOE+00 3.6795E-05 O.OOOOE+00 8.6621E-06 O.OOOOE+00 5.2259E-05 9.800 O.OOOOE+00 3.6795E-05 O.OOOOE+00 8.6621E-06 O.OOOOE+00 5.2276E-05 10.100 O.OOOOE+00 3.6795E-05 O.OOOOE+00 8.6621E-06 O.OOOOE+00 5.2289E-05 10.400 O.OOOOE+00 3.6795E-05 O.OOOOE+00 8.6621E-06 O.OOOOE+00 5.2300E-05 24.000 O.OOOOE+00 3.6795E-05 O.OOOOE+00 8.6621E-06 O.OOOOE+00 5.2343E-05 96.000 O.OOOOE+00 3.6795E-05 O.OOOOE+00 8.6621E-06 O.OOOOE+00 5.2343E-05 720.000 O.OOOOE+00 3.6795E-05 O.OOOOE+00 8.6621E-06 O.OOOOE+00 5.2343E-05

1. 1. 1. 1. w##############################s##########

Worst Two-Hour Doses

1. 1. 1. 1. ~###############################################fiiii~fi

nt# f fi#ii fi fi i i fi fi fi i fiii fi f

CA06454 Rev. 000 Page 99 of 125 eab Time Whole Body Thyroid TEDE (hr) (rem) (rem) (rem) 0.0 3.6795E-OS O.OOOOE+O0 3.6795E-05

CA06454 Rev.000 Page 100 of 125 A1TACHMENT Z CEASEC2 OUTPUT FILE Cumulative Dose Summary t#iiif# ff# ifffiiif ffifififfiiiffi ififif fiiffiiiff fiiff iiiiff fififfiiififf fi#i ifififi##ifif#i eab lpz cr Time Thyroid TEDE Thyroid TEDE Thyroid TEDE (hr) (rem) (rem) (rem) (rem) (rem) (rem) 0.000 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 0.333 3.2712E-03 1.0189E-04 7.7010E-04 2.3988E-05 9.6991E-03 2.9786E-04 O.500 4.8988E-03 1.5258E-04 1.1533E-03 3.5919E-05 1.9681E-02 6.0438E-04 0.800 7.8134E-03 2.4331E-04 1.8394E-03 5.7280E-05 3.9925E-02 1.2259E-03 1.100 1.0709E-02 3.3344E-04 2.5212E-03 7.8498E-05 6.1712E-02 1.8948E-03 1.400 1.3587E-02 4.2297E-04 3.1986E-03 9.9574E-05 8.4171E-02 2.5843E-03 1.700 1.6446E-02 5.1190E-04 3.8717E-03 1.2051E-04 1.0688E-01 3.2814E-03 2.000 1.9287E-02 6.0024E-04 4.5405E-03 1.4131E-04 1.2964E-01 3.9798E-03 2.300 1.9287E-02 6.0024E-04 4.5405E-03 1.4131E-04 1.4590E-01 4.4789E-03 2.600 1.9287E-02 6.0024E-04 4.5405E-03 1.4131E-04 1.5378E-01 4.7208E-03 2.900 1.9287E-02 6.0024E-04 4.5405E-03 1.4131E-04 1.5760E-01 4.8380E-03 3.200 1.9287E-02 6.0024E-04 4.5405E-03 1.4131E-04 1.5946E-01 4.8949E-03 3.500 1.9287E-02 6.0024E-04 4.5405E-03 1.4131E-04 1.6035E-01 4.922SE-03 3.800 1.9287E-02 6.0024E-04 4.5405E-03 1.4131E-04 1.6079E-01 4.9358E-03 4.100 1.9287E-02 6.0024E-04 4.5405E-03 1.4131E-04 1.6100E-01 4.9423E-03 4.400 1.9287E-02 6.0024E-04 4.5405E-03 1.4131E-04 1.6110E-01 4.9454E-03 4.700 1.9287E-02 6.0024E-04 4.5405E-03 1.4131E-04 1.6115E-01 4.9470E-03 5.000 1.9287E-02 6.0024E-04 4.5405E-03 1.4131E-04 1.6118E-01 4.9477E-03 5.300 1.9287E-02 6.0024E-04 4.5405E-03 1.4131E-04 1.6119E-01 4.9481E-03 5.600 1.9287E-02 6.0024E-04 4.5405E-03 1.4131E-04 1.6119E-01 4.9482E-03 5.900 1.9287E-02 6.0024E-04 4.5405E-03 1.4131E-04 1.6120E-01 4.9483E-03 6.200 1.9287E-02 6.0024E-04 4.5405E-03 1.4131E-04 1.6120E-01 4.9484E-03 6.500 1.9287E-02 6.0024E-04 4.5405E-03 1.4131E-04 1.6120E-01 4.9484E-03 6.800 1.9287E-02 6.0024E-04 4.5405E-03 1.4131E-04 1.6120E-01 4.9484E-03 7.100 1.9287E-02 6.0024E-04 4.5405E-03 1.4131E-04 1.6120E-01 4.9484E-03 7.400 1.9287E-02 6.0024E-04 4.5405E-03 1.4131E-04 1.6120E-01 4.9484E-03 7.700 1.9287E-02 6.0024E-04 4.5405E-03 1.4131E-04 1.6120E-01 4.9484E-03 8.000 1.9287E-02 6.0024E-04 4.5405E-03 1.4131E-04 1.6120E-01 4.9484E-03 8.300 1.9287E-02 6.0024E-04 4.5405E-03 1.4131E-04 1.6120E-01 4.9484E-03 8.600 1.9287E-02 6.0024E-04 4.5405E-03 1.4131E-04 1.6120E-01 4.9484E-03 8.900 1.9287E-02 6.0024E-04 4.5405E-03 1.4131E-04 1.6120E-01 4.9484E-03 9.200 1.9287E-02 6.0024E-04 4.5405E-03 1.4131E-04 1.6120E-01 4.9484E-03 9.500 1.9287E-02 6.0024E-04 4.5405E-03 1.4131E-04 1.6120E-01 4.9484E-03 9.800 1.9287E-02 6.0024E-04 4.5405E-03 1.4131E-04 1.6120E-01 4.9484E-03 10.100 1.9287E-02 6.0024E-04 4.5405E-03 1.4131E-04 1.6120E-01 4.9484E-03 10.400 1.9287E-02 6.0024E-04 4.5405E-03 1.4131E-04 1.6120E-01 4.9484E-03 24.000 1.9287E-02 6.0024E-04 4.5405E-03 1.4131E-04 1.6120E-01 4 .9484E-03 96.000 1.9287E-02 6.0024E-04 4.5405E-03 1.4131E-04 1.6120E-01 4.9484E-03 720.000 1.9287E-02 6.0024E-04 4.5405E-03 1.4131E-04 1.6120E-01 4.9484E-03 Worst Two-Hour Doses

1. 1. 1. 1. iiffiffiifiifiiffiffi##################################fiififfifiifi

CA06454 Rev.000 Page 101 of 125 eab Time Whole Body Thyroid TEDE (hr) (rem) (rem) (rem) 0.0 8.6279E-06 1.9287E-02 6.0024E-04

CA06454 Rev.000 Page 102 of 125 ATTACHMENT AA CEACTMT OUTPUT FILE Cumulative Dose Summary EAB LPZ cr Time Thyroid TEDE Thyroid TEDE Thyroid TEDE (hr) (rem) (rem) (rem) (rem) (rem) (rem) 0.000 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 0.092 1.1984E+00 5.0944E-02 3.0420E-01 1.2932E-02 3.3051E-01 1.0664E-02 0.333 4.3174E+00 1.7880E-01 1.0959E+00 4.5387E-02 4.1116E+00 1.3215E-01 0.733 7.8710E+00 3.2365E-01 1.9980E+00 8.2157E-02 1.3550E+01 4.3494E-01 1.033 9.1919E+00 3.8086E-01 2.3333E+00 9.6680E-02 1.9039E+01 6.1148E-01 1.333 9.9233E+00 4.1577E-01 2.5190E+00 1.0554E-01 2.2815E+01 7.3374E-01 1.633 1.0328E+01 4.3830E-01 2.6218E+00 1.1126E-01 2.5247E+01 8.1343E-01 1.933 1.0553E+01 4.5383E-01 2.6788E+00 1.1520E-01 2.6751E+01 8.6378E-01 2.000 1.0587E+01 4.5664E-01 2.6875E+00 1.1592E-01 2.6995E+01 8.7208E-01 2.300 1.0587E+01 4.5664E-01 2.6893E+00 1.1610E-01 2.7772E+01 8.9932E-01 2.600 1.0587E+01 4.5664E-01 2.6904E+00 1.1625E-01 2.8198E+01 9.1520E-01 2.900 1.0587E+01 4.5664E-01 2.6909E+00 1.1637E-01 2.8432E+01 9.2481E-01 3.200 1.0587E+01 4.5664E-01 2.6912E+00 1.1648E-01 2.8561E+01 9.3091E-01 3.500 1.0587E+01 4.5664E-01 2.6914E+00 1.1657E-01 2.8632E+01 9.3504E-01 3.800 1.0587E+01 4.5664E-01 2.6915E+00 1.1666E-01 2.8672E+01 9.3803E-01 4.100 1.0587E+01 4.5664E-01 2.6916E+00 1.1674E-01 2.8694E+01 9.4034E-01 4.400 1.0587E+01 4.5664E-01 2.6916E+00 1.1681E-01 2.8706E+01 9.4224E-01 4.700 1.0587E+01 4.5664E-01 2.6916E+00 1.1688E-01 2.8713E+01 9.4386E-01 5.000 1.0587E+01 4.5664E-01 2.6916E+00 1.1695E-01 2.8717E+01 9.4530E-01 5.300 1.0587E+01 4.5664E-01 2.6916E+00 1.1701E-01 2.8720E+01 9.4660E-01 5.600 1.0587E+01 4.5664E-01 2.6917E+00 1.1707E-01 2.8721E+01 9.4780E-01 5.900 1.0587E+01 4.5664E-01 2.6917E+00 1.1712E-01 2.8722E+01 9.4891E-01 6.200 1.0587E+01 4.5664E-01 2.6917E+00 1.1717E-01 2.8723E+01 9.4994E-01 6.500 1.0587E+01 4.5664E-01 2.6917E+00 1.1722E-01 2.8723E+01 9.5091E-01 6.800 1.0587E+01 4.5664E-01 2.6917E+00 1.1727E-01 2.8723E+01 9.5182E-01 7.100 1.0587E+01 4.5664E-01 2.6917E+00 1.1731E-01 2.8724E+01 9.5267E-01 7.400 1.0587E+01 4.5664E-01 2.6917E+00 1.1735E-01 2.8724E+01 9.5348E-01 7.700 1.0587E+01 4.5664E-01 2.6917E+00 1.1739E-01 2.8724E+01 9.5425E-01 8.000 1.0587E+01 4.5664E-01 2.6917E+00 1.1742E-01 2.8724E+01 9.5497E-01 8.300 1.0587E+01 4.5664E-01 2.6917E+00 1.1746E-01 2.8724E+01 9.5562E-01 8.600 1.0587E+01 4.5664E-01 2.6917E+00 1.1749E-01 2.8724E+01 9.5617E-01 8.900 1.0587E+01 4.5664E-01 2.6917E+00 1.1752E-01 2.8724E+01 9.5665E-01 9.200 1.0587E+01 4.5664E-01 2.6917E+00 1.1755E-01 2.8724E+01 9.5706E-01 9.500 1.0587E+01 4.5664E-01 2.6917E+00 1.1758E-01 2.8724E+01 9.5742E-01 9.800 1.0587E+01 4.5664E-01 2.6917E+00 1.1761E-01 2.8724E+01 9.5775E-01 10.100 1.0587E+01 4.5664E-01 2.6917E+00 1.1763E-01 2.8724E+01 9.5804E-01 10.400 1.0587E+01 4.5664E-01 2.6917E+00 1.1766E-01 2.8724E+01 9.5831E-01 24.000 1.0587E+01 4.5664E-01 2.6917E+00 1.1825E-01 2.8724E+01 9.6363E-01 96.000 1.0587E+01 4.5664E-01 2.6917E+00 1.1838E-01 2.8724E+01 9.6582E-01 720.000 1.0587E+01 4.5664E-01 2.6917E+00 1.1862E-01 2.8724E+01 9.6789E-01 Worst Two-Hour Doses

CA06454 Rev.OOO Page 103 of 125 EAB Time Whole Body Thyroid TEDE (hr) (rem) (rem) (rem) 0.0 1.2280E-01 1.0587E+01 4.5664E-01

CA06454 Rev.OOO Page 104 of 125 ATTACHMENT AB ETP-97-064R CONTROL ROOM INLEAKAGE RESULTS

C1f0 L ? 5Y /Ay Co' M.GR aoyn 61p-9p5V

,o/of CALVERT CLIFFS NUCLEAR POWER PLANT TECHNICAL PROCEDURE tj 0d, ENGINEERING TEST PROCEDURE UNIT 0 ETP 97-064R CONTROL ROOM HVAC SYSTEM INLEAKAGE TEST REVISION 0 Effective Date / lf/f/T7 -7 Safety Related X Non-Safety Related _ :_

Writer: D. T. McElheny Sponsor: V. P. Spunar GOPY I

plqc" .10f.

FT-86 CRiv. 1 10/97) - ACTZfW Attachment 2

Page 37 of 40 60d NUCON International, Inc.

K . . .. -

Decay Test Data Estffitdd duration oftest: 2 hQ Beginning cQ.ncent-ition (C7. -19.O Xmb Ending concentration (C(O)): 2:7ppb Time at start of test: - - . . T Tinie"ze ro" for deca test was at 01:15 hours on 18 Nov 97.

Time at end of test: . . :1.2,oi irs on 19 Nov971 Sample time intervals: . 15 minuti e. excent for last samble Time / Sample Concentration Time/Conc. Time/Conc. Time/Conc. Time/Conc.

01:15/ 19.0 / I 01:301 14.8 . . 1 /

01:451 12.1 . /

02:00/ 8.3 _ - - /

/ /

02.oi1 6.7 *. .

. 1*

02:301 5.1 . . . _

- 03:12/ 2.7 - 1 /

(A) Air Change Rate (f/min) (Q)Xnleakage Flow Rate (CM 0.0170 4300 95% Confidence Limit 95% Confidence Interval

() = 0.0170 :Q ... 4000 < <* 4600 -

Clomments: Decav safinlesq taLken at a samnle nort on the discrharve of X1 I retnr fan. All samnle concentrations in the ppb range.

Test personnel signatuze(s) and date: NUCON International Inc. s

ceoo 5 A-y-

_T-86 (Rev. 1 10/97) -CU#12 Atachment2 Page 37 of 40 NUCON International, Inc.

Oay . "

e _ _ _ _ _ _ _ __Dat Estimated duration of test: 1.4 hours4.62963e-5 days 0.00111 hours 6.613757e-6 weeks 1.522e-6 months Beginning concentra tion (Ct): 40.5 ppb Ending concentratior n(C(0)): -_I4.2 ppb Time at start of test : Time "zero" for decay test was at 23:16 hours on 19 Nov 97.

rime at end of test: 0,.46-houms 6h.20 Nov 97

. Sample timreinterval s: 15 minute Time / Sample Concentration Time/Conic. Time/Conc. Time/Couc. Time/Comc.

23:16/ 40.5 I 23:31 / 35.2 .. / /

23:46/ 21.2 / _ I . .

00:01 1 26.7 1 00:16/ 20.3 . l-.. I J 00:31 / 16.7 * / / .I 00:46/ 14.2 / .. /... ...

(A) Air Change Rate (/lmin) (Q) Xnleakage Flow Rate (CF1!

0.0118 - 3000 95% Confidence Limit 95% Confidence Interval (A4)= 0,011,a:R_: Q.Q12_~ _ . 2900 <Q < 3300 Comments: Decay sMnbles tAkeii at a sample port on the discharge of#12 returim n. These samples were taken in c6fiuncfion with samrles taken in CAS and on both CSR retu ducts.

Tle decay sample taken at 23:46 houmrwas disrezarded due to a faulty gas samule bag. -

01H oX Oita Test pefsornel signae(s) and date:

/, ,, X, CJON International Inc.

I?,Je. /O~?

CALVERT CLIFFS NUCLEAR POWER PLANT TECHNICAL PROCEDURE ENGINEERING TEST PROCEDURE UNIT 0 ETP 97-064R CONTROL ROOM HVAC SYSTEM INLEAKAGE TEST REVISION 0 Effective Date //b/??T Safety Related X Non-Safety Related

.copY....

Writer: D. T. McElheny Sponsor V. P. Spunar i

C/o Gy5y Arco 44i. / 6Aor 1ce' P45e lo?

NUCON International, Inc. a TELEPHONE: (614) 846-5710 K1I P.O. BOX 29151 7000 HUNTLEY ROAD COLUMBUS, OHIO 43229 U.SA.

OUTSIDE OHIO: 1.800-992-5192 FAX: (614) 431-08S8 L-Control Room Inleakage Test Report performed for:

Baltimore Gas and Electric Company Calvert Cliffs Nuclear Power Station 1850 Calvert Cliffs Pkwy.

Lusby, Maryland 20657 P.O. No. 16582 20 April 1998 Distribution:

BG&E:

Dale McElheny (1)

NUCON:

12BG847 MF (1)

Field Test (1)

QA. (1)

Marketing (1)

NUCON 12BG847 102

z e- //D)

FT-86 (Rev. 1 10/97) ACU#11 Trip 2 Initial CharacterizationTest Attachment 2 Page 37 of 40 Decay Test-Data Estimated duration of test: 120 minutes Beginning concentration (Ct): 25.0 ppb Ending concentration (C(O)): 4.1 ppb Time at start of test: Time "zero" for decav test was at 22:03 hrs. on 10 Feb 98 Time at end of test: 00:03 hrs. on 11 Feb 98 Sample time intervals: 20 minutes apart Time / Sample Concentration Time/Conc. Time/Conc. Time/Cone. Time/Cone.

22:03 / 25.0 l */ /

22:23/17.9 / ._ /

22:43 /11.9 /

/ */

23:03 / 9.7 r/. /

23:23 / 9.0 /

/

23:43/5.7 l */

/ /

00:03/ 4.1 (A) Air Change Rate ( /min) (Q)Inleakage Flow Rate (CFM) 0.0143 3,600 95% Confidence Limit 95% Confidence Interval

-(A)= 0.0143 A 0.0025 3000 <Q<_< *43QT 44toe:

Comments: Decay samples taken at a sample port on the discharge of #11 return fan. All sample concentrations in the pvb range.

Act y.:z a/42 ec S/>7/

5/3e -7 Ah Test personnel signature(s) and date: NUCON International Inc.

C#O Yy Ago.

CI9-OYer,/ e/

FT-86 (Rev. 1 10/97) ACU#12 Trip 2 Initial CharacterizalionTest Attachment 2 Page 37 of 40 Decay Test Data Estimated duration c)ftest: 120 minutes Beginning concenta ttion (Ct): 47 Rpb Ending concentratio n (C(O)): 12.6 ppb Time at start of test: Time "zero" for decay test was at 02:05 hrs. on 11 Feb 98 Time at end of test: 04:05 brs. on I Feb 98 Sample time interva ..Is:, 20 minutes anart Time / Sample Concentration Time/Conc. Time/Conc. Time/Cone. Time/Conc.

02:05 / 47.0 / l. I 02:25/33.2 / / /

02:45 /27.4 . / / I...

03:05 / 24.8 / /1 /

03:25/21.4 / / /

03:45 / 16.1 / /

/ I 04:05/ 16 /

(A) Air Change Rate ( I/min) (Q) Inleakage Flow Rate (CFM 0.0101 2550

95% Confidence Limit 95% Confidence Interval

(A)= 0.0101 h 0.0018 2100<Q< 3000 Comments: Decay samples taken at a sample port on the discharge of #12 return fan. All sample concentrations in the ppb range.

Test personnel signature(s) and date: NUCON Intemational Inc.

ifz.Ay A e- 11M CALVERT CLIFFS NUCLEAR POWER PLANT TECHNICAL PROCEDURE ENGINEERING TEST PROCEDURE UNIT 0 ETP 97-064R CONTROL ROOM HVAC SYSTEM INLEAKAGE TEST REVISION 0 Effective Date I/1/// /I Safety RelatedX Non-Safety Related Writer D. T. McElheny Sponsor V. P. Spunar Appi

A,,- /. - C4aA.' 4q, 7 Aia. 1/-3

45) .//

NUCON International, Inc. TELEPHONE: (8-14) 846-5710 OUTSIDE OHIO: 1-800-992-5192 I:' P.O. BOX 29151 7000 HUNTLEY ROAD COLUMBUS, OHIO 43229 U.S.A.

FAX: (614) 431-0858 Control Room Inleakage Test Report performed for:

Baltimore Gas and Electric Company Calvert Cliffs Nuclear Power Station 1850 Calvert Cliffs Pkvwy.

Lusby, Maryland 20657 P.O. No. 16582

-~20 April 1998--

Distribution:

BG&E:

. Dale McElheny (1)

NUCON:

12BG847 IVIF (1)

Field Test (1 QA (1)

M~arketing (I)

NUCONL 12BG847 /02

i2.5- /(Y

.FT-86 (Rev. 1 10/97) A CU #11 Trip 2 Test wITemporar ModiicationIn-Place Attachment 2 Page 37 of 40 Decay Test Data Estimated duration cif test: 120 minutes Beginning concentra tion (Ct): 37.5 ppb*

Endipg concentratioi a (C(O)): 9.2 Bib Time at start of test: Time "zero" for decay test was at 01:15 hrs on 12 Feb 98 Time at end of test: 03:15 hrs on 12 Feb 98 Sample time intervalIs:.. 20 minites annart Time / Sample Concentration Time/Conc. Time/Conc. Time/Cone. Time/Conc.

1:15 /37.5 I

/ l /

1:35 /28.1

/

1:55 / 24.7 1. /

2:15 /19.3 _/ _ I 2:35 /15.7

__ _ /

- -- 2:55 /11.7 -_ I 3:15 / 9.2 (A) Air Change Rate (min-) (Q)Inleakage Flow Rate (CFM) 0.0115 2,900 95% Confidence Limit 95% Confidence Interval (A)= 0.0115 A .0010 2650 <Q< 3150 Comments: DecaU samples taken at a sample port on the discharge of #1 1 return fan. All sample concentrations in the pub range.

Test personnel signature(s) and date: NUCON International Inc.

P5ea/1f FT-86 (Rev. 1 10/97) ACU#12 Tri 2 Test wITemporarvModificationIn-place Attachment 2 Page 37 of 40 Decay Test Data

'Estimated duration c)ftest: 120 minutes Beginning concentra ation (Ct): 37.5 pPb Ending concentratio n (C(O)): 9.2 ppb Time at start of test: Time "zero" for decay test was at 21:25 hrs. on 11 Feb 98 Time at end of test: 23:25 hrs. on 11 Feb 98 Sample time interva Is: 20 minutes apart Time / Sample Concentration

Time/Cone. Time/Conc. Time/Conc. Time/Conc.

21:25 / 37.6

/

21:45 /30.2 I 22:05 /25.2

I. I/

22:25 / 22.7 / /

22:45 / 15.5 /

/ /

23:05/ 13.4 * ./

/ I 23:25/ 10.5 (A) Air Change Rate (1/min) (Q) Inleakage Flow Rate (CEM) 0.0109 2,750 95% Confidence Limit 95% Confidence Interval (A)= 0.0109 + .0015 2370 < Q< 3130.

Comments: Decay samples taken at a sample port on the discharge of #12 return fan. All sample concentrations in the vob range.

Test personnel signature(s) and date: NUCON International Inc.

x5c /(G

.. CALVERT CLIFFS NUCLEAR POWER PLANT TECHNICAL PROCEDURE IF.

ENGINEERING TEST PROCEDURE 1,*A q UNIT 0 ETP 97-064R CONTROL ROOM HVAC SYSTEM INLEAKAGE TEST )O _V(

REVISION I Effective Date i/i/F/o Safety Related X Non-Safety Related CONTROLLED COPY Writer. D.T. McElheny Sponsor: T. R. Lupold

C40'66y A/lb. D.04ac2J/7

/1-7* *e44 / .

TELEPHONE: (614) 846-5710 NUCON International, Inc. TOLL FREE: 1-800-992-5192 P.O. BOX 29151 7000 HUNTLEY ROAD FAX: (614) 431-0858 COLUMBUS, OHIO 43229 U.S.A. WEB SITE: www.nucon-Int.com Eol Control Room Inleakage Test Report performed for:

Baltimore Gas and Electric Company Calvert Cliffs Nuclear Power Station 1850 Calvert Cliffs Pkwy. I Lusby, Maryland 20657 P.O. No. 16582 3 March 2000 I

Distribution:

BG&E:

Dale McElheny (1)

NUCON:

12BG658 MF (1)

Field Test (1)

QA (1)

Marketing (1)

NUCON 12BG658 /01

q040Y -Ao P,5es 1/E FT-86 (Rev. 1 10/97) BG&E ETP-97-064R-REV1 Attachment 2 Page 37 of 40 Decay Test Data Estimated duration c)f test: 180 minutes Beginning concentrnition (Ct): 51.4 ppb Ending concentratio n (C(O)): 13.2 ppb Time at start of test: Time "zero" for decay test was at 01:05 hrs. on 26 Jan 00 Time at end of test: 04:05 hrs. on 26 Jan 00 Sample time interva LIs:

.. . 15 nminutes anart Time i Sample Concentration Time/Conc. Time!Cone. *Time/Conc. Time/Conc.

120/23.8 _/_ /

30/ 51.4 135/21.0 */ /

45/ 47.6 150/17.8 60/41.9 165/16.4 - /

75/ 33.0 180/13.2 / /

90/ 30.7 */ /

/

105/29.3 /

I (A) Air Change Rate ( 1/min) (Q) Inleakage Flow Rate (CFAMI) I 0.00896

2600 95% Confidence Limit

95 % Confidence Interval (A) = 0.00896 i 0.00065 2400 < Q < 2800 Comments: Decay samples taken at a sample port on the discharge of #12 return fan. All sample concentrations in the Ppb range.

Test e sntu ) date Ap Oand Test personnel signature(s) and date: NUCON Intemnational Inc.

P45 a 119 FT-86 (Rev. I 10/97) BG&E ETP-97-064R-REVI Attachment 2 Page 37 of 40 Decay Test Data Estimated duration of test: 180 minutes

Beginning concentration (C0): 59.2 ppb ), 15 minutes into test Ending concentration (C(O)): 8.8 ppb Q 195 minutes into test Time at start of test: Time "zero" for decay test was at 23:35 hrs. on 26 Jan 00 Time at end of test: 03:00 hrs. on 27 Jan 00 Sample time intervals: 15 minutes apart to 105 minutes then ( 140. 165, and 195 minutes Time / Sample Concentration Time/Cone. Time/Cone. Time/Cone. Time/Conc.

15/59.2 165/13.8 I I 30/52.5 195/8.8 45/42.8 I

.I I 60/40.2 I 75/36.1 / /

105 /26.2 / /

140/ 17.4 * /

(A) -Air Change Rate ( I/min) (Q) Inleakage Flow Rate (CFmA 0.0103 3000 95% Confidence Limit 95 % Confidence Interval (A)= 0.0103 i 0.00085 2750 < Q < 3250 Comments: Decay samples taken at a sample port on the discharge of #1I return fan. All sample concentrations in the ppb range.

Te s s nn Test personnel signature(s) and date: NUCON Intemnational Inc.

CA06454 Rev.000 Page 120 of 125 ATTACHMENT AC ETP 01-035R PERFLUOROCARBON TRACER GAS TESTING

pa:0,yo Ar20 CALVERT CLIFFS NUCLEAR POWER PLANT TECHNICAL PROCEDURE ENGINEERING TEST PROCEDURE UNIT 0 .

ETP 01-035R PERFLUOROCARBON TRACER GAS TESTING REVISION 0 I

Effective Date _/_____

Safety Related x Non-Safety Related Writer D.T. McElheny Sponsor: M.AS Junge Approved t4 g I Daft-e Date

~...

. JLL 29 102 03: 37PM BNL TAS/'CD 426P I . . , . P. 114

. . .1 .

'%. IV-TRACERV'L1CkLVOLOGY ETR.

BROOKI~AEN NATIONALLBRTR

fATE;' JuV29, 2002

-TO: JOETTi.W.ynn Jr.

AUXc ;iystems r-ngr Unit Calvert Cliffss Nuclear Power Plant.

Lusby, MD 20657 FAX-NO: (410) 495 - 4727 MESSAGE:

John, I'm on vacation this week but wanted to send you the final result but Without my final assessment. Remarkably, total inleakage was 2930 A 185 cdn. Otf ei flows, i &dnj were-Zone Frow/o . ;-:CRdekg .%/oftoltal .-CRo eatle 'Sooft6ow

. A, . -.

Oatside.- _... "1866:+/- A? , 6

.2 AB 366*243 .23

. . .3 TB -'." :.466+/-+-172. .16 599X4; It ;20

.4 W MSIV8. 272 +/-134 9 :. . 44 33 .

5 ACI l... 7 ..274*. 33 9 6 ACW 1 .' 3874 38 L

.7 SWGRS 81-8:.1l14 28 ...;2'1*&10-More next week. I'l1 put a copy in the mailalso.

Total no. of pages including this cover page:

From- Russell N. Dietz - Head Tracer Technology Center. Fax(6 l~ 3 W42887~.

Atmospheni&cSciences Divisdion.

Brookhaven National Laboratory -1,E minil: ditz 'l.gov, Bldg 815E Secretary-i Barb=ral. 1Roland Upton, NY 11973-5000 Seicretaryls email:.ro1aiid~bn1.gov

. I. .

. JI1 Z9 '02 '03:37PM Bb:D~ ECD 426 . * :.' *:* .** P. 2/4

. . .339^-^ Xi~l * - 36:28

-t1-2. 07-26-2002 PROJECT: CALVRRT~ CLIFFS START:'09:0;06 o-06-'90):. 2Lmi-*'A HOUSE:CALVERT CLIFFS -STOP: 10:00 (06--1.8-1:SO2) . ANALYZED: 06-27-1902

-7RALL AIRFEXCHANIGE RATE-:SlSB 141. 5(1fm ONEA10 Z SOUCE-A - MULRTION -L-INFILIAION- -b

.1 GR . %S 0. I {4? 3ii .Sa4-a9 S wd 379 .6 Ot 5' 0

-2 ABn "103858.0 4. 973219} 30896.'3' 1'104-98:6t 390. L6$. .8 338 .BYo38700 .C)12 /%o33959361 41.1130O .1 888191.1 %4i37:3.:8 "(03445.6 il .482 .0 4svs 9458.0 4 189t594 22087.4 5 05~68.3 .5694.9 . 8281.4 XS~ 4. 658 .6.77 91No.'ll AC %2150.0 1 132691, 308iS .8 3244' 16 3222i. 2. 3346.5 1D .042 2 .1 6 No .13 A` 6 .4 30 12620 14492. 4 -1194.7 -891:2. 2P 1907.4 2 .460 0. 541 7 SWMRs 93.2 10 6435. 3381.7 10458.4 165i98 .8 1527 .7 2 .3-4B 0 .246 ZOEZOE _ 72 RAT SD m. /h9)

X.227.2 ZONE-ZONE 6RATE; sZ,$SD.(m/)

-. 46.. 3241 3. . . ..

341703 4 9s114a3 .64 3-, j, 65 ;

3 .7 163Bq 1 15;.6 5 3 a) 3 3` 3 2150.49 133146.4.7" 126145.1'. .'2%1138.57 2 53-0_1 4 '69 ; ~ i 34:.

7 486

.2 5, 312 1 34 .8 5 2 52 66(0'71.' ;~ 5 15.4 J.,

6 .7 551.1 :S05 .4wS) :!

3OE -AS: 16D m3fh4 1.;A; g Dh. ZO::BE¢ SD 807:,#h 2AC5.2~

a 8162 1651.24 0: 34 ;3i1. 1002O.9 424.18 6 )'

_ .7T' 38 D29 .57 .0;. .5. 5.743; 139;w8.1 1 1)38

12. 6.' 6 4'- 75 3 .50 .

. 309-415 57 I 40p5- ! O 3446 q0 0.11.3 ;11016q007 ;9 125.91 021q0.007 .08g*

o5300 7 2.21.d3 O.71y .0 s .8 l16S .0 7.0 .0 - 27.60 0.0 2q0.70 .l

'-PC 7 6ol2 .o l 0.o1 20.196 7.2 8.6 . 2 30.8. .q.9 .70.D .25

.14

~ 0.0 ~ 0OR'01 sooll692 ~ ~ TTA'FO~2 -IN .b!OUST,"0 .6

.03t07g .8 .O .0 ~t iONE R62 AcPE onoq 0.00 0.!29h)' g 3.h4e .2 S001 Z.0.01 .- Ai00SQOl 0t0/h)5 AC 003 .06

7 PCE .f031q0;01 038q013 OlS§004 OO9f135.14% Q.- .Q1 tO40.0~01 '0.827 g 734 0.86 0 0**7, .-

. . 22 ' 4--:, .4.

1. ,

38.9 5 32647.6~~~~~ .. IS29 2.' .7,84 03

4ZY9 4ewwo A1W!

JUL 29 '02 03:38PM ENL DRSiECD 426 CON TRATION(pli/L) P. 3/4 I

I- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

CATSI ptDCH WCP DB T-PtUB PCH ocDCH .IPPCH otWDM wtPDCB 9 27T0CH 4271 7.147 3.899 2.65o 0.637 0.375: b0.09 .0.083 0.000 8;273 71.315. 0,91:j.jEig7 6Bb 7.742 4.630 2.584 1.290 '0.335 O.090 0.115 0.000 2.085 6.U45 0.40D M:D!TED 8149 8107 4.402 2.249 0.733 0.399 0.097 0.096 0.00 9.:463 83B.. C..

12400 9.277 A.610 2.428 0.808 0;4!5 0;iOS: *0I07 ;0.000 10.964 94734-: ;

12921.

L 8.890 i.691 2.325 .0;94. 0.91 0.106 .0L19 0,000 10246 9361 ;234 . :

12055 &689 4 290 2 432 0.B04 0.393 0104 0;122 *0.000 10.329 i5 0.24l>.

.9 .

12631 8322 4.40 2.500 0.777 0.379 0:101 0.123 0.000 9;86 . .8765 *.'232 i0l 8 .262 4.382 2.327 oi 0.758 0.425 0.107. 0.103-. 0.000 9.774 :&.664 0.2932.

12057 . .8.446 4.598 2.370 0.975- 0.389 0,101 0.105 0.000 30.017 8.B83 :.30 11079 7.998 4.410 2.484 0.112. 0.394 0.096 0.096 0.000 9.351 8.289 .0.21.

L 2.169 0.721 0.383 0.093 0.100 0.WQ 6.420 8.346 0.221 4i VI's 040WM.2M8 0.777 0.392 0.100 0.105 0.000 9.924 8;800 0;237.

520 7.126 3.865 2.295 0.657 0.804 0.30! 0.089 0.000 8;413 7.441 0.198.DETED 2268 6.923 4.160 2.469 0.644 0.528 0.110 0.087 P.000 B.174 7.227 0.194 DM-ID 2138 7.555 4.335 2.589 0.698 0.553 0.118 0.096 0.000 5.920 7.996 0.2U1 DETID 3644 8.586 2.498 3.554 0.326 0.184 0.145 0.052 0.00 4.003 3.510 :0.094 DELT, 12.390 0.204 L11B 15.834 0.020 0.015 0.002 0.007 0.000 0Q187 0.164 0.006 DEED 12036 5.449 3.128 7.233 0.502 0.276 0.067 0.065 0.000 6.274 5.52? .00.49 DRLETED I 2302 -12941z.Z 5.221 Q 0.475 nA67& 0.06 0.000 mol 5.2QO 14 DELETE

.O 1.0 l2B3b MN61 3.481 DANS 0.876. 030.1 0.018 000 1.25 l.O9B 0 025 1 EEB

.0~DELETED i7i9 0.031 0.098 2.728 0.014 1.359 0.490 .0.005 -.0000 0.459 0.400 .0.005 DRMED 4627 &552 2.287 1.977 0.323 1.448 0.122 .0.043' 0.000 8.944 3.458 0.092 DELITED 12497 2.791 1.837 1.829 D.249 1.879 .0.106 0.034 0.000 3.014 2.637 0.070 DETED 12188 0O030 11.417 0.020 0.002 0.009 0.001 0.003 . I 0.000 0.000 .. 000 DELE 12063 0.028 10.242 0.141 0.001 0.014 . 0.002 0;007' 0.00 0000 0.000 -0.000 DELEED 12393 0.028 1.611* 1.836 0.098 1.488. 0.33 . 0.000 0.000 0K O.289 0.028 PIMED

.12009 0;079 16.480 0.089 0t076 .0.035 0.011. 0.014 .0;000 0.000 M OD;21; 12264 0.143 35.832 0.214 0.202 0.057 0.013 0.008 O.000 M.OOO. -0.0D.:.C0056-.

12376 0.167 43.634 0.244 0.257 0.03 O.0CS 0.08 0;000 0.000 0.000 b.072 12297 0.52° 14.879 1.321 0.6'8 0.536 0.119 D.009 *,000; .541 .02560 00;201:IE!D 12191.

I69 16.484 1.166 0.639 **X.53 0;ll Q.OO 000 0208 Q;269 . 088-D1E0t 12379. 0.335 30.172 0.222 0.061 'D088 0.012. O.008S. 0.00 0.408 0.357 -. 0!7 12012 1.489 20.586 0.519 0.175 . 0.295 0.030 0.016: 0.000 1.56! M.362 D.049.PDEIED 12244 0.112 25.13 0.138 0.061 0.069 0.003 0.00 O.OOO 0.182 VA160 . 0.017 12155 0.107 26.430 0.094 -.0044 0.031 0.003 0.003 d .OO 0.181 0.159 0.012 12334 0.507 0.312 4.404 0.044 4.923 0.253 .O11 0.000 0.688 0.600 .0.012 DURTED 11218 4.134 2.583 1.088 0.367 0.205 0.049 0.067 . 000 . 4.586 4.026 0.107 DELTED 561 0.053 3.165 0.464 0.092.- 0.219 0.070 0.008 O.000 0.124 0.109 0;025 DE DEI

-201h ~0-22-16ABO MM~ 0.018 0.014 0,012. 0.016 0000 0,i77 07155 O-BE6 11151 0.015 0.204 5.908 D57001 D 0 002 DOtl0.0 L.020 7 0.011 U.002 9590 0.019 OA97 1.035 0.005 . 0.009 0.002 .008 0.0 0 0.025 0.022 0.002 12402 0.020 O.'176 7 297 0.006 0.010 0.002 0.009 0.0 0 0.026 0.023 0.002 12337. 0.014 D.156 6.492 0,004 9.009 0.002 .0.004 0.000 0.020 0.018 fO02' 12417 0.017 0.235 9.217 0.007 0.009 0M003 0.008 0.000 0.024 0.022 :t.002 12425 O.030 0.205 8.388 0.008 0.010. 0.003' 0.005 0,000 0.038' M.03 0&0o3::

1 :2488 .Th062 0.3 15.438 12383 0.15 0.195, 6.342 0009o>.o DADS o 0.007.

0 *;O8 0.00 0.001 .90.

0.00o

'OiTED. 0i064.

. 0000021 020 0-419 002 1220D 0.055 0.320 10.741 0.088. :0.009 O.'a . l 4 8o000- O8. V8056: .0.050 o00 - .

12178 0M013 0.279. 9.691 0.006. 0.009 .001 0205 0.000 U.019 0.017 0 002 . --

12288 V.031 0.S82 12.712 .0013 0.008 0.02 0.011 *0000 0.035 0.031 0-004 D4LETED :. .

IM U 1221 6 ,9 0.227. ; 0 .01 i_ 12156 Q-036 A 7 .1 090 0M P-~

18 0.009 O0 01 081 0.020 9 34D 0.00b U.001 O.UOU O.018 0.011 0;0U6.

i 1319 0.020 0.1& M.490 0.11 0.01? 07.51 O.OOB 0.000 0.B77 O.91 0.00 i 707 0.020 0.128 4.011 0.009 0.021 0 68 0.006 0.000 0.612 .0.534 0.004 19R; Q 014 0.120 3.432 0.009 0Q017 0739 0 005 0000 0'667 0582 0 004 1240 12502 MD01 0.016 0.970

.129 0.178 0 203 0.022 0.010 0.04 0.027 0.009 0.005 0.32b EWUIO .02? 0.025 .0 0.378 0.000 0.034 0.031 0.008 12307 0.024 0.751 0.080 0.015 0.007 0.004 0.399 0.000 0.D40 0.035 0.00e 12300 0.031 0.890 0.095 0.019 0.008 0.004 0.385 0.000 0.046- 0.041 0.006 2158 0.019 0.963 0.182 0.022 0.007 0.005 0.392 0.000 0.038 0.034 0.007

.6706 0.017 0.942 0 173 0.022 O.OOB 0.005 0 389 0.000 0.037 0.033 0,001 7750 0.029 0.728 0.084 0.013 0.007 0.03 0.332 0.00D 0.044 0,039 0.004 1I1RM ( fl I IN n AS LOU 0.000 0.003 0.332 0.000 0.043 _AQ38L1 005

.J.: PXB PEP PCH ocPDC ptPDCH mPDCH PTCH C0EMIXTStiL 0.74 0.74. 0.8- 0.62 .>6,5**.88 0.71 60177 NOTES ill gas volumes are reported.at 21.5 and 1 atm..

'he standard deviation in. the source C. strength has been set'. at' .4 X.

standard deviation in the volume measurement has been Bet at 5 Z.

overall normalized condition number, (X(C)/N^1-5)- 0.429 DCt IN 1l36 condition numbers are:

DN a tonal

'ONE i 'r. 3 4 56 7

Iondition Number 1.083 1.017 1.379 1.248 1. 005 l. 124

1. 044

JUL 29 '02 03:39PM BL. DAS/ECD 426 *P

1 .4/4 w .-

. />g 6 .. . . .

f *- --- -': * --r.o: .': ,: .:

.*.. ~

.1 '~ :-,' ;

ILDW-.UTOS ST.D1 P. * . - - _. :.' .-.

F1L~iN/EXItTRS E . t147 0,1142 9B 2 I.O8 0.0455 1.020 0.0363 .

RK 4 &.258 03540 5 LH.046 0.0108 W 6 0.615 0.1209 iR 7 t.908 15.1200 URZORAL 2, 2- 1 0.839 0.4551

/3-!. 1 1.25 0.9277 * - .-- :; . ',-::

4/ - 1 0.181 0.0969 5/ 5- 1 0.069 Q,0093 . .. ,.... ,., . F -

61 6- 1 .0O.029 0.020 .- - :.

7 7- 1 0.026 0.0122. *. - * . * * -.

3/- 2 *19.743 62994T 4t 4- 2 0.032 4O.1957 .- *. -.

5/ 5 0.036 MM27 . .

6/ 6-2 0.036 0.0723 7/ 7-2 0 903 0.7688 4l 4- 3 !IO.35S 89.6471 5/ 5- 3 0,203 0.1401 6/ 8.392 3.1446 117- 3 0.017 0.0174 . .

0.45 0.2269

-4 6,' - 4 0.017 0.0085 7 7- 4 . -0.057 060552 6 6-5 0.483 0.4655: ..

7/1- 5 0.809 1.8474 7J 7:6. 12.975 396.7011 .. --. ,.... j.-" .

ANDARD DPIATIOX OF ptPDCH is ZORn 2 ISGAM n ,.. . ' .. :. - .-

ABDARD DEIATION OF WtM II ZOxl 3 IS EAm YE ANDARD DHVIATIO 01 ptDC .1 ZOM 4 lS1MTER TH ANMD. DIVIA!IOR Of ptDOB IN 20H 7.'IS mm YB ANDAPDDXVIATION OF P)CP IN ME 2 IS GETR TR AiDAD DEvIAIn OF P0GB I ZON 2 IS REATR i 25.

ANDARD DVIATIOP OF PDCB IN ZONE 4tIS G TE YE AN 25 ANDARD DIEVIATION OF PDU IN ZOK 5 IS GUEAM MADAD DEVIATION OF RODCB 1 ZOE 7 IS EATnR 7iAN25 %

ANDARD DIVIATION OF T-FM IN OMS 2 IS GR.AM I AN25 .

ANDARD DEVIATlN Of 7-PTC IN ZONE 4 18 GAM T A':25 SDARD BVIATIO8 OF T-PTCH ZONE 5IS GRE TR ANDAD EIATIO O P CH INZONE 2IS GAT RAR25X ANDARD )EVIAT10J 0 ?MCH IR ZONE 4IS GATE TR ANDARD DIVATA OF DcD IN ZONE 2 IS RTB R MDAD DEVIATION 01 OTVDCH 1 ZONE 3tIS TER E ANDARD DIATION OF PDCU 1i 20NE 4 IS GRATIR Ti AIDAD DVIATION 0! ocWD INZONE 5 IS CWTER T1As25 X ANDARD DPEIATIN 0F IPPC INZONI 2 15 WITHER TH

'IDDIVIATION OF IMPCI INZE 3 IS GTMTHI h DEVIATIOt OF iMC INZONE 5 IS GRIAI THI

ML053220421

Text

Title:

Navigation menu

Search